≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Urethritis and urethral syndrome

DOID EFO Endpoint Browser PheWeb

N14_URETHRITISANDURSYNDR

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — N34
  • Hospital discharge: ICD-8 — 597
  • Cause of death: ICD-10 — N34
  • Cause of death: ICD-8 — 597

2 out of 7 registries used, show all original rules.

923

4. Check minimum number of events

None

923

5. Include endpoints

None

923

6. Filter based on genotype QC (FinnGen only)

870

Control definitions (FinnGen only)

Control exclude
N14_URINOTH

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
N30-N39
Name in latin
Urethritis et syndroma urethrale

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 7952 4797 3097
Only index persons 6830 4132 2698
Unadjusted period prevalence (%)
Whole population 0.12 0.14 0.09
Only index persons 0.13 0.15 0.10
Median age at first event (years)
Whole population 41.23 46.64 32.80
Only index persons 38.67 43.51 31.27

-FinnGen-

Key figures

All Female Male
Number of individuals 870 569 301
Unadjusted period prevalence (%) 0.18 0.20 0.14
Median age at first event (years) 43.40 45.16 40.07

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
923
Matched controls
9230
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N34.3
ICD-10 Finland
Urethral syndrome, unspecified
5597.3
307.7
365
*
UKC02
NOMESCO Finland
Cystoscopy
21.2
307.7
441
382
N30.0
ICD-10 Finland
Acute cystitis
+∞
290.4
263
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
15.7
273.9
270
237
N34.1
ICD-10 Finland
Nonspecific urethritis
980.4
238.8
224
*
R30.0
ICD-10 Finland
Dysuria
20.6
220.6
178
106
TKD00
NOMESCO Finland
Dilatation of urethra
425.9
205.6
199
6
XKD00
NOMESCO Finland
Uroflowmetry
8.6
160.8
241
363
N30
ICD-10 Finland
Cystitis
+∞
142.5
133
*
N30.9
ICD-10 Finland
Cystitis, unspecified
+∞
141.4
132
*
J01EA01
ATC
trimethoprim; systemic
5.6
140.5
391
1073
N34.2
ICD-10 Finland
Other urethritis
490.7
131.5
128
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
7.4
118.3
197
328
U01
ICPC
Dysuria/painful urination
9.3
112.6
147
184
R35
ICD-10 Finland
Polyuria
9.2
109.0
143
180
J01MA02
ATC
ciprofloxacin; systemic
4.3
105.1
491
1935
U07
ICPC
Urine symptom/complaint other
8.2
101.1
147
209
N30.1
ICD-10 Finland
Interstitial cystitis (chronic)
+∞
98.7
93
*
G04BD07
ATC
tolterodine; oral
10.4
88.5
103
110
N39.3
ICD-10 Finland
Stress incontinence
16.3
85.4
74
49
J01CA08
ATC
pivmecillinam; oral
3.7
84.6
504
2258
U02
ICPC
Urinary frequency/urgency
5.1
83.7
207
493
KCV04
NOMESCO Finland
Distension of bladder with fluid
137.0
82.5
87
7
XKC03
NOMESCO Finland
Water cystometry
31.8
82.4
54
18
59709
ICD-8 Finland
Urethritis (non-venereal), Unspecified
+∞
80.4
76
*
G04BD12
ATC
mirabegron; oral
5.9
79.6
160
316
N39.4
ICD-10 Finland
Other specified urinary incontinence
8.7
78.9
106
136
G04BD04
ATC
oxybutynin; oral, transdermal
8.2
77.8
110
150
G04BD08
ATC
solifenacin; oral
8.0
66.4
95
131
U71
ICPC
Cystitis/urinary infection other
7.3
65.3
101
152
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
3.3
60.8
322
1288
59700
ICD-8 Finland
Urethritis (non-venereal), Acuta
+∞
60.1
57
*
U05
ICPC
Urination problems other
7.7
59.4
87
123
TKC20
NOMESCO Finland
Catheterisation of bladder
6.0
57.2
108
199
J02AC01
ATC
fluconazole; systemic
3.0
57.2
473
2418
J01MA06
ATC
norfloxacin; oral
4.0
56.5
185
538
R33
ICD-10 Finland
Retention of urine
6.0
55.7
105
193
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
4.3
55.4
165
447
U13
ICPC
Bladder symptom/complaint other
14.6
54.8
50
36
XKD06
NOMESCO Finland
Physiologic investigation of micturition
15.9
54.0
47
31
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.8
50.3
426
2167
R10.2
ICD-10 Finland
Pelvic and perineal pain
8.7
47.5
62
76
N34.0
ICD-10 Finland
Urethral abscess
+∞
47.3
45
*
R30.1
ICD-10 Finland
Vesical tenesmus
11.0
45.9
50
48
U29
ICPC
Urinary symptom/complaint other
9.4
42.8
52
58
G04BD11
ATC
fesoterodine; oral
14.2
40.1
37
27
R31
ICD-10 Finland
Unspecified haematuria
4.4
39.2
107
269
1530
FHL
Urethrocystoscopy
12.7
38.6
38
31
N30.2
ICD-10 Finland
Other chronic cystitis
+∞
37.8
36
*
A02BC05
ATC
esomeprazole; systemic
2.4
37.2
439
2520
J01MA12
ATC
levofloxacin; systemic
3.0
37.2
205
813
A06AC01
ATC
ispaghula (psylla seeds); oral
2.6
36.8
297
1431
N03AX16
ATC
[U] pregabalin
2.7
36.4
260
1179
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
36.0
316
1582
N94.1
ICD-10 Finland
Dyspareunia
11.3
35.7
38
35
J01XE01
ATC
nitrofurantoin; oral
10.4
35.6
40
40
N06AA09
ATC
amitriptyline; systemic
3.5
34.9
131
412
R53
ICD-10 Finland
Malaise and fatigue
2.5
34.6
288
1403
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.9
33.0
76
166
J01MA01
ATC
ofloxacin; systemic
3.8
33.0
111
324
G04CA02
ATC
tamsulosin; oral
2.8
32.2
197
821
A02BC02
ATC
pantoprazole; systemic
2.4
32.1
672
4820
G04BD09
ATC
trospium; oral
11.8
31.9
33
29
204
Kela drug reimbursment
Leukemia lymphatica
5.9
31.3
58
104
G04AC01, ,
ATC
6.4
30.8
52
85
R30.9
ICD-10 Finland
Painful micturition, unspecified
36.9
30.8
39
11
N02AX02
ATC
tramadol; systemic, rectal
2.2
30.6
429
2590
59702
ICD-8 Finland
Urethritis (non-venereal), Chronica
+∞
30.4
29
*
G04AB05, ,
ATC
7.7
30.3
43
58
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.3
29.5
296
1551
N03AX12
ATC
[U] gabapentin; oral
2.7
29.2
184
775
N06AX21
ATC
duloxetine; oral
3.0
29.2
148
555
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.3
29.1
296
1558
XKD03
NOMESCO Finland
Urethral pressure profilometry
45.4
28.9
35
8
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.5
28.5
216
996
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
5.0
28.2
62
130
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.5
28.1
214
988
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.8
27.9
158
629
N76.0
ICD-10 Finland
Acute vaginitis
3.7
27.6
94
276
J01DB01
ATC
cefalexin; oral
2.8
27.1
792
6319
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.1
25.9
436
2771
M79.7
ICD-10 Finland
Fibromyalgia
5.1
25.8
56
116
SPAT1167
SPAT
Insertion of urinary catheter
6.8
25.7
41
63
R07.4
ICD-10 Finland
Chest pain, unspecified
2.2
25.5
288
1569
P01AB01
ATC
metronidazole; oral, rectal
2.1
24.8
405
2534
UJF32
NOMESCO Finland
Coloscopy
2.3
24.8
255
1335
N06AX11
ATC
mirtazapine; oral
2.1
24.7
347
2054
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
24.0
256
1359
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
89.2
23.8
26
*
A02BC03
ATC
lansoprazole; oral
2.1
23.8
291
1630
M79.6
ICD-10 Finland
Pain in limb
2.0
23.5
439
2868
D01
ICPC
Abdominal pain/cramps general
2.6
23.5
150
632
N30.8
ICD-10 Finland
Other cystitis
+∞
23.0
22
*
R52.9
ICD-10 Finland
Pain, unspecified
2.8
23.0
123
473
N05BA04
ATC
oxazepam; oral
2.2
22.9
270
1486
K30
ICD-10 Finland
Functional dyspepsia
2.7
22.8
136
553
Z3231
NOMESCO Finland
Registered nurse
2.2
22.8
268
1474
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.5
22.8
159
699
J02AC02
ATC
itraconazole; systemic
2.4
22.6
186
882
A04
ICPC
Weakness/tiredness general
2.4
22.3
176
819
R39.1
ICD-10 Finland
Other difficulties with micturition
5.8
22.0
41
74
M01AH01
ATC
celecoxib; oral
2.3
21.8
187
901
KDW96
NOMESCO Finland
Other operations on urethra
225.1
21.7
22
*
N35.9
ICD-10 Finland
Urethral stricture, unspecified
117.8
21.7
23
*
U72
ICPC
Urethritis
8.5
21.5
28
34
G01AF05
ATC
econazole; vaginal
3.1
21.4
94
323
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.8
21.1
118
464
X15
ICPC
Vaginal symptom/complaint other
4.1
21.0
60
155
R06.0
ICD-10 Finland
Dyspnoea
2.1
20.9
272
1548
LEG10
NOMESCO Finland
Vaginal urethrocystopexy
112.6
20.6
22
*
R06AX27
ATC
desloratadine; oral
2.0
20.4
302
1796
K59.09
ICD-10 Finland
Constipation, unspecified
3.4
20.4
75
231
A02BA02
ATC
ranitidine; systemic
2.2
20.3
199
1013
J01MA04
ATC
enoxacin; oral
8.6
20.2
26
31
M54.5
ICD-10 Finland
Low back pain
1.9
20.2
364
2317
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
3.2
20.1
82
269
A02BC01
ATC
omeprazole; systemic
2.0
20.1
269
1543
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
3.3
20.0
79
254
D06
ICPC
Abdominal pain localized other
2.9
19.8
102
383
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.5
19.8
143
637
Z3226
NOMESCO Finland
Physiotherapist
2.3
19.7
181
896
R32
ICD-10 Finland
Unspecified urinary incontinence
6.8
19.7
31
47
JAH01
NOMESCO Finland
Laparoscopy
3.8
19.7
62
172
A01
ICPC
Pain general/multiple sites
2.6
19.6
121
500
M79.0
ICD-10 Finland
Rheumatism, unspecified
4.4
19.2
49
116
N02BF01
ATC
gabapentin; oral
2.7
19.1
115
469
M70.6
ICD-10 Finland
Trochanteric bursitis
2.4
18.8
145
664
N36.1
ICD-10 Finland
Urethral diverticulum
+∞
18.8
18
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.4
18.8
141
638
N02AJ06
ATC
codeine and paracetamol; systemic
1.9
18.7
406
2729
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.2
18.6
181
915
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
193.8
18.6
19
*
C05AA08
ATC
fluocortolone; rectal, topical
2.4
18.5
138
623
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.9
18.5
426
2914
J01AA02
ATC
doxycycline; systemic
2.1
18.4
714
5765
Z2221
NOMESCO Finland
Medical doctor
2.0
18.4
263
1537
R52.2
ICD-10 Finland
Other chronic pain
4.1
18.4
51
129
H04.10
ICD-10 Finland
Dry eye syndrome
2.4
18.3
134
600
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
22.2
18.2
26
12
N05AH04
ATC
quetiapine; oral
2.2
18.2
185
951
N06AX16
ATC
venlafaxine; oral
2.3
18.2
156
748
M01AH05
ATC
etoricoxib; oral
1.9
18.1
590
4484
ZX136
NOMESCO Finland
Intravesicalis
33.6
18.0
23
7
G04CA01
ATC
alfuzosin; oral
2.7
17.9
105
422
M79.1
ICD-10 Finland
Myalgia
2.2
17.8
168
838
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.4
17.8
136
620
N02BF02
ATC
pregabalin; oral
3.0
17.5
80
281
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.6
17.4
109
452
M25.5
ICD-10 Finland
Pain in joint
1.9
17.4
328
2096
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
17.3
495
3594
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.0
17.2
247
1440
H02AB06
ATC
prednisolone; systemic
1.8
17.1
440
3088
L03
ICPC
Low back symptom/complaint
1.9
17.1
287
1765
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.6
17.0
103
421
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
19.7
16.9
25
13
A07AA02
ATC
nystatin; oral
3.2
16.9
69
227
7362
FHL
Urethral dilatation in anesthesia or operating room
+∞
16.7
16
*
R01AD09
ATC
mometasone; nasal
1.8
16.7
432
3031
M03BC01
ATC
orphenadrine (citrate); systemic
2.0
16.6
221
1255
L28
ICPC
Limited function/disability (L)
2.1
16.5
173
898
G44.2
ICD-10 Finland
Tension-type headache
2.2
16.5
150
736
F45.8
ICD-10 Finland
Other somatoform disorders
2.8
16.5
87
331
R4110
NOMESCO Finland
Physiotherapy
1.9
16.4
258
1550
G03CA04
ATC
estriol; systemic, vaginal
3.0
16.3
77
275
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
16.3
423
2963
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
3.0
16.3
76
270
J01DA01
ATC
[U] cefalexin
1.8
16.1
571
4376
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
5.7
16.1
30
54
R51.80
ICD-10 Finland
Headache
2.1
16.0
169
880
R42
ICD-10 Finland
Dizziness and giddiness
2.0
15.9
220
1262
D11
ICPC
Diarrhoea
2.3
15.9
128
596
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.0
15.8
208
1174
R07.0
ICD-10 Finland
Pain in throat
2.8
15.8
83
315
59708
ICD-8 Finland
Urethritis (non-venereal), Alia definita
+∞
15.7
15
*
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
86.6
15.6
17
*
Z71.8
ICD-10 Finland
Other specified counselling
1.8
15.5
322
2104
H02AB07
ATC
prednisone; oral
2.3
15.5
136
657
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.3
15.4
130
617
R03AC02
ATC
salbutamol; inhalant
1.8
15.4
521
3918
R01AD08
ATC
fluticasone; nasal
1.9
15.4
274
1707
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
23.8
15.2
21
9
J01MA14
ATC
moxifloxacin; systemic
2.6
15.1
92
376
Z01.2
ICD-10 Finland
Dental examination
1.7
15.1
434
3112
J01FA10
ATC
azithromycin; systemic
1.8
15.1
539
4108
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
15.0
477
3514
R11
ICD-10 Finland
Nausea and vomiting
2.5
15.0
96
402
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
4.3
15.0
39
94
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.0
15.0
70
249
N06AB04
ATC
citalopram; systemic
2.0
14.9
198
1118
U04
ICPC
Incontinence urine
3.6
14.9
50
145
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.7
14.8
506
3798
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.5
14.8
102
442
D07AD01
ATC
clobetasol; topical
2.1
14.7
167
892
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.2
14.5
58
188
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.4
14.5
110
499
R51.81
ICD-10 Finland
Facial pain NOS
4.3
14.2
37
89
N05CF01
ATC
zopiclone; oral
1.8
14.2
292
1892
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.8
14.2
43
116
7325
FHL
Bladder stretching
43.2
14.1
17
*
N94.2
ICD-10 Finland
Vaginismus
43.2
14.1
17
*
R01AD12
ATC
fluticasone furoate; nasal
1.8
14.1
299
1957
ZXE00
NOMESCO Finland
One hour or less
1.7
14.0
342
2327
R01AD58
ATC
fluticasone, combinations; nasal
1.8
14.0
244
1503
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.4
13.9
102
455
K10.3
ICD-10 Finland
Alveolitis of jaws
3.1
13.8
58
194
A03CA02
ATC
clidinium and psycholeptics; oral
3.1
13.8
60
205
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
13.7
208
1225
R03BA05
ATC
fluticasone; inhalant
2.0
13.6
184
1042
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
2.0
13.6
174
968
5951A
ICD-9 Finland
Cystitis, Chronic interstitial cystitis
+∞
13.6
13
*
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
4.0
13.5
38
97
R12
ICD-10 Finland
Heartburn
2.5
13.5
87
365
A06AD11
ATC
lactulose; oral
2.2
13.5
131
657
J01FF01
ATC
clindamycin; systemic
1.8
13.4
243
1512
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.9
13.3
186
1065
K07.60
ICD-10 Finland
Snapping jaw
2.9
13.3
62
220
A03FA02
ATC
cisapride; oral, rectal
2.7
13.3
74
289
S01GX01
ATC
cromoglicic acid; ophthalmic
1.9
13.2
201
1183
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.5
13.2
86
363
H57.1
ICD-10 Finland
Ocular pain
3.3
13.1
51
163
G43.9
ICD-10 Finland
Migraine, unspecified
2.7
13.0
72
280
N06AX26
ATC
vortioxetine; oral
2.5
13.0
84
353
A99
ICPC
Disease/condition unspecnature/site
2.3
13.0
106
495
J01XX05
ATC
methenamine; oral
13.2
13.0
22
17
N41.1
ICD-10 Finland
Chronic prostatitis
5.1
13.0
27
54
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
12.9
196
1153
C07AA05
ATC
propranolol; systemic
1.9
12.9
201
1193
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.9
12.8
209
1257
TKC22
NOMESCO Finland
Catheterisation instruction
10.7
12.8
24
23
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.7
12.8
388
2785
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.8
12.8
275
1798
A06AC51
ATC
ispaghula, combinations; oral
3.1
12.8
53
176
H92.0
ICD-10 Finland
Otalgia
2.7
12.6
68
261
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
70.9
12.6
14
*
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.0
12.6
158
871
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
12.5
323
2217
N34
ICD-10 Finland
Urethritis and urethral syndrome
+∞
12.5
12
*
G01AA10
ATC
clindamycin; vaginal
2.1
12.5
135
705
A02BC04
ATC
rabeprazole; oral
2.3
12.5
96
437
R13
ICD-10 Finland
Dysphagia
2.6
12.4
74
299
AA1AD
NOMESCO Finland
CT of head and brain
1.8
12.4
244
1552
M94.0
ICD-10 Finland
Chondrocostal junction syndrome [Tietze]
4.3
12.3
32
77
M03BX02
ATC
tizanidine; oral
1.7
12.3
554
4385
K21
ICD-10 Finland
Gastro-oesophageal reflux disease
2.7
12.3
70
277
KCW96
NOMESCO Finland
Other operations on bladder
38.1
12.2
15
*
N06AB06
ATC
sertraline; oral
2.1
12.2
120
604
N06AB10
ATC
escitalopram; oral
1.9
12.2
188
1109
N04BC05
ATC
pramipexole; oral
2.5
12.2
76
314
N02BE01
ATC
paracetamol; systemic, rectal
2.1
12.2
813
7188
J05AB01
ATC
aciclovir; systemic
1.8
12.2
210
1283
SPAT1263
SPAT
Sampling
1.7
12.1
367
2624
N76.8
ICD-10 Finland
Other specified inflammation of vagina and vulva
5.3
12.1
24
46
JN3AD
NOMESCO Finland
Abdominal CT examination
2.1
12.0
118
594
R20.2
ICD-10 Finland
Paraesthesia of skin
2.6
12.0
73
298
G01AF04
ATC
miconazole; vaginal
3.1
12.0
52
177
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.0
12.0
134
708
R50.9
ICD-10 Finland
Fever, unspecified
2.0
12.0
133
701
R02
ICPC
Shortness of breath/dyspnoea
2.1
12.0
126
651
L29.2
ICD-10 Finland
Pruritus vulvae
4.6
12.0
28
62
WX110
NOMESCO Finland
Infiltration anesthesia
1.7
11.9
646
5341
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
47.3
11.9
14
*
D19
ICPC
Teeth/gum symptom/complaint
1.7
11.9
295
1999
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.2
11.9
111
548
R05
ICPC
Cough
1.8
11.9
238
1520
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
11.8
274
1823
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
5.2
11.8
24
47
UJF30
NOMESCO Finland
Ileoscopy through colon
2.2
11.8
100
475
S29
ICPC
Skin symptom/complaint other
1.8
11.7
189
1130
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.3
11.7
91
416
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
2.2
11.7
105
510
R30
ICD-10 Finland
Pain associated with micturition
30.5
11.7
15
5
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.3
11.7
93
430
WX320
NOMESCO Finland
Spinalanesthesy
1.8
11.6
216
1348
N36.2
ICD-10 Finland
Urethral caruncle
65.8
11.6
13
*
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.4
11.6
84
372
XF402
NOMESCO Finland
ECG with work load test
2.3
11.6
95
444
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.7
11.6
267
1772
SHA01
NOMESCO Finland
Stomatognathic treatment, simple
2.1
11.5
113
569
N17
ICPC
Vertigo/dizziness
2.1
11.5
125
654
N36.8
ICD-10 Finland
Other specified disorders of urethra
121.5
11.4
12
*
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
11.4
181
1076
K59.1
ICD-10 Finland
Functional diarrhoea
2.7
11.4
61
234
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.7
11.3
243
1579
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
2.1
11.3
114
580
N05CF02
ATC
zolpidem; oral
1.9
11.2
165
957
A11
ICPC
Chest pain NOS
2.4
11.2
82
365
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.4
11.1
77
334
L13
ICPC
Hip symptom/complaint
1.8
11.1
177
1054
R07.3
ICD-10 Finland
Other chest pain
2.1
11.0
105
522
R60.9
ICD-10 Finland
Oedema, unspecified
2.8
11.0
55
203
WZC00
NOMESCO Finland
Treatment plan or consultation
1.6
11.0
328
2322
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
11.0
179
1072
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.5
10.9
70
293
SAA01
NOMESCO Finland
Simple examination of mouth
1.7
10.9
654
5478
H02AB04
ATC
methylprednisolone; systemic
2.0
10.9
133
724
N77.1*B37.3
ICD-10 Finland
Candidiasis of vulva and vagina
4.3
10.9
28
67
WX002
NOMESCO Finland
Sedation and analgesia
1.9
10.8
162
944
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.3
10.8
83
377
X59
ICD-10 Finland
Exposure to unspecified factor
1.8
10.8
173
1030
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.9
10.8
145
816
A01AB09
ATC
miconazole; local oral
2.3
10.7
87
405
A01AB04
ATC
amphotericin B; local oral
2.8
10.7
53
195
N03AE01
ATC
clonazepam; systemic
2.6
10.6
60
236
R96
ICPC
Asthma
2.2
10.6
97
474
L17
ICPC
Foot/toe symptom/complaint
1.7
10.6
273
1859
M54
ICD-10 Finland
Dorsalgia
2.0
10.6
117
615
M54.4
ICD-10 Finland
Lumbago with sciatica
1.8
10.6
166
982
N81.6
ICD-10 Finland
Rectocele
2.7
10.6
58
225
M01AB05
ATC
diclofenac; systemic, rectal
1.6
10.6
577
4704
KH1AD
NOMESCO Finland
CT of urinary organs
3.6
10.6
34
96
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
3.3
10.5
40
126
H01
ICPC
Ear pain/earache
2.0
10.5
116
610
N35.8
ICD-10 Finland
Other urethral stricture
+∞
10.4
10
*
6256A
ICD-9 Finland
Pain and other symptoms associated with female genital organs, Stress incontinence, female
+∞
10.4
10
*
59701
ICD-8 Finland
Urethritis (non-venereal), Recidivans
+∞
10.4
10
*
J01CA04
ATC
amoxicillin; systemic
1.8
10.4
741
6446
M01AE02
ATC
naproxen; oral, rectal
1.6
10.4
509
4038
SFA10
NOMESCO Finland
One-surface restoration
1.6
10.4
495
3902
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
32.9
10.3
13
*
M01AH02
ATC
rofecoxib; oral
2.0
10.3
116
613
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
10.3
132
731
N03AX09
ATC
lamotrigine; oral
2.8
10.3
53
199
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
10.3
134
746
K08.80
ICD-10 Finland
Toothache NOS
2.2
10.3
95
467
M54.1
ICD-10 Finland
Radiculopathy
3.1
10.2
43
144
L01
ICPC
Neck symptom/complaint
1.8
10.2
158
930
J01FA06
ATC
roxithromycin; oral
1.6
10.2
350
2554
D06AX01
ATC
fusidic acid; topical
2.1
10.1
94
463
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
4.5
10.1
24
54
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.7
10.1
56
219
A97
ICPC
No disease
1.8
10.0
182
1123
J01DA09
ATC
[U] cefadroxil
1.7
9.9
233
1545
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
4.0
9.9
28
72
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
4.0
9.9
28
72
R51
ICD-10 Finland
Headache
2.5
9.9
62
257
S21
ICPC
Skin texture symptom/complaint
1.9
9.9
138
786
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
2.1
9.8
97
489
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
4.8
9.8
22
47
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
9.8
215
1400
M01AE03
ATC
ketoprofen; systemic, rectal
1.6
9.6
311
2230
N95.2
ICD-10 Finland
Postmenopausal atrophic vaginitis
2.3
9.6
78
363
N02AA05
ATC
oxycodone; systemic
1.9
9.6
144
838
UJH02
NOMESCO Finland
Anoscopy
3.1
9.6
39
128
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
9.6
292
2064
K59.0
ICD-10 Finland
Constipation
2.7
9.5
53
207
N05BA01
ATC
diazepam; systemic, rectal
1.9
9.5
121
667
R01BA52
ATC
pseudoephedrine, combinations; oral
1.6
9.5
258
1772
ULA02
NOMESCO Finland
Kolposcopy
2.1
9.5
93
467
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
2.5
9.5
58
238
X23
ICPC
Fear sexually transm dis female
2.6
9.5
53
208
X14
ICPC
Vaginal discharge
3.9
9.5
27
70
N06AA10
ATC
nortriptyline; systemic
3.9
9.5
27
70
A29
ICPC
General symptom/complaint other
1.9
9.4
117
640
359
Kela drug reimbursment
Mirabegroni
101.0
9.4
10
*
N32.83
ICD-10 Finland
Nozzle synergy in the bladder neck
101.0
9.4
10
*
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
101.0
9.4
10
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
9.4
271
1888
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
9.4
88
434
D07AB02
ATC
hydrocortisone butyrate; topical
1.6
9.4
264
1828
N05BA12
ATC
alprazolam; oral
2.1
9.4
94
476
59504
ICD-8 Finland
Cystitis, Interstitialis (Hunner)
+∞
9.4
9
*
SPAT1211
SPAT
Application of soft bandage
2.2
9.4
81
387
SPAT1172
SPAT
Guidance concerning hydration
4.4
9.4
23
53
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.1
9.3
92
463
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.9
9.3
125
702
ZXD20
NOMESCO Finland
Day surgery
1.9
9.3
116
636
N76.1
ICD-10 Finland
Subacute and chronic vaginitis
3.6
9.3
30
85
N76.3
ICD-10 Finland
Subacute and chronic vulvitis
7.4
9.2
21
29
R06AE07
ATC
cetirizine; oral
1.5
9.2
385
2919
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.9
9.2
121
674
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.7
9.2
51
199
D03
ICPC
Heartburn
2.9
9.2
44
159
R09
ICPC
Sinus symptom/complaint
2.1
9.2
86
425
Z01.7
ICD-10 Finland
Laboratory examination
1.8
9.1
149
890
L02
ICPC
Back symptom/complaint
2.0
9.1
100
524
L19
ICPC
Muscle symptom/complaint NOS
3.4
9.1
33
101
H03AA01
ATC
levothyroxine sodium; systemic
1.7
9.1
212
1399
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
11.6
9.1
16
14
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
9.1
359
2688
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.2
9.1
75
352
A28
ICPC
Limited function/disability NOS
1.8
9.1
135
784
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.9
9.1
126
716
N95.0
ICD-10 Finland
Postmenopausal bleeding
2.2
9.0
80
387
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
3.5
9.0
31
92
J01XX01
ATC
fosfomycin; systemic
4.3
9.0
23
55
R03BA02
ATC
budesonide; inhalant
1.8
9.0
165
1021
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.5
8.9
406
3134
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.9
8.8
40
140
T78.4
ICD-10 Finland
Allergy, unspecified
2.7
8.8
46
174
P06
ICPC
Sleep disturbance
1.9
8.8
118
662
J05AB11
ATC
valaciclovir; oral
1.8
8.8
132
768
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
4.2
8.8
23
56
U08
ICPC
Urinary retention
6.7
8.7
21
32
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
2.7
8.7
45
170
N80.0
ICD-10 Finland
Endometriosis of uterus
3.8
8.7
26
70
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.3
8.6
67
307
K80
ICPC
Cardiac arrhythmia NOS
2.1
8.6
83
415
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.2
8.6
33
105
N48.1
ICD-10 Finland
Balanoposthitis
3.9
8.6
25
66
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.9
8.6
123
706
D07AC13
ATC
mometasone; topical
1.6
8.5
249
1734
WX402
NOMESCO Finland
General anaesthesia
1.7
8.5
190
1240
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
8.4
159
989
P01
ICPC
Feeling anxious/nervous/tense
1.8
8.4
123
709
7321
FHL
TU biopsy, coagulation or laser
90.9
8.4
9
*
M01AB55
ATC
diclofenac, combinations; oral
2.3
8.4
61
271
ZXC20
NOMESCO Finland
Use of chemical agents
4.0
8.4
23
58
X58
ICD-10 Finland
Exposure to other specified factors
1.8
8.4
134
795
D02
ICPC
Abdominal pain epigastric
2.3
8.3
63
285
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.2
8.3
71
338
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.1
8.3
79
393
C10AC01
ATC
colestyramine; oral
3.3
8.3
30
92
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.0
8.2
91
478
ZXA10
NOMESCO Finland
Bilateral
1.7
8.2
151
933
L60.0
ICD-10 Finland
Ingrowing nail
2.5
8.2
50
205
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.4
8.2
58
255
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.1
8.2
78
388
J01DC02
ATC
cefuroxime; systemic
2.4
8.2
54
230
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
3.5
8.1
27
78
D20
ICPC
Mouth/tongue/lip symptom/complaint
2.6
8.1
48
194
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
2.3
8.1
60
269
G04BD
ATC
Drugs for urinary frequency and incontinence
33.7
8.1
10
*
R21
ICPC
Throat symptom/complaint
1.6
8.1
192
1270
F01
ICPC
Eye pain
3.1
8.1
33
109
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.0
8.1
89
467
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.2
8.1
65
302
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.2
8.0
69
329
SPAT1254
SPAT
Administration of medicine
1.8
8.0
125
735
B02AA02
ATC
tranexamic acid; systemic
1.8
8.0
129
766
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.6
8.0
210
1425
SPAT1255
SPAT
Intravenous administration of medicine
2.4
7.9
54
233
A63.0
ICD-10 Finland
Anogenital (venereal) warts
2.8
7.9
40
149
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
7.9
85
442
D04
ICPC
Rectal/anal pain
4.7
7.9
18
39
L08
ICPC
Shoulder symptom/complaint
1.6
7.9
196
1310
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
3.6
7.9
25
70
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.4
7.8
55
241
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
9.5
7.8
15
16
N05CD07
ATC
temazepam; oral
1.9
7.8
99
546
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
3.0
7.8
34
117
S80.0
ICD-10 Finland
Contusion of knee
2.1
7.8
74
368
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.0
7.8
85
445
XQ800
NOMESCO Finland
Prick test
2.2
7.8
69
334
N94.8
ICD-10 Finland
Other specified conditions associated with female genital organs and menstrual cycle
15.2
7.7
12
8
N36.9
ICD-10 Finland
Urethral disorder, unspecified
45.4
7.7
9
*
R03BA08
ATC
ciclesonide; inhalant
2.0
7.7
85
446
N03AG01
ATC
valproic acid; systemic, rectal
2.3
7.7
58
262
E0000UV, ,
ATC
1.5
7.7
357
2741
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
7.7
81
418
I49.4
ICD-10 Finland
Other and unspecified premature depolarization
2.8
7.7
38
140
Y6099
ICD-8 Finland
Prenatal care and observation
2.6
7.7
44
175
L18
ICPC
Muscle pain
2.6
7.7
45
181
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
3.8
7.7
23
62
D07AC01
ATC
betamethasone; topical
1.5
7.7
309
2305
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
2.5
7.6
49
206
R05
ICD-10 Finland
Cough
1.6
7.6
188
1254
C07AB07
ATC
bisoprolol; oral
1.5
7.6
382
2979
R60.0
ICD-10 Finland
Localized oedema
1.9
7.6
101
565
N89.9
ICD-10 Finland
Noninflammatory disorder of vagina, unspecified
12.0
7.6
13
11
S18
ICPC
Laceration/cut
1.5
7.6
392
3075
P99
ICPC
Psychological disorders other
2.9
7.5
34
119
R39.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the urinary system
7.2
7.5
17
24
LEF03
NOMESCO Finland
Posterior colporrpahy with sutures for primary rectocele
3.0
7.5
33
114
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.0
7.5
21
54
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
4.5
7.5
18
41
R06AX22
ATC
ebastine; oral
1.7
7.4
150
949
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.5
7.4
352
2709
R06AE09
ATC
levocetirizine; oral
1.8
7.4
128
776
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.8
7.4
107
615
N80.9
ICD-10 Finland
Endometriosis, unspecified
3.8
7.4
22
59
M02AA10
ATC
ketoprofen; topical
1.7
7.4
134
824
R10.0
ICD-10 Finland
Acute abdomen
3.0
7.3
32
110
ZXA05
NOMESCO Finland
Left side
1.6
7.3
190
1282
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.2
7.3
28
89
N31.0
ICD-10 Finland
Uninhibited neuropathic bladder, not elsewhere classified
+∞
7.3
7
*
KDD10
NOMESCO Finland
Excision of diverticulum of urethra
+∞
7.3
7
*
N32.0
ICD-10 Finland
Bladder-neck obstruction
+∞
7.3
7
*
N32.89
ICD-10 Finland
Other specified disorders of bladder
+∞
7.3
7
*
SPAT1216
SPAT
Assessment of functional ability
1.8
7.3
120
717
N02CC05
ATC
almotriptan; oral
2.7
7.3
39
150
SPAT1312
SPAT
General health counselling
1.5
7.3
264
1923
K29.7
ICD-10 Finland
Gastritis, unspecified
2.9
7.2
34
122
A56.0
ICD-10 Finland
Chlamydial infection of lower genitourinary tract
3.7
7.2
22
60
R03DC03
ATC
montelukast; oral
1.7
7.2
145
917
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
4.5
7.2
17
38
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.8
7.2
105
605
U06
ICPC
Haematuria
4.0
7.2
20
51
LEG12
NOMESCO Finland
Transobturatoric tape
30.3
7.2
9
*
N64.4
ICD-10 Finland
Mastodynia
2.8
7.1
34
123
N06AX12
ATC
bupropion; oral
2.1
7.1
65
318
M01AX17
ATC
nimesulide; oral
1.6
7.1
190
1290
M54.8
ICD-10 Finland
Other dorsalgia
2.5
7.1
45
188
R83
ICPC
Respiratory infection other
1.6
7.1
221
1554
P01BA02
ATC
hydroxychloroquine; oral
2.0
7.1
78
409
J01FA09
ATC
clarithromycin; systemic
1.5
7.1
262
1913
M01AC06
ATC
meloxicam; systemic, rectal
1.5
7.1
303
2280
D12
ICPC
Constipation
2.9
7.1
33
118
N76.5
ICD-10 Finland
Ulceration of vagina
10.1
7.0
13
13
M54.6
ICD-10 Finland
Pain in thoracic spine
2.0
7.0
75
389
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.9
7.0
88
483
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.9
7.0
84
454
N06AB03
ATC
fluoxetine; oral
1.8
7.0
105
610
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
7.0
277
2051
F29
ICPC
Eye symptom/complaint other
1.9
7.0
94
528
M54.3
ICD-10 Finland
Sciatica
2.3
7.0
54
247
A03FA01
ATC
metoclopramide; systemic, rectal
1.6
7.0
186
1263
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.6
6.9
38
148
Z50.1
ICD-10 Finland
Other physical therapy
2.4
6.9
47
203
R74
ICPC
Upper respiratory infection acute
1.5
6.9
292
2190
C03CA01
ATC
furosemide; systemic
1.5
6.9
223
1581
ZXD05
NOMESCO Finland
Urgent procedure
1.5
6.9
245
1773
R4110, ,
SPAT
1.8
6.8
116
699
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.9
6.8
81
436
W52
ICD-10 Finland
Crushed, pushed or stepped on by crowd or human stampede
4.2
6.8
18
44
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.1
6.8
61
296
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
2.0
6.8
69
351
L29
ICPC
Musculoskeletal sympt/complt other
2.0
6.8
79
422
G03DA02
ATC
medroxyprogesterone; systemic
2.0
6.8
77
408
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
6.8
226
1612
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.8
6.8
111
662
LEB00
NOMESCO Finland
Biopsy of vagina
3.7
6.8
21
58
SPAT1325
SPAT
Vaccination
1.5
6.8
260
1911
7434
FHL
Abdominal urethrocystopexy
40.4
6.8
8
*
SPAT1251
SPAT
Organisation of medication
2.7
6.7
34
127
I84.5
ICD-10 Finland
External hemorrhoids without complication
2.9
6.7
30
105
59012
ICD-8 Finland
Infections of kidney, Pyelocystitis
22.7
6.7
9
*
N07AA03
ATC
distigmine; systemic
22.7
6.7
9
*
UKD02
NOMESCO Finland
Urethroscopy
22.7
6.7
9
*
LWW96
NOMESCO Finland
Other reoperation in gynaecological surgery
22.7
6.7
9
*
G47.3
ICD-10 Finland
Sleep apnoea
1.6
6.7
177
1199
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.2
6.6
55
259
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.5
6.6
220
1567
S06.0
ICD-10 Finland
Concussion
1.8
6.6
93
530
Z00.0
ICD-10 Finland
General medical examination
1.6
6.6
166
1110
A13
ICPC
Concern/fear medical treatment
3.5
6.6
22
64
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.8
6.6
98
568
SPAT1262
SPAT
Handing over of treatment supplies
1.7
6.6
133
841
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
4.2
6.6
17
41
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
2.5
6.5
40
165
C01DA14
ATC
isosorbide mononitrate; oral
1.7
6.5
111
670
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
3.7
6.5
20
55
N81.1
ICD-10 Finland
Cystocele
2.2
6.5
51
235
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
5.8
6.5
17
30
B01AB05
ATC
enoxaparin; parenteral
1.5
6.5
241
1759
R55
ICD-10 Finland
Syncope and collapse
1.8
6.4
93
534
L12
ICPC
Hand/finger symptom/complaint
1.6
6.4
152
1000
J01FA01
ATC
erythromycin; systemic
1.7
6.4
116
711
SXA20
NOMESCO Finland
Local application of medicine to mouth
2.1
6.4
59
290
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
3.8
6.4
19
51
78551
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD
2.9
6.4
28
97
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
2.9
6.4
28
97
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.7
6.3
116
714
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.0
6.3
70
368
SPAT1301
SPAT
No procedures
1.5
6.3
247
1818
M01AE01
ATC
ibuprofen; systemic, rectal
1.7
6.3
805
7415
WX702
NOMESCO Finland
Supraglottic ventilation device
2.2
6.3
51
238
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
11.1
6.3
11
10
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.2
6.3
52
245
XJH00
NOMESCO Finland
Transanal ultrasonography
2.7
6.3
33
126
N41.0
ICD-10 Finland
Acute prostatitis
3.9
6.3
18
47
SCA01
NOMESCO Finland
Preventive oral health care, short
1.5
6.3
247
1821
D22
ICD-10 Finland
Melanocytic naevi
2.3
6.3
48
219
DFF00
NOMESCO Finland
Pure tone audiometry
1.8
6.3
87
494
N03AF01
ATC
carbamazepine; oral, rectal
2.3
6.2
45
200
K92.1
ICD-10 Finland
Melaena
2.3
6.2
45
200
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
3.1
6.2
25
82
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.0
6.2
63
321
WX400
NOMESCO Finland
Inhalation anesthesy
2.5
6.2
39
163
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
2.4
6.2
43
188
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
3.6
6.2
20
57
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.0
6.2
66
343
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
3.3
6.2
23
72
S63.5
ICD-10 Finland
Sprain and strain of wrist
2.5
6.2
37
151
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
2.4
6.1
41
176
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
2.3
6.1
44
195
M03BX01
ATC
baclofen; systemic
3.8
6.1
18
48
M48.0
ICD-10 Finland
Spinal stenosis
1.8
6.1
92
536
K03.28
ICD-10 Finland
Other erosion of teeth
2.9
6.1
27
94
T81.9
ICD-10 Finland
Unspecified complication of procedure
3.6
6.1
19
53
R03AC12
ATC
salmeterol; inhalant
2.4
6.1
40
171
M01AG02
ATC
tolfenamic acid; oral, rectal
1.7
6.1
128
819
R23.3
ICD-10 Finland
Spontaneous ecchymoses
3.2
6.0
23
73
K58
ICD-10 Finland
Irritable bowel syndrome
2.9
6.0
28
100
N03AX11
ATC
topiramate; oral
3.0
6.0
26
89
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
3.4
6.0
21
63
G03DB01
ATC
dydrogesterone; oral
1.7
6.0
105
638
F51.0
ICD-10 Finland
Nonorganic insomnia
1.6
6.0
146
967
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.8
6.0
82
463

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Urology
34 [38004474]
1.7e+00
2.4e+00
3.4e+00
—
4.1e+00
3.4e+00
2.1e+00
cases:11.86%
controls:2.31%
cases:12.91%
controls:1.38%
cases:7.12%
controls:0.26%
—
—
cases:14.29%
controls:0.26%
cases:29.73%
controls:1.34%
cases:19.88%
controls:2.91%
90
175
669
7387
98
104
661
7458
54
20
704
7542
—
108
20
648
7535
217
99
513
7289
133
193
536
6433
trimethoprim; oral, parenteral
J01EA01 [21602931]
1.9e+00
2.7e+00
3.3e+00
1.0e+50
4.2e+00
2.4e+00
1.9e+00
cases:18.18%
controls:3.12%
cases:14.36%
controls:1.12%
cases:4.09%
controls:0.16%
cases:3.56%
controls:0.00%
cases:4.23%
controls:0.07%
cases:10.27%
controls:1.06%
cases:18.98%
controls:3.37%
138
236
621
7326
109
85
650
7477
31
12
727
7550
27
0
731
7562
32
5
724
7550
75
78
655
7310
127
223
542
6403
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
1.9e+00
2.7e+00
3.7e+00
1.0e+50
3.8e+00
2.0e+00
1.5e+00
cases:17.92%
controls:3.17%
cases:12.65%
controls:0.97%
cases:4.09%
controls:0.11%
cases:1.85%
controls:0.00%
cases:3.57%
controls:0.08%
cases:6.71%
controls:0.93%
cases:14.20%
controls:3.46%
136
240
623
7322
96
73
663
7489
31
8
727
7554
14
0
744
7562
27
6
729
7549
49
69
681
7319
95
229
574
6397
Polyuria
R35 [45539331]
2.5e+00
4.2e+00
1.0e+50
1.0e+50
1.0e+50
3.9e+00
3.2e+00
cases:3.43%
controls:0.29%
cases:4.22%
controls:0.07%
cases:1.98%
controls:0.00%
cases:0.92%
controls:0.00%
cases:1.72%
controls:0.00%
cases:3.97%
controls:0.08%
cases:5.38%
controls:0.24%
26
22
733
7540
32
5
727
7557
15
0
743
7562
7
0
751
7562
13
0
743
7555
29
6
701
7382
36
16
633
6610
pivmecillinam; oral
J01CA08 [21602827]
1.6e+00
2.3e+00
3.3e+00
1.0e+50
2.6e+00
2.0e+00
1.8e+00
cases:22.92%
controls:5.51%
cases:15.81%
controls:1.93%
cases:3.96%
controls:0.15%
cases:1.45%
controls:0.00%
cases:3.17%
controls:0.24%
cases:12.19%
controls:1.85%
cases:26.46%
controls:5.84%
174
417
585
7145
120
146
639
7416
30
11
728
7551
11
0
747
7562
24
18
732
7537
89
137
641
7251
177
387
492
6239
Bacteria identified in Urine by Culture
630-4 [3026008]
1.1e+00
2.2e+00
4.0e+00
1.0e+50
2.7e+00
2.0e+00
1.4e+00
cases:7.64%
controls:2.74%
cases:9.22%
controls:1.08%
cases:6.20%
controls:0.12%
cases:3.56%
controls:0.00%
cases:3.57%
controls:0.25%
cases:9.18%
controls:1.29%
cases:14.65%
controls:4.09%
58
207
701
7355
70
82
689
7480
47
9
711
7553
27
0
731
7562
27
19
729
7536
67
95
663
7293
98
271
571
6355
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
1.0e+00
1.9e+00
4.2e+00
1.0e+50
3.1e+00
1.9e+00
1.1e+00
cases:9.49%
controls:3.62%
cases:10.80%
controls:1.81%
cases:8.58%
controls:0.15%
cases:4.49%
controls:0.00%
cases:3.97%
controls:0.19%
cases:10.55%
controls:1.65%
cases:13.30%
controls:4.98%
72
274
687
7288
82
137
677
7425
65
11
693
7551
34
0
724
7562
30
14
726
7541
77
122
653
7266
89
330
580
6296
methenamine; oral
J01XX05 [21603065]
3.4e+00
3.0e+00
—
—
—
3.2e+00
3.5e+00
cases:2.64%
controls:0.09%
cases:1.32%
controls:0.07%
—
—
—
—
—
—
cases:2.05%
controls:0.08%
cases:2.84%
controls:0.09%
20
7
739
7555
10
5
749
7557
—
—
—
15
6
715
7382
19
6
650
6620
mirabegron; oral
G04BD12 [43534790]
1.8e+00
2.3e+00
1.9e+00
1.0e+50
3.2e+00
1.8e+00
2.0e+00
cases:3.56%
controls:0.61%
cases:3.56%
controls:0.37%
cases:0.92%
controls:0.15%
cases:0.66%
controls:0.00%
cases:1.59%
controls:0.07%
cases:2.88%
controls:0.50%
cases:6.13%
controls:0.89%
27
46
732
7516
27
28
732
7534
7
11
751
7551
5
0
753
7562
12
5
744
7550
21
37
709
7351
41
59
628
6567
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
9.6e-01
1.8e+00
3.9e+00
1.0e+50
3.3e+00
1.9e+00
1.0e+00
cases:7.51%
controls:3.02%
cases:9.22%
controls:1.63%
cases:7.65%
controls:0.17%
cases:4.22%
controls:0.00%
cases:4.10%
controls:0.16%
cases:9.04%
controls:1.50%
cases:12.11%
controls:4.62%
57
228
702
7334
70
123
689
7439
58
13
700
7549
32
0
726
7562
31
12
725
7543
66
111
664
7277
81
306
588
6320
Bacteria [Presence] in Urine
87829-8 [36304419]
1.0e+00
1.9e+00
4.1e+00
1.0e+50
2.8e+00
1.9e+00
1.1e+00
cases:6.72%
controls:2.57%
cases:7.91%
controls:1.26%
cases:6.60%
controls:0.12%
cases:3.56%
controls:0.00%
cases:2.25%
controls:0.15%
cases:7.12%
controls:1.11%
cases:10.61%
controls:3.64%
51
194
708
7368
60
95
699
7467
50
9
708
7553
27
0
731
7562
17
11
739
7544
52
82
678
7306
71
241
598
6385
Cystoscopy
UKC02 [2001306005]
2.6e+00
3.1e+00
—
1.0e+50
—
4.0e+00
3.0e+00
cases:7.77%
controls:0.65%
cases:7.11%
controls:0.33%
—
—
cases:21.90%
controls:0.00%
—
—
cases:11.51%
controls:0.23%
cases:11.96%
controls:0.65%
59
49
700
7513
54
25
705
7537
—
166
0
592
7562
—
84
17
646
7371
80
43
589
6583
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
1.0e+00
1.8e+00
4.0e+00
1.0e+50
2.9e+00
1.9e+00
1.1e+00
cases:6.98%
controls:2.64%
cases:7.77%
controls:1.34%
cases:6.46%
controls:0.13%
cases:3.69%
controls:0.00%
cases:2.51%
controls:0.15%
cases:7.53%
controls:1.23%
cases:10.76%
controls:3.85%
53
200
706
7362
59
101
700
7461
49
10
709
7552
28
0
730
7562
19
11
737
7544
55
91
675
7297
72
255
597
6371
Leukocytes [#/volume] in Urine
30405-5 [3018095]
9.4e-01
1.8e+00
3.9e+00
1.0e+50
3.1e+00
1.7e+00
9.1e-01
cases:8.56%
controls:3.53%
cases:10.54%
controls:1.90%
cases:8.44%
controls:0.19%
cases:4.75%
controls:0.00%
cases:4.63%
controls:0.23%
cases:9.86%
controls:1.95%
cases:13.90%
controls:6.13%
65
267
694
7295
80
144
679
7418
64
14
694
7548
36
0
722
7562
35
17
721
7538
72
144
658
7244
93
406
576
6220
Other specified urinary incontinence
N39.4 [45577525]
3.3e+00
3.2e+00
—
1.0e+50
—
3.4e+00
2.3e+00
cases:3.16%
controls:0.12%
cases:2.64%
controls:0.11%
—
—
cases:0.92%
controls:0.00%
—
—
cases:2.05%
controls:0.07%
cases:2.69%
controls:0.29%
24
9
735
7553
20
8
739
7554
—
7
0
751
7562
—
15
5
715
7383
18
19
651
6607
oxybutynin; oral, transdermal
G04BD04 [21602637]
2.5e+00
3.7e+00
1.0e+50
—
—
3.3e+00
2.4e+00
cases:3.95%
controls:0.33%
cases:3.03%
controls:0.08%
cases:1.06%
controls:0.00%
—
—
—
—
cases:1.78%
controls:0.07%
cases:2.09%
controls:0.20%
30
25
729
7537
23
6
736
7556
8
0
750
7562
—
—
13
5
717
7383
14
13
655
6613
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
8.7e-01
1.9e+00
3.7e+00
1.0e+50
2.7e+00
1.7e+00
1.0e+00
cases:19.24%
controls:9.08%
cases:22.92%
controls:4.34%
cases:15.17%
controls:0.44%
cases:8.84%
controls:0.00%
cases:8.33%
controls:0.64%
cases:20.00%
controls:4.37%
cases:28.10%
controls:12.47%
146
687
613
6875
174
328
585
7234
115
33
643
7529
67
0
691
7562
63
48
693
7507
146
323
584
7065
188
826
481
5800
Urine symptom/complaint other
U07 [2002001142]
2.4e+00
3.4e+00
—
—
—
3.4e+00
2.4e+00
cases:2.24%
controls:0.21%
cases:2.24%
controls:0.08%
—
—
—
—
—
—
cases:2.05%
controls:0.07%
cases:3.29%
controls:0.30%
17
16
742
7546
17
6
742
7556
—
—
—
15
5
715
7383
22
20
647
6606
Outpatient Visit
OP [9202]
5.4e-01
8.3e-01
1.3e+00
5.4e+00
1.5e+00
1.2e+00
9.2e-01
cases:70.62%
controls:58.42%
cases:60.87%
controls:40.51%
cases:23.35%
controls:7.82%
cases:43.93%
controls:0.37%
cases:28.04%
controls:8.29%
cases:67.53%
controls:39.28%
cases:85.20%
controls:69.68%
536
4418
223
3144
462
3063
297
4499
177
591
581
6971
333
28
425
7534
212
626
544
6929
493
2902
237
4486
570
4617
99
2009
Pain localized to other parts of lower abdomen
R10.3 [45534426]
1.6e+00
2.2e+00
3.6e+00
1.0e+50
—
2.4e+00
1.8e+00
cases:8.70%
controls:1.94%
cases:6.46%
controls:0.79%
cases:2.77%
controls:0.08%
cases:1.45%
controls:0.00%
—
—
cases:6.30%
controls:0.61%
cases:14.20%
controls:2.70%
66
147
693
7415
49
60
710
7502
21
6
737
7556
11
0
747
7562
—
46
45
684
7343
95
179
574
6447
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
7.0e-01
1.6e+00
3.6e+00
1.0e+50
2.9e+00
1.6e+00
1.0e+00
cases:4.08%
controls:2.06%
cases:5.01%
controls:1.08%
cases:4.22%
controls:0.12%
cases:2.51%
controls:0.00%
cases:1.98%
controls:0.11%
cases:4.11%
controls:0.87%
cases:6.88%
controls:2.55%
31
156
728
7406
38
82
721
7480
32
9
726
7553
19
0
739
7562
15
8
741
7547
30
64
700
7324
46
169
623
6457
Retention of urine
R33 [45587507]
2.5e+00
3.0e+00
1.0e+50
1.0e+50
—
3.2e+00
2.6e+00
cases:1.58%
controls:0.13%
cases:2.11%
controls:0.11%
cases:2.11%
controls:0.00%
cases:0.66%
controls:0.00%
—
—
cases:2.05%
controls:0.08%
cases:2.69%
controls:0.21%
12
10
747
7552
16
8
743
7554
16
0
742
7562
5
0
753
7562
—
15
6
715
7382
18
14
651
6612
fluconazole; oral, parenteral
J02AC01 [21603080]
1.3e+00
1.9e+00
2.6e+00
—
2.3e+00
1.6e+00
1.4e+00
cases:20.82%
controls:6.41%
cases:13.31%
controls:2.25%
cases:3.43%
controls:0.25%
—
—
cases:1.85%
controls:0.19%
cases:9.18%
controls:2.04%
cases:21.67%
controls:6.13%
158
485
601
7077
101
170
658
7392
26
19
732
7543
—
14
14
742
7541
67
151
663
7237
145
406
524
6220
Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6357-8 [3024950]
1.1e+00
1.7e+00
3.3e+00
1.0e+50
2.4e+00
1.6e+00
1.1e+00
cases:6.98%
controls:2.49%
cases:5.80%
controls:1.08%
cases:1.72%
controls:0.07%
cases:1.45%
controls:0.00%
cases:1.59%
controls:0.15%
cases:3.97%
controls:0.87%
cases:8.97%
controls:3.29%
53
188
706
7374
44
82
715
7480
13
5
745
7557
11
0
747
7562
12
11
744
7544
29
64
701
7324
60
218
609
6408
Dysuria
R30.0 [45592416]
3.3e+00
4.2e+00
1.0e+50
1.0e+50
—
—
3.5e+00
cases:3.16%
controls:0.12%
cases:5.27%
controls:0.08%
cases:2.51%
controls:0.00%
cases:1.06%
controls:0.00%
—
—
—
—
cases:4.33%
controls:0.14%
24
9
735
7553
40
6
719
7556
19
0
739
7562
8
0
750
7562
—
—
29
9
640
6617
Medical doctor
Z2221 [2001311556]
9.5e-01
1.3e+00
2.4e+00
—
3.0e+00
2.0e+00
1.3e+00
cases:8.17%
controls:3.33%
cases:3.29%
controls:0.90%
cases:1.06%
controls:0.09%
—
—
cases:1.85%
controls:0.09%
cases:4.79%
controls:0.68%
cases:8.07%
controls:2.26%
62
252
697
7310
25
68
734
7494
8
7
750
7555
—
14
7
742
7548
35
50
695
7338
54
150
615
6476
solifenacin; oral
G04BD08 [21602641]
2.5e+00
2.5e+00
—
—
—
3.4e+00
2.4e+00
cases:2.90%
controls:0.24%
cases:1.58%
controls:0.13%
—
—
—
—
—
—
cases:2.05%
controls:0.07%
cases:2.84%
controls:0.26%
22
18
737
7544
12
10
747
7552
—
—
—
15
5
715
7383
19
17
650
6609
Osmolality of Urine
2695-5 [3026782]
8.0e-01
1.6e+00
3.5e+00
1.0e+50
2.5e+00
1.5e+00
1.0e+00
cases:4.74%
controls:2.18%
cases:5.01%
controls:1.07%
cases:3.43%
controls:0.11%
cases:2.11%
controls:0.00%
cases:1.85%
controls:0.16%
cases:3.56%
controls:0.83%
cases:5.83%
controls:2.23%
36
165
723
7397
38
81
721
7481
26
8
732
7554
16
0
742
7562
14
12
742
7543
26
61
704
7327
39
148
630
6478
tolterodine; oral
G04BD07 [21602640]
2.4e+00
2.7e+00
—
—
—
3.4e+00
2.4e+00
cases:2.37%
controls:0.22%
cases:1.71%
controls:0.12%
—
—
—
—
—
—
cases:2.33%
controls:0.08%
cases:3.74%
controls:0.36%
18
17
741
7545
13
9
746
7553
—
—
—
17
6
713
7382
25
24
644
6602
Other and unspecified abdominal pain
R10.4 [45568113]
1.2e+00
1.7e+00
2.5e+00
—
2.5e+00
1.6e+00
1.3e+00
cases:12.78%
controls:4.23%
cases:6.72%
controls:1.34%
cases:1.98%
controls:0.16%
—
—
cases:0.79%
controls:0.07%
cases:6.16%
controls:1.34%
cases:15.55%
controls:4.69%
97
320
662
7242
51
101
708
7461
15
12
743
7550
—
6
5
750
7550
45
99
685
7289
104
311
565
6315
sulfadiazine and trimethoprim
J01EE02 [21602962]
1.2e+00
1.9e+00
2.5e+00
1.0e+50
2.6e+00
1.2e+00
1.3e+00
cases:8.43%
controls:2.67%
cases:5.14%
controls:0.77%
cases:1.45%
controls:0.12%
cases:0.92%
controls:0.00%
cases:1.06%
controls:0.08%
cases:1.78%
controls:0.54%
cases:6.88%
controls:1.99%
64
202
695
7360
39
58
720
7504
11
9
747
7553
7
0
751
7562
8
6
748
7549
13
40
717
7348
46
132
623
6494
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
8.8e-01
1.7e+00
3.8e+00
1.0e+50
2.5e+00
1.1e+00
5.6e-01
cases:5.80%
controls:2.50%
cases:6.85%
controls:1.39%
cases:3.56%
controls:0.08%
cases:1.32%
controls:0.00%
cases:2.12%
controls:0.17%
cases:4.52%
controls:1.61%
cases:8.37%
controls:4.98%
44
189
715
7373
52
105
707
7457
27
6
731
7556
10
0
748
7562
16
13
740
7542
33
119
697
7269
56
330
613
6296
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
1.2e+00
1.8e+00
3.1e+00
1.0e+50
2.4e+00
1.3e+00
6.1e-01
cases:7.91%
controls:2.54%
cases:7.51%
controls:1.31%
cases:2.90%
controls:0.13%
cases:1.06%
controls:0.00%
cases:2.25%
controls:0.20%
cases:5.07%
controls:1.45%
cases:9.72%
controls:5.52%
60
192
699
7370
57
99
702
7463
22
10
736
7552
8
0
750
7562
17
15
739
7540
37
107
693
7281
65
366
604
6260
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
1.4e+00
2.2e+00
—
1.0e+50
3.2e+00
2.1e+00
1.3e+00
cases:4.22%
controls:1.12%
cases:4.35%
controls:0.50%
—
—
cases:2.37%
controls:0.00%
cases:1.98%
controls:0.08%
cases:5.21%
controls:0.64%
cases:7.17%
controls:2.16%
32
85
727
7477
33
38
726
7524
—
18
0
740
7562
15
6
741
7549
38
47
692
7341
48
143
621
6483
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
7.9e-01
1.6e+00
3.1e+00
—
2.4e+00
1.4e+00
8.9e-01
cases:19.10%
controls:9.69%
cases:20.69%
controls:5.00%
cases:11.08%
controls:0.56%
—
—
cases:7.01%
controls:0.68%
cases:16.44%
controls:4.70%
cases:27.20%
controls:13.36%
145
733
614
6829
157
378
602
7184
84
42
674
7520
—
53
51
703
7504
120
347
610
7041
182
885
487
5741
norfloxacin; oral
J01MA06 [21603013]
2.0e+00
3.3e+00
—
—
—
3.0e+00
1.9e+00
cases:6.06%
controls:0.85%
cases:3.82%
controls:0.15%
—
—
—
—
—
—
cases:2.88%
controls:0.15%
cases:4.63%
controls:0.75%
46
64
713
7498
29
11
730
7551
—
—
—
21
11
709
7377
31
50
638
6576
Limited function/disability NOS
A28 [2002000162]
9.8e-01
1.3e+00
2.1e+00
2.3e+00
2.2e+00
1.3e+00
1.6e-01
cases:2.37%
controls:0.90%
cases:1.98%
controls:0.56%
cases:1.72%
controls:0.21%
cases:0.79%
controls:0.08%
cases:1.59%
controls:0.19%
cases:2.33%
controls:0.68%
cases:2.69%
controls:2.31%
18
68
741
7494
15
42
744
7520
13
16
745
7546
6
6
752
7556
12
14
744
7541
17
50
713
7338
18
153
651
6473
Urinary tract infection, site not specified
N39.0 [45548665]
3.0e+00
4.0e+00
1.0e+50
—
1.0e+50
—
3.0e+00
cases:5.14%
controls:0.26%
cases:4.74%
controls:0.09%
cases:1.98%
controls:0.00%
—
—
cases:1.32%
controls:0.00%
—
—
cases:9.12%
controls:0.51%
39
20
720
7542
36
7
723
7555
15
0
743
7562
—
10
0
746
7555
—
61
34
608
6592
pH of Urine
2756-5 [3015736]
9.1e-01
1.6e+00
3.2e+00
1.0e+50
2.3e+00
1.2e+00
7.2e-01
cases:10.80%
controls:4.67%
cases:11.07%
controls:2.46%
cases:5.01%
controls:0.21%
cases:2.51%
controls:0.00%
cases:3.57%
controls:0.36%
cases:8.22%
controls:2.68%
cases:14.95%
controls:7.86%
82
353
677
7209
84
186
675
7376
38
16
720
7546
19
0
739
7562
27
27
729
7528
60
198
670
7190
100
521
569
6105
nitrofurantoin; oral
J01XE01 [21603058]
1.9e+00
3.2e+00
—
—
—
2.4e+00
2.5e+00
cases:9.09%
controls:1.41%
cases:8.04%
controls:0.37%
—
—
—
—
—
—
cases:4.66%
controls:0.46%
cases:12.11%
controls:1.13%
69
107
690
7455
61
28
698
7534
—
—
—
34
34
696
7354
81
75
588
6551
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
8.7e-01
1.6e+00
3.2e+00
1.0e+50
2.4e+00
1.2e+00
6.8e-01
cases:12.65%
controls:5.73%
cases:14.36%
controls:3.28%
cases:7.39%
controls:0.32%
cases:2.90%
controls:0.00%
cases:4.89%
controls:0.48%
cases:10.68%
controls:3.56%
cases:18.39%
controls:10.28%
96
433
663
7129
109
248
650
7314
56
24
702
7538
22
0
736
7562
37
36
719
7519
78
263
652
7125
123
681
546
5945
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
8.5e-01
1.6e+00
3.1e+00
1.0e+50
2.3e+00
1.2e+00
6.9e-01
cases:13.18%
controls:6.07%
cases:14.89%
controls:3.32%
cases:7.39%
controls:0.37%
cases:3.03%
controls:0.00%
cases:5.03%
controls:0.50%
cases:10.82%
controls:3.64%
cases:18.98%
controls:10.49%
100
459
659
7103
113
251
646
7311
56
28
702
7534
23
0
735
7562
38
38
718
7517
79
269
651
7119
127
695
542
5931
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
8.3e-01
1.6e+00
3.2e+00
1.0e+50
2.3e+00
1.2e+00
6.7e-01
cases:12.65%
controls:5.92%
cases:14.76%
controls:3.37%
cases:7.12%
controls:0.32%
cases:3.17%
controls:0.00%
cases:4.89%
controls:0.50%
cases:10.68%
controls:3.64%
cases:18.54%
controls:10.46%
96
448
663
7114
112
255
647
7307
54
24
704
7538
24
0
734
7562
37
38
719
7517
78
269
652
7119
124
693
545
5933
Physiotherapy
R4110 [2001310233]
7.5e-01
1.3e+00
2.7e+00
—
2.0e+00
1.7e+00
1.1e+00
cases:6.32%
controls:3.08%
cases:3.16%
controls:0.86%
cases:1.19%
controls:0.08%
—
—
cases:0.93%
controls:0.13%
cases:4.11%
controls:0.79%
cases:8.22%
controls:2.81%
48
233
711
7329
24
65
735
7497
9
6
749
7556
—
7
10
749
7545
30
58
700
7330
55
186
614
6440
Dysuria/painful urination
U01 [2002001137]
2.8e+00
2.4e+00
—
—
1.0e+50
1.9e+00
2.5e+00
cases:4.08%
controls:0.26%
cases:2.11%
controls:0.20%
—
—
—
—
cases:0.66%
controls:0.00%
cases:1.10%
controls:0.16%
cases:4.19%
controls:0.36%
31
20
728
7542
16
15
743
7547
—
—
5
0
751
7555
8
12
722
7376
28
24
641
6602
Uroflowmetry
44856007 [4261340]
1.7e+00
2.7e+00
—
—
—
2.9e+00
2.3e+00
cases:3.43%
controls:0.67%
cases:3.82%
controls:0.28%
—
—
—
—
—
—
cases:5.48%
controls:0.32%
cases:5.98%
controls:0.60%
26
51
733
7511
29
21
730
7541
—
—
—
40
24
690
7364
40
40
629
6586
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
1.4e+00
2.1e+00
—
1.0e+50
2.9e+00
2.0e+00
1.1e+00
cases:3.95%
controls:1.03%
cases:4.22%
controls:0.52%
—
—
cases:2.37%
controls:0.00%
cases:1.59%
controls:0.09%
cases:4.93%
controls:0.73%
cases:7.32%
controls:2.54%
30
78
729
7484
32
39
727
7523
—
18
0
740
7562
12
7
744
7548
36
54
694
7334
49
168
620
6458
Ultrasound measurement of residual urine
KC1EE [2001305918]
2.1e+00
2.6e+00
—
—
—
2.5e+00
2.2e+00
cases:3.56%
controls:0.45%
cases:2.37%
controls:0.17%
—
—
—
—
—
—
cases:3.01%
controls:0.26%
cases:4.48%
controls:0.53%
27
34
732
7528
18
13
741
7549
—
—
—
22
19
708
7369
30
35
639
6591
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
8.7e-01
1.6e+00
2.8e+00
1.0e+50
2.1e+00
1.2e+00
7.7e-01
cases:7.38%
controls:3.24%
cases:8.30%
controls:1.79%
cases:3.30%
controls:0.21%
cases:1.45%
controls:0.00%
cases:2.25%
controls:0.29%
cases:5.62%
controls:1.76%
cases:10.46%
controls:5.13%
56
245
703
7317
63
135
696
7427
25
16
733
7546
11
0
747
7562
17
22
739
7533
41
130
689
7258
70
340
599
6286
Cytology report of Urine Cyto stain
47525-1 [3049717]
2.5e+00
2.6e+00
—
—
—
2.1e+00
2.1e+00
cases:1.98%
controls:0.16%
cases:1.05%
controls:0.08%
—
—
—
—
—
—
cases:0.96%
controls:0.12%
cases:2.09%
controls:0.27%
15
12
744
7550
8
6
751
7556
—
—
—
7
9
723
7379
14
18
655
6608
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
7.4e-01
1.5e+00
3.1e+00
1.0e+50
2.1e+00
1.0e+00
6.8e-01
cases:10.01%
controls:5.04%
cases:11.86%
controls:2.78%
cases:5.67%
controls:0.28%
cases:2.51%
controls:0.00%
cases:3.31%
controls:0.40%
cases:7.53%
controls:2.83%
cases:14.35%
controls:7.82%
76
381
683
7181
90
210
669
7352
43
21
715
7541
19
0
739
7562
25
30
731
7525
55
209
675
7179
96
518
573
6108
General Surgery
2 [38004447]
7.6e-01
1.1e+00
2.4e+00
—
2.4e+00
1.5e+00
1.0e+00
cases:28.72%
controls:15.83%
cases:13.70%
controls:5.24%
cases:7.39%
controls:0.71%
—
—
cases:7.94%
controls:0.75%
cases:18.77%
controls:4.89%
cases:31.54%
controls:14.55%
218
1197
541
6365
104
396
655
7166
56
54
702
7508
—
60
57
696
7498
137
361
593
7027
211
964
458
5662
lidocaine
C05AD01 [21601618]
1.7e+00
3.2e+00
—
—
—
2.5e+00
1.7e+00
cases:1.45%
controls:0.26%
cases:2.24%
controls:0.09%
—
—
—
—
—
—
cases:0.96%
controls:0.08%
cases:1.79%
controls:0.33%
11
20
748
7542
17
7
742
7555
—
—
—
7
6
723
7382
12
22
657
6604
lidocaine; ointment
D04AB01 [21602020]
1.7e+00
3.2e+00
—
—
—
2.3e+00
1.7e+00
cases:1.45%
controls:0.26%
cases:2.24%
controls:0.09%
—
—
—
—
—
—
cases:0.82%
controls:0.08%
cases:1.79%
controls:0.33%
11
20
748
7542
17
7
742
7555
—
—
—
6
6
724
7382
12
22
657
6604
Urinary frequency/urgency
U02 [2002001138]
2.1e+00
2.8e+00
—
—
—
2.0e+00
1.9e+00
cases:6.06%
controls:0.78%
cases:3.69%
controls:0.24%
—
—
—
—
—
—
cases:2.47%
controls:0.32%
cases:5.23%
controls:0.80%
46
59
713
7503
28
18
731
7544
—
—
—
18
24
712
7364
35
53
634
6573
amitriptyline; oral, parenteral
N06AA09 [21604696]
1.3e+00
1.4e+00
1.8e+00
—
1.5e+00
1.6e+00
1.3e+00
cases:8.96%
controls:2.68%
cases:5.27%
controls:1.39%
cases:1.45%
controls:0.25%
—
—
cases:1.46%
controls:0.33%
cases:5.48%
controls:1.20%
cases:10.76%
controls:3.06%
68
203
691
7359
40
105
719
7457
11
19
747
7543
—
11
25
745
7530
40
89
690
7299
72
203
597
6423
Venereal disease screening
171128005 [4064905]
1.3e+00
2.7e+00
—
—
—
2.8e+00
1.9e+00
cases:2.37%
controls:0.69%
cases:1.84%
controls:0.13%
—
—
—
—
—
—
cases:2.19%
controls:0.14%
cases:4.33%
controls:0.66%
18
52
741
7510
14
10
745
7552
—
—
—
16
10
714
7378
29
44
640
6582
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
5.3e-01
1.4e+00
3.1e+00
1.0e+50
2.2e+00
1.0e+00
7.6e-01
cases:5.80%
controls:3.49%
cases:7.51%
controls:2.00%
cases:4.35%
controls:0.20%
cases:1.98%
controls:0.00%
cases:2.51%
controls:0.28%
cases:5.75%
controls:2.11%
cases:10.46%
controls:5.18%
44
264
715
7298
57
151
702
7411
33
15
725
7547
15
0
743
7562
19
21
737
7534
42
156
688
7232
70
343
599
6283
Unspecified haematuria
R31 [45553726]
2.0e+00
2.4e+00
—
1.0e+50
1.0e+50
2.0e+00
2.0e+00
cases:2.64%
controls:0.37%
cases:1.32%
controls:0.12%
—
—
cases:1.06%
controls:0.00%
cases:0.66%
controls:0.00%
cases:1.51%
controls:0.20%
cases:2.69%
controls:0.36%
20
28
739
7534
10
9
749
7553
—
8
0
750
7562
5
0
751
7555
11
15
719
7373
18
24
651
6602
Emergency Room Visit
ER [9203]
6.8e-01
1.1e+00
2.2e+00
—
2.1e+00
1.3e+00
9.9e-01
cases:40.45%
controls:25.61%
cases:24.64%
controls:9.42%
cases:9.10%
controls:1.07%
—
—
cases:6.75%
controls:0.89%
cases:25.62%
controls:8.72%
cases:49.33%
controls:26.61%
307
1937
452
5625
187
712
572
6850
69
81
689
7481
—
51
67
705
7488
187
644
543
6744
330
1763
339
4863
Obstetrics / Gynecology
16 [38004461]
7.4e-01
1.2e+00
1.7e+00
—
2.2e+00
1.4e+00
9.9e-01
cases:27.14%
controls:15.14%
cases:18.58%
controls:6.31%
cases:6.20%
controls:1.16%
—
—
cases:7.41%
controls:0.90%
cases:20.27%
controls:5.78%
cases:34.68%
controls:16.42%
206
1145
553
6417
141
477
618
7085
47
88
711
7474
—
56
68
700
7487
148
427
582
6961
232
1088
437
5538
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
3.2e-01
7.3e-01
1.3e+00
3.5e+00
1.4e+00
6.8e-01
4.2e-01
cases:24.77%
controls:19.32%
cases:22.53%
controls:12.25%
cases:7.39%
controls:2.18%
cases:5.28%
controls:0.17%
cases:8.60%
controls:2.34%
cases:22.05%
controls:12.56%
cases:35.72%
controls:26.65%
188
1461
571
6101
171
926
588
6636
56
165
702
7397
40
13
718
7549
65
177
691
7378
161
928
569
6460
239
1766
430
4860
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
9.1e-01
9.7e-01
1.8e+00
—
2.2e+00
1.3e+00
1.1e+00
cases:12.91%
controls:5.62%
cases:6.32%
controls:2.50%
cases:2.24%
controls:0.38%
—
—
cases:2.65%
controls:0.30%
cases:9.45%
controls:2.67%
cases:17.34%
controls:6.72%
98
425
661
7137
48
189
711
7373
17
29
741
7533
—
20
23
736
7532
69
197
661
7191
116
445
553
6181
Specific gravity of Urine by Refractometry
5810-7 [3019150]
5.8e-01
1.3e+00
3.0e+00
1.0e+50
2.4e+00
9.0e-01
4.9e-01
cases:5.53%
controls:3.16%
cases:6.32%
controls:1.73%
cases:3.56%
controls:0.19%
cases:1.72%
controls:0.00%
cases:2.38%
controls:0.23%
cases:4.52%
controls:1.88%
cases:8.52%
controls:5.37%
42
239
717
7323
48
131
711
7431
27
14
731
7548
13
0
745
7562
18
17
738
7538
33
139
697
7249
57
356
612
6270
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
LC2BE [2001306544]
9.8e-01
2.0e+00
2.2e+00
1.0e+50
2.3e+00
1.7e+00
1.3e+00
cases:8.17%
controls:3.23%
cases:6.59%
controls:0.95%
cases:1.06%
controls:0.12%
cases:3.03%
controls:0.00%
cases:0.66%
controls:0.07%
cases:5.48%
controls:1.02%
cases:13.15%
controls:3.95%
62
244
697
7318
50
72
709
7490
8
9
750
7553
23
0
735
7562
5
5
751
7550
40
75
690
7313
88
262
581
6364
Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
21416-3 [3003510]
1.1e+00
1.9e+00
—
1.0e+50
2.4e+00
1.6e+00
1.1e+00
cases:6.59%
controls:2.25%
cases:5.53%
controls:0.89%
—
—
cases:1.32%
controls:0.00%
cases:1.46%
controls:0.13%
cases:3.42%
controls:0.73%
cases:8.67%
controls:3.05%
50
170
709
7392
42
67
717
7495
—
10
0
748
7562
11
10
745
7545
25
54
705
7334
58
202
611
6424
Catheterisation of bladder
TKC20 [2001306020]
2.4e+00
2.9e+00
1.0e+50
—
1.0e+50
—
2.6e+00
cases:1.19%
controls:0.11%
cases:1.58%
controls:0.09%
cases:1.06%
controls:0.00%
—
—
cases:0.79%
controls:0.00%
—
—
cases:2.84%
controls:0.23%
9
8
750
7554
12
7
747
7555
8
0
750
7562
—
6
0
750
7555
—
19
15
650
6611
Upper gastrointestinal surgery
106 [44777669]
9.5e-01
9.7e-01
1.5e+00
—
1.8e+00
1.3e+00
1.2e+00
cases:12.78%
controls:5.36%
cases:5.40%
controls:2.13%
cases:1.45%
controls:0.32%
—
—
cases:1.59%
controls:0.28%
cases:6.99%
controls:1.95%
cases:17.64%
controls:5.90%
97
405
662
7157
41
161
718
7401
11
24
747
7538
—
12
21
744
7534
51
144
679
7244
118
391
551
6235
tamsulosin; oral
G04CA02 [21602669]
1.2e+00
1.6e+00
—
1.0e+50
1.9e+00
1.6e+00
1.3e+00
cases:5.67%
controls:1.77%
cases:5.80%
controls:1.24%
—
—
cases:1.58%
controls:0.00%
cases:1.98%
controls:0.29%
cases:5.62%
controls:1.22%
cases:6.73%
controls:2.01%
43
134
716
7428
44
94
715
7468
—
12
0
746
7562
15
22
741
7533
41
90
689
7298
45
133
624
6493
gabapentin; oral
N02BF01 [955005]
1.4e+00
1.4e+00
1.1e+00
—
1.9e+00
1.5e+00
1.3e+00
cases:4.35%
controls:1.14%
cases:3.16%
controls:0.82%
cases:0.79%
controls:0.28%
—
—
cases:1.19%
controls:0.17%
cases:3.70%
controls:0.84%
cases:7.03%
controls:2.04%
33
86
726
7476
24
62
735
7500
6
21
752
7541
—
9
13
747
7542
27
62
703
7326
47
135
622
6491
clindamycin; vaginal
G01AA10 [21602372]
8.6e-01
1.7e+00
2.2e+00
—
—
1.6e+00
1.2e+00
cases:6.06%
controls:2.64%
cases:4.74%
controls:0.91%
cases:0.92%
controls:0.11%
—
—
—
—
cases:3.70%
controls:0.80%
cases:8.07%
controls:2.67%
46
200
713
7362
36
69
723
7493
7
8
751
7554
—
—
27
59
703
7329
54
177
615
6449
Emergency Room and Inpatient Visit
ERIP [262]
7.3e-01
1.1e+00
1.7e+00
—
2.4e+00
8.6e-01
5.6e-01
cases:4.74%
controls:2.35%
cases:4.61%
controls:1.53%
cases:1.06%
controls:0.19%
—
—
cases:1.32%
controls:0.12%
cases:4.11%
controls:1.79%
cases:10.31%
controls:6.17%
36
178
723
7384
35
116
724
7446
8
14
750
7548
—
10
9
746
7546
30
132
700
7256
69
409
600
6217
Bacteria identified in Blood by Culture
600-7 [3023368]
7.4e-01
9.9e-01
2.3e+00
—
2.2e+00
1.2e+00
5.5e-01
cases:4.48%
controls:2.20%
cases:2.77%
controls:1.04%
cases:0.79%
controls:0.08%
—
—
cases:1.32%
controls:0.15%
cases:3.56%
controls:1.12%
cases:6.28%
controls:3.71%
34
166
725
7396
21
79
738
7483
6
6
752
7556
—
10
11
746
7544
26
83
704
7305
42
246
627
6380
Office Visit
OMOP4822458 [581477]
6.3e-01
7.4e-01
2.2e+00
1.0e+50
2.1e+00
1.0e+00
7.4e-01
cases:11.20%
controls:6.29%
cases:4.48%
controls:2.18%
cases:1.72%
controls:0.19%
cases:0.79%
controls:0.00%
cases:2.25%
controls:0.29%
cases:4.93%
controls:1.84%
cases:11.81%
controls:6.02%
85
476
674
7086
34
165
725
7397
13
14
745
7548
6
0
752
7562
17
22
739
7533
36
136
694
7252
79
399
590
6227
ofloxacin; oral, parenteral
J01MA01 [21603008]
2.0e+00
3.2e+00
—
—
—
2.0e+00
2.2e+00
cases:3.29%
controls:0.46%
cases:2.24%
controls:0.09%
—
—
—
—
—
—
cases:0.68%
controls:0.09%
cases:2.54%
controls:0.29%
25
35
734
7527
17
7
742
7555
—
—
—
5
7
725
7381
17
19
652
6607
General Practice
1 [38004446]
7.8e-01
9.9e-01
1.7e+00
1.0e+50
2.1e+00
9.7e-01
8.9e-01
cases:17.26%
controls:8.73%
cases:8.96%
controls:3.52%
cases:2.24%
controls:0.44%
cases:7.52%
controls:0.00%
cases:2.65%
controls:0.34%
cases:8.90%
controls:3.56%
cases:21.82%
controls:10.29%
131
660
628
6902
68
266
691
7296
17
33
741
7529
57
0
701
7562
20
26
736
7529
65
263
665
7125
146
682
523
5944
Cystitis/urinary infection other
U71 [2002001191]
1.9e+00
3.1e+00
1.0e+50
—
—
1.4e+00
2.3e+00
cases:1.58%
controls:0.25%
cases:1.45%
controls:0.07%
cases:0.66%
controls:0.00%
—
—
—
—
cases:0.68%
controls:0.16%
cases:2.69%
controls:0.27%
12
19
747
7543
11
5
748
7557
5
0
753
7562
—
—
5
12
725
7376
18
18
651
6608
Abdominal pain localized other
D06 [2002000305]
1.3e+00
1.9e+00
—
—
—
2.1e+00
1.8e+00
cases:2.50%
controls:0.71%
cases:1.58%
controls:0.25%
—
—
—
—
—
—
cases:0.96%
controls:0.12%
cases:3.59%
controls:0.63%
19
54
740
7508
12
19
747
7543
—
—
—
7
9
723
7379
24
42
645
6584
Emergency Medicine
93 [38004510]
4.8e-01
1.0e+00
2.2e+00
—
1.8e+00
8.6e-01
4.9e-01
cases:12.25%
controls:7.96%
cases:11.07%
controls:4.35%
cases:5.41%
controls:0.63%
—
—
cases:3.44%
controls:0.57%
cases:10.14%
controls:4.53%
cases:21.23%
controls:14.14%
93
602
666
6960
84
329
675
7233
41
48
717
7514
—
26
43
730
7512
74
335
656
7053
142
937
527
5689
ispaghula (psylla seeds); oral
A06AC01 [21600555]
1.3e+00
1.5e+00
—
—
1.7e+00
1.2e+00
1.2e+00
cases:7.38%
controls:2.22%
cases:4.35%
controls:1.04%
—
—
—
—
cases:1.19%
controls:0.23%
cases:3.84%
controls:1.18%
cases:8.97%
controls:2.93%
56
168
703
7394
33
79
726
7483
—
—
9
17
747
7538
28
87
702
7301
60
194
609
6432
Pharmacy visit
OMOP4822462 [581458]
5.5e-01
8.4e-01
8.7e-01
2.8e+00
9.2e-01
7.6e-01
5.3e-01
cases:94.07%
controls:90.11%
cases:88.93%
controls:77.61%
cases:58.05%
controls:36.72%
cases:23.22%
controls:1.77%
cases:59.39%
controls:36.77%
cases:88.77%
controls:78.64%
cases:94.62%
controls:91.17%
714
6814
45
748
675
5869
84
1693
440
2777
318
4785
176
134
582
7428
449
2778
307
4777
648
5810
82
1578
633
6041
36
585
cefalexin; oral
J01DB01 [21602870]
7.8e-01
1.1e+00
1.6e+00
—
1.5e+00
9.0e-01
9.0e-01
cases:41.77%
controls:24.82%
cases:18.58%
controls:7.34%
cases:4.09%
controls:0.86%
—
—
cases:4.23%
controls:0.95%
cases:16.99%
controls:7.67%
cases:44.69%
controls:24.78%
317
1877
442
5685
141
555
618
7007
31
65
727
7497
—
32
72
724
7483
124
567
606
6821
299
1642
370
4984
Abdominal pain/cramps general
D01 [2002000300]
1.4e+00
1.8e+00
—
—
—
2.3e+00
1.2e+00
cases:3.43%
controls:0.87%
cases:1.71%
controls:0.28%
—
—
—
—
—
—
cases:1.64%
controls:0.16%
cases:3.59%
controls:1.16%
26
66
733
7496
13
21
746
7541
—
—
—
12
12
718
7376
24
77
645
6549
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
1.9e-01
5.1e-01
1.1e+00
3.5e+00
1.2e+00
3.6e-01
2.1e-01
cases:23.85%
controls:20.54%
cases:22.53%
controls:14.88%
cases:6.86%
controls:2.37%
cases:5.01%
controls:0.16%
cases:7.67%
controls:2.53%
cases:21.10%
controls:15.78%
cases:34.53%
controls:29.93%
181
1553
578
6009
171
1125
588
6437
52
179
706
7383
38
12
720
7550
58
191
698
7364
154
1166
576
6222
231
1983
438
4643
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
1.8e-01
5.0e-01
1.1e+00
3.5e+00
1.2e+00
3.6e-01
2.1e-01
cases:23.85%
controls:20.70%
cases:22.66%
controls:15.09%
cases:6.73%
controls:2.39%
cases:5.01%
controls:0.16%
cases:7.80%
controls:2.61%
cases:21.37%
controls:15.92%
cases:34.53%
controls:30.05%
181
1565
578
5997
172
1141
587
6421
51
181
707
7381
38
12
720
7550
59
197
697
7358
156
1176
574
6212
231
1991
438
4635
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
7.2e-01
1.2e+00
—
—
2.5e+00
1.3e+00
6.9e-01
cases:3.95%
controls:1.97%
cases:2.64%
controls:0.79%
—
—
—
—
cases:0.79%
controls:0.07%
cases:3.29%
controls:0.91%
cases:5.38%
controls:2.78%
30
149
729
7413
20
60
739
7502
—
—
6
5
750
7550
24
67
706
7321
36
184
633
6442
Laboratory Visit
OMOP4822461 [32036]
9.4e-02
3.1e-01
1.3e+00
3.5e+00
1.1e+00
2.9e-01
6.8e-02
cases:32.02%
controls:30.01%
cases:34.52%
controls:27.86%
cases:23.48%
controls:7.72%
cases:13.46%
controls:0.49%
cases:19.84%
controls:7.84%
cases:35.07%
controls:28.74%
cases:43.50%
controls:41.84%
243
2269
516
5293
262
2107
497
5455
178
584
580
6978
102
37
656
7525
150
592
606
6963
256
2123
474
5265
291
2772
378
3854
Outpatient Hospital
22 [8756]
5.5e-01
8.1e-01
1.5e+00
—
1.5e+00
1.2e+00
8.1e-01
cases:31.49%
controls:20.93%
cases:13.04%
controls:6.24%
cases:2.90%
controls:0.69%
—
—
cases:2.91%
controls:0.65%
cases:16.16%
controls:5.63%
cases:30.94%
controls:16.62%
239
1583
520
5979
99
472
660
7090
22
52
736
7510
—
22
49
734
7506
118
416
612
6972
207
1101
462
5525
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
1.2e-01
4.4e-01
1.1e+00
3.2e+00
1.1e+00
3.4e-01
2.2e-01
cases:25.43%
controls:23.17%
cases:25.30%
controls:17.85%
cases:8.97%
controls:3.08%
cases:4.75%
controls:0.20%
cases:8.99%
controls:3.22%
cases:24.66%
controls:18.84%
cases:38.27%
controls:33.16%
193
1752
566
5810
192
1350
567
6212
68
233
690
7329
36
15
722
7547
68
243
688
7312
180
1392
550
5996
256
2197
413
4429
Acute tubulo-interstitial nephritis
N10 [45543856]
2.0e+00
1.3e+00
—
—
—
2.7e+00
1.5e+00
cases:3.95%
controls:0.56%
cases:1.05%
controls:0.29%
—
—
—
—
—
—
cases:2.19%
controls:0.15%
cases:3.59%
controls:0.85%
30
42
729
7520
8
22
751
7540
—
—
—
16
11
714
7377
24
56
645
6570
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
9.0e-01
9.0e-01
—
—
1.8e+00
1.3e+00
1.3e+00
cases:10.80%
controls:4.69%
cases:5.01%
controls:2.10%
—
—
—
—
cases:1.85%
controls:0.32%
cases:6.99%
controls:1.96%
cases:15.70%
controls:5.03%
82
355
677
7207
38
159
721
7403
—
—
14
24
742
7531
51
145
679
7243
105
333
564
6293
Inpatient Hospital
21 [8717]
5.3e-01
8.6e-01
1.5e+00
—
1.6e+00
9.2e-01
8.0e-01
cases:40.97%
controls:29.07%
cases:19.37%
controls:9.22%
cases:5.01%
controls:1.19%
—
—
cases:4.76%
controls:1.03%
cases:19.45%
controls:8.74%
cases:40.36%
controls:23.36%
311
2198
448
5364
147
697
612
6865
38
90
720
7472
—
36
78
720
7477
142
646
588
6742
270
1548
399
5078
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
2.3e-01
5.2e-01
1.1e+00
3.0e+00
1.1e+00
3.5e-01
2.8e-01
cases:18.58%
controls:15.38%
cases:18.84%
controls:12.18%
cases:6.33%
controls:2.12%
cases:3.56%
controls:0.19%
cases:6.61%
controls:2.20%
cases:17.40%
controls:12.93%
cases:29.90%
controls:24.31%
141
1163
618
6399
143
921
616
6641
48
160
710
7402
27
14
731
7548
50
166
706
7389
127
955
603
6433
200
1611
469
5015
Stress incontinence
N39.3 [45539046]
2.8e+00
—
—
—
—
—
3.3e+00
cases:1.32%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:2.84%
controls:0.11%
10
6
749
7556
—
—
—
—
—
19
7
650
6619
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
7.3e-01
1.2e+00
—
—
2.3e+00
1.0e+00
9.2e-01
cases:5.80%
controls:2.88%
cases:3.16%
controls:1.01%
—
—
—
—
cases:0.79%
controls:0.08%
cases:2.74%
controls:1.02%
cases:7.92%
controls:3.32%
44
218
715
7344
24
76
735
7486
—
—
6
6
750
7549
20
75
710
7313
53
220
616
6406
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
1.3e+00
1.7e+00
—
—
—
1.7e+00
1.4e+00
cases:4.22%
controls:1.20%
cases:2.11%
controls:0.41%
—
—
—
—
—
—
cases:2.05%
controls:0.37%
cases:6.13%
controls:1.54%
32
91
727
7471
16
31
743
7531
—
—
—
15
27
715
7361
41
102
628
6524
Dorsalgia, unspecified
M54.9 [45538791]
1.5e+00
1.6e+00
—
—
—
1.9e+00
1.0e+00
cases:2.90%
controls:0.67%
cases:1.05%
controls:0.21%
—
—
—
—
—
—
cases:1.10%
controls:0.16%
cases:2.99%
controls:1.10%
22
51
737
7511
8
16
751
7546
—
—
—
8
12
722
7376
20
73
649
6553
Physical Medicine And Rehabilitation
25 [38004468]
7.3e-01
1.1e+00
1.9e+00
—
1.1e+00
1.3e+00
9.8e-01
cases:8.17%
controls:4.10%
cases:4.48%
controls:1.51%
cases:1.45%
controls:0.22%
—
—
cases:0.79%
controls:0.26%
cases:6.03%
controls:1.69%
cases:12.26%
controls:4.98%
62
310
697
7252
34
114
725
7448
11
17
747
7545
—
6
20
750
7535
44
125
686
7263
82
330
587
6296
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
1.5e-01
3.9e-01
1.0e+00
3.2e+00
1.0e+00
3.5e-01
8.6e-02
cases:22.40%
controls:19.85%
cases:20.29%
controls:14.64%
cases:6.99%
controls:2.64%
cases:4.22%
controls:0.19%
cases:7.41%
controls:2.78%
cases:20.14%
controls:15.08%
cases:30.04%
controls:28.27%
170
1501
589
6061
154
1107
605
6455
53
200
705
7362
32
14
726
7548
56
210
700
7345
147
1114
583
6274
201
1873
468
4753
estradiol; nasal, oral, parenteral, rectal, transdermal, vaginal
G03CA03 [21602517]
8.1e-01
1.1e+00
1.1e+00
—
9.7e-01
9.3e-01
1.1e+00
cases:24.51%
controls:12.66%
cases:22.40%
controls:8.97%
cases:5.94%
controls:2.10%
—
—
cases:6.08%
controls:2.40%
cases:20.55%
controls:9.26%
cases:32.29%
controls:14.28%
186
957
573
6605
170
678
589
6884
45
159
713
7403
—
46
181
710
7374
150
684
580
6704
216
946
453
5680
Leukocytes [#/volume] in Blood
26464-8 [3010813]
7.9e-02
3.5e-01
9.9e-01
3.1e+00
1.0e+00
3.7e-01
1.7e-01
cases:28.06%
controls:26.50%
cases:27.80%
controls:21.32%
cases:10.03%
controls:3.99%
cases:5.15%
controls:0.24%
cases:10.58%
controls:4.04%
cases:28.90%
controls:21.89%
cases:41.55%
controls:37.43%
213
2004
546
5558
211
1612
548
5950
76
302
682
7260
39
18
719
7544
80
305
676
7250
211
1617
519
5771
278
2480
391
4146
venlafaxine; oral
N06AX16 [21604745]
9.9e-01
1.0e+00
1.3e+00
—
1.8e+00
1.1e+00
9.7e-01
cases:3.69%
controls:1.40%
cases:1.98%
controls:0.73%
cases:0.92%
controls:0.26%
—
—
cases:1.46%
controls:0.25%
cases:2.47%
controls:0.81%
cases:4.78%
controls:1.87%
28
106
731
7456
15
55
744
7507
7
20
751
7542
—
11
19
745
7536
18
60
712
7328
32
124
637
6502
MCH [Entitic mass]
28539-5 [3035941]
7.0e-02
3.6e-01
9.7e-01
3.1e+00
1.0e+00
3.7e-01
1.7e-01
cases:27.80%
controls:26.42%
cases:27.80%
controls:21.21%
cases:9.89%
controls:3.99%
cases:5.15%
controls:0.24%
cases:10.58%
controls:4.01%
cases:28.77%
controls:21.81%
cases:41.55%
controls:37.38%
211
1998
548
5564
211
1604
548
5958
75
302
683
7260
39
18
719
7544
80
303
676
7252
210
1611
520
5777
278
2477
391
4149
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
7.0e-02
3.6e-01
9.7e-01
3.1e+00
1.0e+00
3.7e-01
1.7e-01
cases:27.93%
controls:26.54%
cases:27.93%
controls:21.30%
cases:9.89%
controls:4.01%
cases:5.15%
controls:0.24%
cases:10.71%
controls:4.05%
cases:28.77%
controls:21.87%
cases:41.55%
controls:37.47%
212
2007
547
5555
212
1611
547
5951
75
303
683
7259
39
18
719
7544
81
306
675
7249
210
1616
520
5772
278
2483
391
4143
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
7.4e-02
3.6e-01
9.7e-01
3.1e+00
1.0e+00
3.7e-01
1.7e-01
cases:27.93%
controls:26.47%
cases:27.80%
controls:21.20%
cases:9.89%
controls:3.99%
cases:5.15%
controls:0.24%
cases:10.58%
controls:4.02%
cases:28.77%
controls:21.82%
cases:41.55%
controls:37.40%
212
2002
547
5560
211
1603
548
5959
75
302
683
7260
39
18
719
7544
80
304
676
7251
210
1612
520
5776
278
2478
391
4148
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
7.4e-02
3.6e-01
9.7e-01
3.1e+00
1.0e+00
3.7e-01
1.7e-01
cases:27.93%
controls:26.47%
cases:27.80%
controls:21.24%
cases:9.89%
controls:3.99%
cases:5.15%
controls:0.24%
cases:10.58%
controls:4.02%
cases:28.77%
controls:21.83%
cases:41.55%
controls:37.43%
212
2002
547
5560
211
1606
548
5956
75
302
683
7260
39
18
719
7544
80
304
676
7251
210
1613
520
5775
278
2480
391
4146
Platelets [#/volume] in Blood
26515-7 [3007461]
8.0e-02
3.6e-01
9.6e-01
3.1e+00
1.0e+00
3.7e-01
1.7e-01
cases:27.93%
controls:26.36%
cases:27.80%
controls:21.16%
cases:9.89%
controls:4.02%
cases:5.15%
controls:0.24%
cases:10.58%
controls:4.02%
cases:28.63%
controls:21.78%
cases:41.41%
controls:37.37%
212
1993
547
5569
211
1600
548
5962
75
304
683
7258
39
18
719
7544
80
304
676
7251
209
1609
521
5779
277
2476
392
4150
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
7.4e-02
3.6e-01
9.6e-01
3.1e+00
1.0e+00
3.7e-01
1.7e-01
cases:27.93%
controls:26.47%
cases:27.80%
controls:21.25%
cases:9.89%
controls:4.02%
cases:5.15%
controls:0.24%
cases:10.58%
controls:4.02%
cases:28.77%
controls:21.83%
cases:41.55%
controls:37.41%
212
2002
547
5560
211
1607
548
5955
75
304
683
7258
39
18
719
7544
80
304
676
7251
210
1613
520
5775
278
2479
391
4147
pH of Urine by Test strip
5803-2 [3022621]
1.1e+00
2.0e+00
2.8e+00
—
—
1.2e+00
7.3e-01
cases:2.11%
controls:0.74%
cases:2.37%
controls:0.33%
cases:1.06%
controls:0.07%
—
—
—
—
cases:1.37%
controls:0.42%
cases:3.29%
controls:1.61%
16
56
743
7506
18
25
741
7537
8
5
750
7557
—
—
10
31
720
7357
22
107
647
6519
pantoprazole; oral, parenteral
A02BC02 [21600097]
8.3e-01
9.5e-01
8.4e-01
—
1.3e+00
9.9e-01
9.2e-01
cases:22.00%
controls:10.94%
cases:13.83%
controls:5.86%
cases:3.17%
controls:1.39%
—
—
cases:3.84%
controls:1.09%
cases:14.52%
controls:5.93%
cases:29.45%
controls:14.20%
167
827
592
6735
105
443
654
7119
24
105
734
7457
—
29
82
727
7473
106
438
624
6950
197
941
472
5685
oxycodone; oral, parenteral
N02AA05 [21604260]
1.0e+00
1.5e+00
—
—
2.2e+00
1.1e+00
9.3e-01
cases:1.71%
controls:0.63%
cases:2.11%
controls:0.46%
—
—
—
—
cases:0.93%
controls:0.11%
cases:1.92%
controls:0.62%
cases:3.44%
controls:1.39%
13
48
746
7514
16
35
743
7527
—
—
7
8
749
7547
14
46
716
7342
23
92
646
6534
Choriogonadotropin [Units/volume] in Urine
25372-4 [3023511]
1.3e+00
2.5e+00
—
—
—
2.0e+00
1.2e+00
cases:1.58%
controls:0.42%
cases:0.92%
controls:0.08%
—
—
—
—
—
—
cases:0.96%
controls:0.14%
cases:1.35%
controls:0.41%
12
32
747
7530
7
6
752
7556
—
—
—
7
10
723
7378
9
27
660
6599
Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
24111-7 [3011371]
1.3e+00
1.7e+00
—
1.0e+50
—
1.5e+00
1.2e+00
cases:3.56%
controls:1.01%
cases:2.24%
controls:0.42%
—
—
cases:1.19%
controls:0.00%
—
—
cases:1.92%
controls:0.43%
cases:5.53%
controls:1.77%
27
76
732
7486
17
32
742
7530
—
9
0
749
7562
—
14
32
716
7356
37
117
632
6509
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
6.9e-01
9.9e-01
1.6e+00
—
1.8e+00
1.3e+00
8.4e-01
cases:5.80%
controls:2.99%
cases:3.69%
controls:1.40%
cases:0.92%
controls:0.19%
—
—
cases:1.06%
controls:0.17%
cases:3.84%
controls:1.12%
cases:7.62%
controls:3.44%
44
226
715
7336
28
106
731
7456
7
14
751
7548
—
8
13
748
7542
28
83
702
7305
51
228
618
6398
valproic acid; oral, parenteral, rectal
N03AG01 [21604422]
1.4e+00
1.2e+00
—
—
—
1.3e+00
1.7e+00
cases:2.37%
controls:0.58%
cases:1.58%
controls:0.48%
—
—
—
—
—
—
cases:1.64%
controls:0.47%
cases:3.29%
controls:0.62%
18
44
741
7518
12
36
747
7526
—
—
—
12
35
718
7353
22
41
647
6585
estriol; oral, parenteral, vaginal
G03CA04 [21602518]
1.1e+00
1.6e+00
—
—
—
1.8e+00
1.1e+00
cases:2.64%
controls:0.87%
cases:1.84%
controls:0.38%
—
—
—
—
—
—
cases:1.64%
controls:0.28%
cases:2.69%
controls:0.92%
20
66
739
7496
14
29
745
7533
—
—
—
12
21
718
7367
18
61
651
6565
azithromycin; oral, parenteral
J01FA10 [21602978]
8.4e-01
9.8e-01
2.0e+00
1.0e+50
1.1e+00
1.0e+00
6.8e-01
cases:17.65%
controls:8.46%
cases:6.32%
controls:2.47%
cases:1.32%
controls:0.19%
cases:2.11%
controls:0.00%
cases:1.06%
controls:0.36%
cases:5.75%
controls:2.10%
cases:15.70%
controls:8.62%
134
640
625
6922
48
187
711
7375
10
14
748
7548
16
0
742
7562
8
27
748
7528
42
155
688
7233
105
571
564
6055
pregabalin; oral
N02BF02 [955152]
1.2e+00
1.4e+00
6.9e-01
—
—
1.4e+00
1.4e+00
cases:6.46%
controls:1.97%
cases:3.69%
controls:0.90%
cases:0.79%
controls:0.40%
—
—
—
—
cases:3.97%
controls:0.97%
cases:8.97%
controls:2.37%
49
149
710
7413
28
68
731
7494
6
30
752
7532
—
—
29
72
701
7316
60
157
609
6469
Low back pain
M54.5 [45553207]
6.4e-01
8.6e-01
2.3e+00
—
—
8.9e-01
8.0e-01
cases:6.98%
controls:3.81%
cases:2.77%
controls:1.19%
cases:0.92%
controls:0.09%
—
—
—
—
cases:3.15%
controls:1.31%
cases:10.16%
controls:4.83%
53
288
706
7274
21
90
738
7472
7
7
751
7555
—
—
23
97
707
7291
68
320
601
6306
esomeprazole; oral, parenteral
A02BC05 [21600100]
1.2e+00
1.2e+00
1.1e+00
—
8.6e-01
1.1e+00
9.6e-01
cases:14.23%
controls:4.83%
cases:7.77%
controls:2.58%
cases:1.72%
controls:0.58%
—
—
cases:1.46%
controls:0.62%
cases:7.40%
controls:2.67%
cases:15.55%
controls:6.61%
108
365
651
7197
59
195
700
7367
13
44
745
7518
—
11
47
745
7508
54
197
676
7191
104
438
565
6188
Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
21613-5 [3006093]
1.3e+00
1.6e+00
—
1.0e+50
—
1.6e+00
9.7e-01
cases:5.01%
controls:1.39%
cases:3.16%
controls:0.67%
—
—
cases:1.19%
controls:0.00%
—
—
cases:2.60%
controls:0.55%
cases:5.53%
controls:2.17%
38
105
721
7457
24
51
735
7511
—
9
0
749
7562
—
19
41
711
7347
37
144
632
6482
Diaphragmatic hernia without obstruction or gangrene
K44.9 [45533596]
1.6e+00
—
—
—
—
2.3e+00
1.5e+00
cases:1.45%
controls:0.29%
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.11%
cases:2.09%
controls:0.48%
11
22
748
7540
—
—
—
—
8
8
722
7380
14
32
655
6594
Base excess in Venous blood by calculation
1927-3 [3002032]
1.0e+00
1.2e+00
—
—
2.5e+00
1.7e+00
1.6e-01
cases:1.71%
controls:0.63%
cases:1.58%
controls:0.48%
—
—
—
—
cases:0.79%
controls:0.07%
cases:2.47%
controls:0.46%
cases:2.09%
controls:1.80%
13
48
746
7514
12
36
747
7526
—
—
6
5
750
7550
18
34
712
7354
14
119
655
6507
Sedation and analgesia
WX002 [2001310758]
8.1e-01
1.9e+00
—
—
—
1.5e+00
1.1e+00
cases:3.03%
controls:1.38%
cases:1.58%
controls:0.24%
—
—
—
—
—
—
cases:1.37%
controls:0.30%
cases:3.59%
controls:1.18%
23
104
736
7458
12
18
747
7544
—
—
—
10
22
720
7366
24
78
645
6548
alfuzosin; oral
G04CA01 [21602668]
1.1e+00
1.4e+00
—
—
1.7e+00
1.3e+00
1.6e+00
cases:2.24%
controls:0.73%
cases:1.98%
controls:0.50%
—
—
—
—
cases:0.93%
controls:0.17%
cases:1.78%
controls:0.51%
cases:3.44%
controls:0.72%
17
55
742
7507
15
38
744
7524
—
—
7
13
749
7542
13
38
717
7350
23
48
646
6578
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
9.8e-01
1.5e+00
—
—
—
1.9e+00
1.0e+00
cases:2.77%
controls:1.06%
cases:1.58%
controls:0.37%
—
—
—
—
—
—
cases:2.19%
controls:0.34%
cases:3.44%
controls:1.25%
21
80
738
7482
12
28
747
7534
—
—
—
16
25
714
7363
23
83
646
6543
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
8.4e-02
3.1e-01
9.5e-01
3.1e+00
9.4e-01
3.7e-01
1.9e-01
cases:17.79%
controls:16.60%
cases:17.13%
controls:13.18%
cases:6.33%
controls:2.54%
cases:4.09%
controls:0.20%
cases:6.61%
controls:2.70%
cases:18.63%
controls:13.63%
cases:28.40%
controls:24.78%
135
1255
624
6307
130
997
629
6565
48
192
710
7370
31
15
727
7547
50
204
706
7351
136
1007
594
6381
190
1642
479
4984
celecoxib; oral
M01AH01 [21603992]
7.8e-01
1.9e+00
—
—
—
1.3e+00
1.3e+00
cases:3.43%
controls:1.60%
cases:2.37%
controls:0.37%
—
—
—
—
—
—
cases:1.51%
controls:0.42%
cases:5.83%
controls:1.65%
26
121
733
7441
18
28
741
7534
—
—
—
11
31
719
7357
39
109
630
6517
celecoxib
L01XX33 [21603805]
7.8e-01
1.9e+00
—
—
—
1.3e+00
1.3e+00
cases:3.43%
controls:1.60%
cases:2.37%
controls:0.37%
—
—
—
—
—
—
cases:1.51%
controls:0.42%
cases:5.83%
controls:1.65%
26
121
733
7441
18
28
741
7534
—
—
—
11
31
719
7357
39
109
630
6517
CBC panel - Blood by Automated count
58410-2 [40761511]
1.6e-01
3.7e-01
9.2e-01
2.7e+00
8.4e-01
4.0e-01
1.6e-01
cases:25.03%
controls:22.14%
cases:20.29%
controls:14.90%
cases:5.41%
controls:2.22%
cases:2.11%
controls:0.15%
cases:5.42%
controls:2.42%
cases:20.27%
controls:14.52%
cases:33.18%
controls:29.70%
190
1674
569
5888
154
1127
605
6435
41
168
717
7394
16
11
742
7551
41
183
715
7372
148
1073
582
6315
222
1968
447
4658
Dyspareunia
N94.1 [45534149]
2.6e+00
—
—
—
—
—
2.6e+00
cases:1.19%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:2.24%
controls:0.17%
9
7
750
7555
—
—
—
—
—
15
11
654
6615
Nausea and vomiting
R11 [45539317]
1.3e+00
—
—
—
—
2.3e+00
1.4e+00
cases:2.11%
controls:0.57%
—
—
—
—
—
—
—
—
cases:1.51%
controls:0.15%
cases:2.99%
controls:0.72%
16
43
743
7519
—
—
—
—
11
11
719
7377
20
48
649
6578
Supplier / Service Provider
OMOP5117446 [33004]
-9.7e-01
-7.4e-01
—
—
—
3.5e+00
3.3e+00
cases:12.52%
controls:27.43%
cases:4.74%
controls:9.43%
—
—
—
—
—
—
cases:4.38%
controls:0.14%
cases:15.40%
controls:0.69%
95
2074
664
5488
36
713
723
6849
—
—
—
32
10
698
7378
103
46
566
6580
Limited function/disability (L)
L28 [2002000647]
7.0e-01
1.2e+00
2.8e+00
—
1.7e+00
1.1e+00
1.1e+00
cases:2.37%
controls:1.19%
cases:1.84%
controls:0.57%
cases:1.32%
controls:0.08%
—
—
cases:0.66%
controls:0.12%
cases:1.64%
controls:0.55%
cases:5.08%
controls:1.83%
18
90
741
7472
14
43
745
7519
10
6
748
7556
—
5
9
751
7546
12
41
718
7347
34
121
635
6505
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
4.1e-01
7.5e-01
1.4e+00
—
1.6e+00
7.2e-01
5.9e-01
cases:10.67%
controls:7.33%
cases:7.11%
controls:3.50%
cases:1.58%
controls:0.40%
—
—
cases:1.98%
controls:0.40%
cases:6.71%
controls:3.40%
cases:17.64%
controls:10.65%
81
554
678
7008
54
265
705
7297
12
30
746
7532
—
15
30
741
7525
49
251
681
7137
118
706
551
5920
Gastro-oesophageal reflux disease without oesophagitis
K21.9 [45538509]
1.4e+00
1.8e+00
—
—
—
1.3e+00
1.9e+00
cases:2.37%
controls:0.60%
cases:1.32%
controls:0.22%
—
—
—
—
—
—
cases:0.68%
controls:0.19%
cases:4.48%
controls:0.71%
18
45
741
7517
10
17
749
7545
—
—
—
5
14
725
7374
30
47
639
6579
FVC percent change Respiratory system
69982-7 [42868471]
1.0e+00
1.1e+00
—
—
—
2.2e+00
1.8e+00
cases:3.03%
controls:1.08%
cases:0.79%
controls:0.28%
—
—
—
—
—
—
cases:0.96%
controls:0.11%
cases:3.89%
controls:0.65%
23
82
736
7480
6
21
753
7541
—
—
—
7
8
723
7380
26
43
643
6583
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
1.0e+00
1.1e+00
—
—
—
2.2e+00
1.8e+00
cases:3.03%
controls:1.08%
cases:0.79%
controls:0.28%
—
—
—
—
—
—
cases:0.96%
controls:0.11%
cases:3.89%
controls:0.65%
23
82
736
7480
6
21
753
7541
—
—
—
7
8
723
7380
26
43
643
6583
FEV1/FVC --post bronchodilation
69970-2 [42868459]
1.0e+00
1.1e+00
—
—
—
2.2e+00
1.8e+00
cases:3.03%
controls:1.08%
cases:0.79%
controls:0.28%
—
—
—
—
—
—
cases:0.96%
controls:0.11%
cases:3.89%
controls:0.65%
23
82
736
7480
6
21
753
7541
—
—
—
7
8
723
7380
26
43
643
6583
FEV1 percent change
69983-5 [42868472]
1.0e+00
1.1e+00
—
—
—
2.2e+00
1.8e+00
cases:3.03%
controls:1.08%
cases:0.79%
controls:0.28%
—
—
—
—
—
—
cases:0.96%
controls:0.11%
cases:3.89%
controls:0.65%
23
82
736
7480
6
21
753
7541
—
—
—
7
8
723
7380
26
43
643
6583
FEV1 --post bronchodilation
20155-8 [3023550]
1.0e+00
1.1e+00
—
—
—
2.2e+00
1.8e+00
cases:3.03%
controls:1.08%
cases:0.79%
controls:0.28%
—
—
—
—
—
—
cases:0.96%
controls:0.11%
cases:3.89%
controls:0.65%
23
82
736
7480
6
21
753
7541
—
—
—
7
8
723
7380
26
43
643
6583
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
9.3e-01
8.7e-01
1.5e+00
—
1.8e+00
1.0e+00
1.3e+00
cases:5.40%
controls:2.21%
cases:2.24%
controls:0.95%
cases:0.66%
controls:0.15%
—
—
cases:1.06%
controls:0.17%
cases:2.47%
controls:0.91%
cases:5.68%
controls:1.66%
41
167
718
7395
17
72
742
7490
5
11
753
7551
—
8
13
748
7542
18
67
712
7321
38
110
631
6516
Physiotherapist
Z3226 [2001311560]
7.2e-01
1.6e+00
—
—
—
2.0e+00
1.4e+00
cases:3.56%
controls:1.77%
cases:1.84%
controls:0.40%
—
—
—
—
—
—
cases:2.74%
controls:0.37%
cases:5.08%
controls:1.27%
27
134
732
7428
14
30
745
7532
—
—
—
20
27
710
7361
34
84
635
6542
Malignant neoplasm: Overlapping lesion of bladder
C67.8 [45532924]
—
—
—
—
—
2.7e+00
2.3e+00
—
—
—
—
—
—
—
—
—
—
cases:0.96%
controls:0.07%
cases:0.90%
controls:0.09%
—
—
—
—
—
7
5
723
7383
6
6
663
6620
General anesthesia, balanced
WX408 [2001310808]
9.6e-01
1.3e+00
—
—
—
1.5e+00
1.1e+00
cases:6.46%
controls:2.57%
cases:2.24%
controls:0.60%
—
—
—
—
—
—
cases:2.19%
controls:0.47%
cases:5.38%
controls:1.89%
49
194
710
7368
17
45
742
7517
—
—
—
16
35
714
7353
36
125
633
6501
FEV1/FVC
19926-5 [3011505]
1.0e+00
1.2e+00
—
—
—
2.0e+00
1.9e+00
cases:3.29%
controls:1.23%
cases:1.19%
controls:0.34%
—
—
—
—
—
—
cases:0.96%
controls:0.14%
cases:4.63%
controls:0.69%
25
93
734
7469
9
26
750
7536
—
—
—
7
10
723
7378
31
46
638
6580
FEV1
20150-9 [3024653]
1.0e+00
1.2e+00
—
—
—
2.0e+00
1.9e+00
cases:3.29%
controls:1.23%
cases:1.19%
controls:0.34%
—
—
—
—
—
—
cases:0.96%
controls:0.14%
cases:4.63%
controls:0.69%
25
93
734
7469
9
26
750
7536
—
—
—
7
10
723
7378
31
46
638
6580
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
1.0e+00
1.2e+00
—
—
—
2.0e+00
1.9e+00
cases:3.29%
controls:1.23%
cases:1.19%
controls:0.34%
—
—
—
—
—
—
cases:0.96%
controls:0.14%
cases:4.63%
controls:0.69%
25
93
734
7469
9
26
750
7536
—
—
—
7
10
723
7378
31
46
638
6580
Urinary tract ultrasound examination
KH1AE [2001306329]
2.3e+00
—
—
—
—
—
2.6e+00
cases:2.11%
controls:0.22%
—
—
—
—
—
—
—
—
—
—
cases:2.09%
controls:0.15%
16
17
743
7545
—
—
—
—
—
14
10
655
6616
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
1.2e+00
1.5e+00
—
—
—
1.5e+00
7.7e-01
cases:2.77%
controls:0.89%
cases:2.50%
controls:0.58%
—
—
—
—
—
—
cases:2.33%
controls:0.54%
cases:4.78%
controls:2.26%
21
67
738
7495
19
44
740
7518
—
—
—
17
40
713
7348
32
150
637
6476
Urination problems other
U05 [2002001140]
2.6e+00
—
—
—
—
2.3e+00
—
cases:1.19%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.82%
controls:0.08%
—
—
9
7
750
7555
—
—
—
—
6
6
724
7382
—
Other specified inflammation of vagina and vulva
N76.8 [45553454]
2.5e+00
—
—
—
—
—
2.3e+00
cases:0.79%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
cases:1.05%
controls:0.11%
6
5
753
7557
—
—
—
—
—
7
7
662
6619
Malaise and fatigue
R53 [45553741]
1.1e+00
1.1e+00
—
—
—
1.4e+00
1.1e+00
cases:4.22%
controls:1.44%
cases:2.37%
controls:0.78%
—
—
—
—
—
—
cases:2.88%
controls:0.70%
cases:8.67%
controls:3.08%
32
109
727
7453
18
59
741
7503
—
—
—
21
52
709
7336
58
204
611
6422
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
9.5e-01
1.1e+00
—
—
—
1.5e+00
1.2e+00
cases:6.59%
controls:2.64%
cases:2.64%
controls:0.89%
—
—
—
—
—
—
cases:3.01%
controls:0.72%
cases:8.67%
controls:2.72%
50
200
709
7362
20
67
739
7495
—
—
—
22
53
708
7335
58
180
611
6446
Stomach Pathology biopsy report
66114-0 [40768797]
8.9e-01
1.4e+00
—
—
—
1.3e+00
1.2e+00
cases:2.90%
controls:1.22%
cases:1.84%
controls:0.48%
—
—
—
—
—
—
cases:1.78%
controls:0.49%
cases:4.48%
controls:1.43%
22
92
737
7470
14
36
745
7526
—
—
—
13
36
717
7352
30
95
639
6531
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
5.6e-01
6.7e-01
7.6e-01
—
1.7e+00
1.1e+00
7.1e-01
cases:8.43%
controls:4.99%
cases:5.14%
controls:2.68%
cases:0.79%
controls:0.37%
—
—
cases:1.85%
controls:0.36%
cases:7.12%
controls:2.53%
cases:14.05%
controls:7.46%
64
377
695
7185
39
203
720
7359
6
28
752
7534
—
14
27
742
7528
52
187
678
7201
94
494
575
6132
Ultrasound examination of uterus and parametria
LC2AE [2001306543]
1.8e+00
1.3e+00
—
—
—
1.5e+00
1.4e+00
cases:3.95%
controls:0.69%
cases:0.92%
controls:0.26%
—
—
—
—
—
—
cases:1.23%
controls:0.27%
cases:3.74%
controls:0.98%
30
52
729
7510
7
20
752
7542
—
—
—
9
20
721
7368
25
65
644
6561
Case Management Agency
251B00000X [38004193]
8.1e-02
1.8e-01
6.9e-01
3.4e+00
5.4e-01
1.8e-01
1.7e-01
cases:49.67%
controls:47.66%
cases:46.11%
controls:41.62%
cases:27.84%
controls:16.17%
cases:22.69%
controls:0.94%
cases:25.66%
controls:16.76%
cases:47.26%
controls:42.83%
cases:62.93%
controls:58.77%
377
3604
382
3958
350
3147
409
4415
211
1223
547
6339
172
71
586
7491
194
1266
562
6289
345
3164
385
4224
421
3894
248
2732
Gas panel - Venous blood
24339-4 [3000991]
1.3e+00
1.5e+00
—
—
—
1.8e+00
7.5e-01
cases:1.58%
controls:0.42%
cases:1.32%
controls:0.29%
—
—
—
—
—
—
cases:1.92%
controls:0.34%
cases:2.39%
controls:1.15%
12
32
747
7530
10
22
749
7540
—
—
—
14
25
716
7363
16
76
653
6550
Differential panel, method unspecified - Blood
69738-3 [42870588]
7.8e-01
7.6e-01
5.9e-01
—
1.4e+00
7.5e-01
8.3e-01
cases:8.43%
controls:4.05%
cases:5.40%
controls:2.59%
cases:0.92%
controls:0.52%
—
—
cases:1.72%
controls:0.41%
cases:5.34%
controls:2.59%
cases:12.26%
controls:5.73%
64
306
695
7256
41
196
718
7366
7
39
751
7523
—
13
31
743
7524
39
191
691
7197
82
380
587
6246
Home Visit
OMOP4822459 [581476]
2.9e-01
6.1e-01
1.5e+00
1.8e+00
1.3e+00
5.7e-01
3.4e-01
cases:4.61%
controls:3.48%
cases:3.43%
controls:1.89%
cases:2.37%
controls:0.56%
cases:1.19%
controls:0.20%
cases:2.25%
controls:0.62%
cases:3.84%
controls:2.21%
cases:8.52%
controls:6.23%
35
263
724
7299
26
143
733
7419
18
42
740
7520
9
15
749
7547
17
47
739
7508
28
163
702
7225
57
413
612
6213
Acute vaginitis
N76.0 [45543891]
1.5e+00
1.6e+00
—
—
—
1.6e+00
1.4e+00
cases:1.45%
controls:0.33%
cases:0.92%
controls:0.19%
—
—
—
—
—
—
cases:1.10%
controls:0.22%
cases:3.59%
controls:0.89%
11
25
748
7537
7
14
752
7548
—
—
—
8
16
722
7372
24
59
645
6567
codeine and paracetamol
N02AJ06 [1123647]
6.1e-01
9.4e-01
1.2e+00
—
7.4e-01
9.8e-01
8.0e-01
cases:15.02%
controls:8.73%
cases:7.25%
controls:2.95%
cases:2.24%
controls:0.69%
—
—
cases:1.19%
controls:0.57%
cases:8.36%
controls:3.32%
cases:18.68%
controls:9.33%
114
660
645
6902
55
223
704
7339
17
52
741
7510
—
9
43
747
7512
61
245
669
7143
125
618
544
6008
lorazepam; oral, parenteral, sublingual
N05BA06 [21604571]
1.3e+00
9.5e-01
—
—
—
1.6e+00
1.6e+00
cases:2.50%
controls:0.69%
cases:1.05%
controls:0.41%
—
—
—
—
—
—
cases:1.78%
controls:0.37%
cases:3.14%
controls:0.65%
19
52
740
7510
8
31
751
7531
—
—
—
13
27
717
7361
21
43
648
6583
Internal Medicine
11 [38004456]
6.1e-01
7.4e-01
1.6e+00
—
8.0e-01
8.0e-01
7.8e-01
cases:27.67%
controls:17.18%
cases:14.89%
controls:7.72%
cases:4.49%
controls:0.98%
—
—
cases:2.78%
controls:1.27%
cases:14.38%
controls:7.02%
cases:30.79%
controls:16.95%
210
1299
549
6263
113
584
646
6978
34
74
724
7488
—
21
96
735
7459
105
519
625
6869
206
1123
463
5503
dequalinium; vaginal
G01AC05 [21602381]
—
2.8e+00
—
—
—
—
1.7e+00
—
—
cases:1.32%
controls:0.08%
—
—
—
—
—
—
—
—
cases:1.64%
controls:0.32%
—
10
6
749
7556
—
—
—
—
11
21
658
6605
Taking care of patient’s/customer’s hygiene
SPAT1137 [2001700238]
—
2.3e+00
—
—
2.2e+00
1.4e+00
1.0e+00
—
—
cases:1.05%
controls:0.11%
—
—
—
—
cases:0.79%
controls:0.09%
cases:0.96%
controls:0.23%
cases:1.20%
controls:0.44%
—
8
8
751
7554
—
—
6
7
750
7548
7
17
723
7371
8
29
661
6597
Irritable bowel syndrome without diarrhoea
K58.9 [45538539]
2.2e+00
—
—
—
—
—
2.2e+00
cases:1.32%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
cases:1.79%
controls:0.20%
10
11
749
7551
—
—
—
—
—
12
13
657
6613
Scheduled procedure
ZXD10 [2001311387]
7.8e-01
9.1e-01
—
1.0e+50
2.0e+00
1.5e+00
1.2e+00
cases:9.49%
controls:4.56%
cases:3.43%
controls:1.40%
—
—
cases:1.19%
controls:0.00%
cases:0.66%
controls:0.09%
cases:4.79%
controls:1.08%
cases:10.91%
controls:3.56%
72
345
687
7217
26
106
733
7456
—
9
0
749
7562
5
7
751
7548
35
80
695
7308
73
236
596
6390
etoricoxib; oral
M01AH05 [21603996]
6.1e-01
7.8e-01
1.1e+00
—
1.6e+00
5.8e-01
8.0e-01
cases:14.89%
controls:8.69%
cases:7.11%
controls:3.39%
cases:1.32%
controls:0.42%
—
—
cases:1.85%
controls:0.38%
cases:6.44%
controls:3.71%
cases:22.57%
controls:11.61%
113
657
646
6905
54
256
705
7306
10
32
748
7530
—
14
29
742
7526
47
274
683
7114
151
769
518
5857
Insertion of urinary catheter
SPAT1167 [2001700268]
—
—
—
—
—
2.3e+00
2.0e+00
—
—
—
—
—
—
—
—
—
—
cases:0.96%
controls:0.09%
cases:1.35%
controls:0.18%
—
—
—
—
—
7
7
723
7381
9
12
660
6614
doxycycline; oral, parenteral
J01AA02 [21602800]
5.4e-01
6.5e-01
9.8e-01
—
1.6e+00
8.7e-01
6.3e-01
cases:27.40%
controls:17.98%
cases:9.22%
controls:5.05%
cases:1.19%
controls:0.45%
—
—
cases:1.72%
controls:0.34%
cases:9.86%
controls:4.40%
cases:24.81%
controls:14.96%
208
1360
551
6202
70
382
689
7180
9
34
749
7528
—
13
26
743
7529
72
325
658
7063
166
991
503
5635
alprazolam; oral
N05BA12 [21604577]
8.2e-01
1.1e+00
1.1e+00
—
—
1.1e+00
1.2e+00
cases:3.16%
controls:1.41%
cases:1.84%
controls:0.62%
cases:0.66%
controls:0.21%
—
—
—
—
cases:1.92%
controls:0.64%
cases:3.89%
controls:1.15%
24
107
735
7455
14
47
745
7515
5
16
753
7546
—
—
14
47
716
7341
26
76
643
6550
Dyspnoea
R06.0 [45558449]
1.1e+00
1.2e+00
—
—
—
1.2e+00
8.1e-01
cases:5.67%
controls:2.00%
cases:2.37%
controls:0.75%
—
—
—
—
—
—
cases:2.60%
controls:0.81%
cases:5.98%
controls:2.76%
43
151
716
7411
18
57
741
7505
—
—
—
19
60
711
7328
40
183
629
6443
trospium; oral
G04BD09 [21602642]
2.1e+00
—
—
—
—
—
2.2e+00
cases:0.92%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:1.05%
controls:0.12%
7
9
752
7553
—
—
—
—
—
7
8
662
6618
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
5.0e-01
6.2e-01
1.1e+00
—
8.7e-01
5.9e-01
5.2e-01
cases:39.92%
controls:28.68%
cases:21.61%
controls:12.89%
cases:3.69%
controls:1.26%
—
—
cases:3.97%
controls:1.69%
cases:20.82%
controls:12.71%
cases:42.90%
controls:30.89%
303
2169
456
5393
164
975
595
6587
28
95
730
7467
—
30
128
726
7427
152
939
578
6449
287
2047
382
4579
ibuprofen
R02AX02 [1588667]
5.0e-01
6.2e-01
1.1e+00
—
8.7e-01
5.9e-01
5.2e-01
cases:39.92%
controls:28.68%
cases:21.61%
controls:12.89%
cases:3.69%
controls:1.26%
—
—
cases:3.97%
controls:1.69%
cases:20.82%
controls:12.71%
cases:42.90%
controls:30.89%
303
2169
456
5393
164
975
595
6587
28
95
730
7467
—
30
128
726
7427
152
939
578
6449
287
2047
382
4579
clidinium and psycholeptics
A03CA02 [21600204]
1.3e+00
1.5e+00
—
—
—
1.1e+00
1.4e+00
cases:3.03%
controls:0.83%
cases:1.45%
controls:0.32%
—
—
—
—
—
—
cases:0.96%
controls:0.32%
cases:2.84%
controls:0.74%
23
63
736
7499
11
24
748
7538
—
—
—
7
24
723
7364
19
49
650
6577
Headache
R51.80 [2000503603]
1.1e+00
1.1e+00
—
—
—
1.8e+00
1.2e+00
cases:4.22%
controls:1.40%
cases:1.32%
controls:0.46%
—
—
—
—
—
—
cases:2.19%
controls:0.35%
cases:4.48%
controls:1.36%
32
106
727
7456
10
35
749
7527
—
—
—
16
26
714
7362
30
90
639
6536
Bipolar affective disorder, unspecified
F31.9 [45571758]
1.9e+00
-1.0e+50
—
—
—
—
2.2e+00
cases:0.92%
controls:0.13%
cases:0.00%
controls:0.16%
—
—
—
—
—
—
—
—
cases:1.94%
controls:0.21%
7
10
752
7552
0
12
759
7550
—
—
—
—
13
14
656
6612
zolpidem; oral
N05CF02 [21604655]
7.9e-01
1.1e+00
1.9e+00
—
1.5e+00
1.3e+00
9.3e-01
cases:4.08%
controls:1.90%
cases:3.16%
controls:1.06%
cases:0.79%
controls:0.12%
—
—
cases:0.79%
controls:0.19%
cases:3.84%
controls:1.03%
cases:6.73%
controls:2.76%
31
144
728
7418
24
80
735
7482
6
9
752
7553
—
6
14
750
7541
28
76
702
7312
45
183
624
6443
Basophils/Leukocytes in Blood
30180-4 [3022096]
7.2e-01
6.7e-01
9.6e-01
—
1.4e+00
6.2e-01
7.4e-01
cases:11.59%
controls:6.02%
cases:7.11%
controls:3.78%
cases:1.98%
controls:0.77%
—
—
cases:2.51%
controls:0.62%
cases:6.99%
controls:3.87%
cases:16.89%
controls:8.83%
88
455
671
7107
54
286
705
7276
15
58
743
7504
—
19
47
737
7508
51
286
679
7102
113
585
556
6041
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
7.0e-01
6.7e-01
8.7e-01
—
1.4e+00
6.3e-01
7.3e-01
cases:11.59%
controls:6.10%
cases:7.11%
controls:3.77%
cases:1.85%
controls:0.78%
—
—
cases:2.51%
controls:0.62%
cases:6.99%
controls:3.83%
cases:16.74%
controls:8.81%
88
461
671
7101
54
285
705
7277
14
59
744
7503
—
19
47
737
7508
51
283
679
7105
112
584
557
6042
Monocytes/Leukocytes in Blood
26485-3 [3019069]
6.9e-01
6.5e-01
8.7e-01
—
1.4e+00
6.3e-01
7.6e-01
cases:11.46%
controls:6.08%
cases:7.11%
controls:3.83%
cases:1.85%
controls:0.78%
—
—
cases:2.51%
controls:0.62%
cases:6.99%
controls:3.86%
cases:17.04%
controls:8.80%
87
460
672
7102
54
290
705
7272
14
59
744
7503
—
19
47
737
7508
51
285
679
7103
114
583
555
6043
Pain localized to upper abdomen
R10.1 [45568111]
9.3e-01
1.6e+00
—
—
—
1.3e+00
1.6e+00
cases:3.69%
controls:1.49%
cases:2.11%
controls:0.42%
—
—
—
—
—
—
cases:1.51%
controls:0.43%
cases:6.88%
controls:1.48%
28
113
731
7449
16
32
743
7530
—
—
—
11
32
719
7356
46
98
623
6528
Abdominal ultrasound examination
JN3AE [2001305555]
1.2e+00
—
—
—
—
1.7e+00
1.2e+00
cases:2.24%
controls:0.70%
—
—
—
—
—
—
—
—
cases:1.23%
controls:0.22%
cases:2.39%
controls:0.72%
17
53
742
7509
—
—
—
—
9
16
721
7372
16
48
653
6578
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
6.1e-01
5.9e-01
8.9e-01
—
1.4e+00
9.4e-01
6.1e-01
cases:9.62%
controls:5.46%
cases:5.53%
controls:3.13%
cases:1.06%
controls:0.44%
—
—
cases:1.72%
controls:0.44%
cases:7.67%
controls:3.15%
cases:15.55%
controls:9.09%
73
413
686
7149
42
237
717
7325
8
33
750
7529
—
13
33
743
7522
56
233
674
7155
104
602
565
6024
Tension-type headache
G44.2 [45581495]
1.1e+00
1.7e+00
—
—
-1.0e+50
6.8e-01
1.3e+00
cases:3.29%
controls:1.12%
cases:1.71%
controls:0.32%
—
—
—
—
cases:0.00%
controls:0.08%
cases:0.96%
controls:0.49%
cases:5.08%
controls:1.39%
25
85
734
7477
13
24
746
7538
—
—
0
6
756
7549
7
36
723
7352
34
92
635
6534
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
1.0e+00
1.2e+00
—
—
2.5e+00
1.6e+00
3.8e-02
cases:1.71%
controls:0.62%
cases:1.45%
controls:0.46%
—
—
—
—
cases:0.79%
controls:0.07%
cases:2.47%
controls:0.49%
cases:1.94%
controls:1.87%
13
47
746
7515
11
35
748
7527
—
—
6
5
750
7550
18
36
712
7352
13
124
656
6502
Day surgery
ZXD20 [2001311388]
1.0e+00
1.1e+00
—
—
—
1.8e+00
1.3e+00
cases:2.37%
controls:0.87%
cases:0.92%
controls:0.32%
—
—
—
—
—
—
cases:1.10%
controls:0.19%
cases:3.44%
controls:0.92%
18
66
741
7496
7
24
752
7538
—
—
—
8
14
722
7374
23
61
646
6565
Telehealth
OMOP5556618 [722455]
3.8e-01
6.4e-01
1.2e+00
—
8.8e-01
5.9e-01
4.1e-01
cases:23.98%
controls:17.80%
cases:14.49%
controls:8.17%
cases:4.22%
controls:1.30%
—
—
cases:2.91%
controls:1.23%
cases:12.74%
controls:7.50%
cases:21.97%
controls:15.77%
182
1346
577
6216
110
618
649
6944
32
98
726
7464
—
22
93
734
7462
93
554
637
6834
147
1045
522
5581
Headache
R51 [45558474]
6.9e-01
—
—
—
—
2.3e+00
1.8e+00
cases:0.92%
controls:0.46%
—
—
—
—
—
—
—
—
cases:0.82%
controls:0.08%
cases:1.94%
controls:0.33%
7
35
752
7527
—
—
—
—
6
6
724
7382
13
22
656
6604
pH of Venous blood
2746-6 [3012544]
8.8e-01
1.2e+00
—
—
2.5e+00
1.6e+00
3.3e-01
cases:1.58%
controls:0.66%
cases:1.58%
controls:0.49%
—
—
—
—
cases:0.79%
controls:0.07%
cases:2.33%
controls:0.47%
cases:2.54%
controls:1.84%
12
50
747
7512
12
37
747
7525
—
—
6
5
750
7550
17
35
713
7353
17
122
652
6504
Cells panel - Urine sediment
58434-2 [40761535]
7.0e-01
1.7e+00
—
1.0e+50
—
1.4e+00
1.1e+00
cases:2.11%
controls:1.06%
cases:2.11%
controls:0.41%
—
—
cases:0.92%
controls:0.00%
—
—
cases:1.78%
controls:0.46%
cases:2.69%
controls:0.94%
16
80
743
7482
16
31
743
7531
—
7
0
751
7562
—
13
34
717
7354
18
62
651
6564
Kolposcopy
ULA02 [2001306679]
1.1e+00
1.2e+00
—
—
—
1.8e+00
1.2e+00
cases:2.77%
controls:0.97%
cases:1.19%
controls:0.36%
—
—
—
—
—
—
cases:1.64%
controls:0.27%
cases:2.69%
controls:0.86%
21
73
738
7489
9
27
750
7535
—
—
—
12
20
718
7368
18
57
651
6569
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1.4e-01
3.9e-01
8.0e-01
2.0e+00
8.6e-01
3.1e-01
1.3e-01
cases:24.24%
controls:21.71%
cases:21.87%
controls:15.91%
cases:5.41%
controls:2.51%
cases:1.06%
controls:0.15%
cases:5.69%
controls:2.49%
cases:20.96%
controls:16.23%
cases:35.13%
controls:32.13%
184
1642
575
5920
166
1203
593
6359
41
190
717
7372
8
11
750
7551
43
188
713
7367
153
1199
577
6189
235
2129
434
4497
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
5.2e-01
5.2e-01
7.6e-01
—
8.6e-01
7.3e-01
6.4e-01
cases:33.47%
controls:23.06%
cases:19.24%
controls:12.35%
cases:4.49%
controls:2.14%
—
—
cases:4.37%
controls:1.89%
cases:22.88%
controls:12.51%
cases:43.05%
controls:28.45%
254
1744
505
5818
146
934
613
6628
34
162
724
7400
—
33
143
723
7412
167
924
563
6464
288
1885
381
4741
Gastroenterology
10 [38004455]
1.0e+00
9.2e-01
8.7e-01
—
—
9.8e-01
1.1e+00
cases:8.17%
controls:3.17%
cases:3.69%
controls:1.51%
cases:0.66%
controls:0.28%
—
—
—
—
cases:3.29%
controls:1.26%
cases:10.91%
controls:3.80%
62
240
697
7322
28
114
731
7448
5
21
753
7541
—
—
24
93
706
7295
73
252
596
6374
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
6.5e-01
6.1e-01
8.7e-01
—
1.4e+00
6.7e-01
7.3e-01
cases:11.33%
controls:6.28%
cases:6.98%
controls:3.90%
cases:1.85%
controls:0.78%
—
—
cases:2.38%
controls:0.62%
cases:7.40%
controls:3.91%
cases:17.04%
controls:9.04%
86
475
673
7087
53
295
706
7267
14
59
744
7503
—
18
47
738
7508
54
289
676
7099
114
599
555
6027
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
5.7e-01
5.7e-01
1.9e+00
—
—
9.2e-01
6.6e-01
cases:7.38%
controls:4.32%
cases:4.48%
controls:2.58%
cases:0.92%
controls:0.15%
—
—
—
—
cases:5.62%
controls:2.31%
cases:13.90%
controls:7.68%
56
327
703
7235
34
195
725
7367
7
11
751
7551
—
—
41
171
689
7217
93
509
576
6117
Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]
1.0e+00
—
—
—
—
2.2e+00
1.7e+00
cases:1.05%
controls:0.38%
—
—
—
—
—
—
—
—
cases:1.64%
controls:0.18%
cases:2.69%
controls:0.48%
8
29
751
7533
—
—
—
—
12
13
718
7375
18
32
651
6594
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
6.4e-01
6.1e-01
9.6e-01
—
1.4e+00
6.4e-01
6.8e-01
cases:11.59%
controls:6.49%
cases:7.11%
controls:3.98%
cases:1.98%
controls:0.77%
—
—
cases:2.51%
controls:0.62%
cases:7.40%
controls:4.05%
cases:16.89%
controls:9.31%
88
491
671
7071
54
301
705
7261
15
58
743
7504
—
19
47
737
7508
54
299
676
7089
113
617
556
6009
clonazepam; oral, parenteral
N03AE01 [21604415]
1.2e+00
1.5e+00
—
—
—
1.1e+00
1.2e+00
cases:2.24%
controls:0.66%
cases:1.45%
controls:0.33%
—
—
—
—
—
—
cases:1.10%
controls:0.37%
cases:2.09%
controls:0.62%
17
50
742
7512
11
25
748
7537
—
—
—
8
27
722
7361
14
41
655
6585
Allergy, unspecified
T78.4 [45580373]
1.6e+00
—
—
—
—
2.3e+00
1.4e+00
cases:1.45%
controls:0.29%
—
—
—
—
—
—
—
—
cases:0.82%
controls:0.08%
cases:1.05%
controls:0.27%
11
22
748
7540
—
—
—
—
6
6
724
7382
7
18
662
6608
Allergy/allergic reaction NOS
A92 [2002000225]
2.0e+00
—
—
—
—
—
1.9e+00
cases:1.05%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
cases:1.35%
controls:0.20%
8
11
751
7551
—
—
—
—
—
9
13
660
6613
Incontinence urine
U04 [2002001139]
2.0e+00
2.3e+00
—
—
—
—
1.9e+00
cases:1.05%
controls:0.15%
cases:0.66%
controls:0.07%
—
—
—
—
—
—
—
—
cases:1.49%
controls:0.23%
8
11
751
7551
5
5
754
7557
—
—
—
—
10
15
659
6611
Other dorsalgia
M54.8 [45538790]
—
—
—
—
—
2.3e+00
1.6e+00
—
—
—
—
—
—
—
—
—
—
cases:0.68%
controls:0.07%
cases:1.49%
controls:0.32%
—
—
—
—
—
5
5
725
7383
10
21
659
6605
Neurology
13 [38004458]
7.4e-01
5.2e-01
1.3e+00
—
8.4e-01
8.7e-01
9.9e-01
cases:13.83%
controls:7.11%
cases:5.27%
controls:3.21%
cases:1.58%
controls:0.45%
—
—
cases:1.19%
controls:0.52%
cases:7.12%
controls:3.13%
cases:17.79%
controls:7.41%
105
538
654
7024
40
243
719
7319
12
34
746
7528
—
9
39
747
7516
52
231
678
7157
119
491
550
6135
Gastro-oesophageal reflux disease with oesophagitis
K21.0 [45543296]
1.3e+00
1.5e+00
—
—
—
1.5e+00
1.0e+00
cases:2.11%
controls:0.58%
cases:1.05%
controls:0.24%
—
—
—
—
—
—
cases:1.23%
controls:0.27%
cases:2.09%
controls:0.75%
16
44
743
7518
8
18
751
7544
—
—
—
9
20
721
7368
14
50
655
6576
Supine thorax X-ray examination
GD1QA [2001303648]
1.3e+00
1.6e+00
—
—
—
1.3e+00
1.0e+00
cases:2.37%
controls:0.66%
cases:1.19%
controls:0.25%
—
—
—
—
—
—
cases:1.37%
controls:0.37%
cases:3.59%
controls:1.34%
18
50
741
7512
9
19
750
7543
—
—
—
10
27
720
7361
24
89
645
6537
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
3.8e-01
7.9e-01
9.9e-01
—
1.5e+00
9.0e-01
7.0e-01
cases:9.09%
controls:6.39%
cases:6.72%
controls:3.17%
cases:1.58%
controls:0.60%
—
—
cases:2.38%
controls:0.56%
cases:7.26%
controls:3.10%
cases:15.25%
controls:8.23%
69
483
690
7079
51
240
708
7322
12
45
746
7517
—
18
42
738
7513
53
229
677
7159
102
545
567
6081
Basophils [#/volume] in Blood
26444-0 [3006315]
6.1e-01
5.9e-01
8.3e-01
—
1.3e+00
6.4e-01
7.1e-01
cases:11.59%
controls:6.64%
cases:7.25%
controls:4.15%
cases:1.98%
controls:0.87%
—
—
cases:2.38%
controls:0.69%
cases:7.81%
controls:4.28%
cases:18.09%
controls:9.78%
88
502
671
7060
55
314
704
7248
15
66
743
7496
—
18
52
738
7503
57
316
673
7072
121
648
548
5978
metronidazole; oral, rectal
P01AB01 [21604857]
9.4e-01
1.0e+00
—
1.0e+50
1.6e+00
9.3e-01
8.8e-01
cases:14.89%
controls:6.39%
cases:5.27%
controls:1.93%
—
—
cases:0.92%
controls:0.00%
cases:0.66%
controls:0.13%
cases:3.97%
controls:1.61%
cases:11.81%
controls:5.25%
113
483
646
7079
40
146
719
7416
—
7
0
751
7562
5
10
751
7545
29
119
701
7269
79
348
590
6278
Monocytes [#/volume] in Blood
26484-6 [3001604]
5.9e-01
5.9e-01
8.3e-01
—
1.3e+00
6.5e-01
7.0e-01
cases:11.33%
controls:6.61%
cases:7.25%
controls:4.15%
cases:1.98%
controls:0.87%
—
—
cases:2.38%
controls:0.69%
cases:7.81%
controls:4.25%
cases:17.94%
controls:9.75%
86
500
673
7062
55
314
704
7248
15
66
743
7496
—
18
52
738
7503
57
314
673
7074
120
646
549
5980
Microorganisms panel - Urine sediment
58435-9 [40761536]
7.5e-01
1.4e+00
—
1.0e+50
—
1.4e+00
9.9e-01
cases:1.98%
controls:0.94%
cases:1.98%
controls:0.50%
—
—
cases:0.66%
controls:0.00%
—
—
cases:1.78%
controls:0.45%
cases:2.39%
controls:0.91%
15
71
744
7491
15
38
744
7524
—
5
0
753
7562
—
13
33
717
7355
16
60
653
6566
Constipation
K59.0 [45557663]
1.8e+00
—
—
—
—
—
1.9e+00
cases:1.45%
controls:0.24%
—
—
—
—
—
—
—
—
—
—
cases:1.05%
controls:0.15%
11
18
748
7544
—
—
—
—
—
7
10
662
6616
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
9.8e-01
1.2e+00
—
—
—
1.8e+00
7.9e-01
cases:1.71%
controls:0.65%
cases:1.58%
controls:0.48%
—
—
—
—
—
—
cases:1.92%
controls:0.34%
cases:3.74%
controls:1.74%
13
49
746
7513
12
36
747
7526
—
—
—
14
25
716
7363
25
115
644
6511
Eosinophils [#/volume] in Blood
26449-9 [3013115]
6.4e-01
5.6e-01
7.8e-01
—
1.2e+00
5.8e-01
7.1e-01
cases:12.25%
controls:6.84%
cases:7.38%
controls:4.35%
cases:1.98%
controls:0.91%
—
—
cases:2.38%
controls:0.70%
cases:7.81%
controls:4.52%
cases:18.68%
controls:10.16%
93
517
666
7045
56
329
703
7233
15
69
743
7493
—
18
53
738
7502
57
334
673
7054
125
673
544
5953
Cervical spine MRI examination with high intensity magnet
NA1BG [2001306990]
1.8e+00
—
—
—
—
—
2.0e+00
cases:1.45%
controls:0.25%
—
—
—
—
—
—
—
—
—
—
cases:1.49%
controls:0.21%
11
19
748
7543
—
—
—
—
—
10
14
659
6612
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
5.4e-01
7.0e-01
1.1e+00
—
1.9e+00
9.8e-01
8.4e-01
cases:6.19%
controls:3.69%
cases:2.64%
controls:1.32%
cases:0.66%
controls:0.21%
—
—
cases:1.06%
controls:0.16%
cases:3.56%
controls:1.37%
cases:10.31%
controls:4.72%
47
279
712
7283
20
100
739
7462
5
16
753
7546
—
8
12
748
7543
26
101
704
7287
69
313
600
6313
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
5.8e-01
5.7e-01
9.0e-01
—
1.2e+00
6.5e-01
6.7e-01
cases:11.99%
controls:7.09%
cases:7.38%
controls:4.32%
cases:2.11%
controls:0.87%
—
—
cases:2.38%
controls:0.70%
cases:8.22%
controls:4.45%
cases:18.09%
controls:10.16%
91
536
668
7026
56
327
703
7235
16
66
742
7496
—
18
53
738
7502
60
329
670
7059
121
673
548
5953
itraconazole; oral, parenteral
J02AC02 [21603081]
9.9e-01
1.8e+00
—
—
—
1.1e+00
9.4e-01
cases:3.95%
controls:1.51%
cases:2.50%
controls:0.44%
—
—
—
—
—
—
cases:1.23%
controls:0.41%
cases:2.84%
controls:1.13%
30
114
729
7448
19
33
740
7529
—
—
—
9
30
721
7358
19
75
650
6551
One hour or less
ZXE00 [2001311394]
7.8e-01
7.0e-01
—
1.0e+50
1.7e+00
1.7e+00
1.2e+00
cases:9.22%
controls:4.47%
cases:2.90%
controls:1.45%
—
—
cases:0.92%
controls:0.00%
cases:0.79%
controls:0.15%
cases:5.34%
controls:1.04%
cases:11.21%
controls:3.61%
70
338
689
7224
22
110
737
7452
—
7
0
751
7562
6
11
750
7544
39
77
691
7311
75
239
594
6387
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
1.2e+00
1.3e+00
—
—
—
1.4e+00
1.1e+00
cases:2.24%
controls:0.70%
cases:1.32%
controls:0.37%
—
—
—
—
—
—
cases:1.78%
controls:0.46%
cases:3.44%
controls:1.16%
17
53
742
7509
10
28
749
7534
—
—
—
13
34
717
7354
23
77
646
6549
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
1.3e+00
1.2e+00
—
—
—
1.3e+00
1.1e+00
cases:2.64%
controls:0.70%
cases:1.58%
controls:0.46%
—
—
—
—
—
—
cases:1.51%
controls:0.43%
cases:3.59%
controls:1.28%
20
53
739
7509
12
35
747
7527
—
—
—
11
32
719
7356
24
85
645
6541
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
5.8e-01
5.0e-01
1.5e+00
—
8.4e-01
9.6e-01
5.6e-01
cases:8.70%
controls:5.06%
cases:5.67%
controls:3.53%
cases:1.85%
controls:0.41%
—
—
cases:1.19%
controls:0.52%
cases:8.36%
controls:3.37%
cases:17.04%
controls:10.49%
66
383
693
7179
43
267
716
7295
14
31
744
7531
—
9
39
747
7516
61
249
669
7139
114
695
555
5931
Psychiatry
26 [38004469]
8.4e-01
7.9e-01
8.0e-01
—
6.1e-01
9.6e-01
9.8e-01
cases:9.35%
controls:4.24%
cases:5.01%
controls:2.34%
cases:2.24%
controls:1.02%
—
—
cases:1.85%
controls:1.02%
cases:6.16%
controls:2.45%
cases:12.71%
controls:5.16%
71
321
688
7241
38
177
721
7385
17
77
741
7485
—
14
77
742
7478
45
181
685
7207
85
342
584
6284
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
7.3e-01
1.0e+00
—
—
—
1.1e+00
7.5e-01
cases:4.74%
controls:2.34%
cases:2.50%
controls:0.91%
—
—
—
—
—
—
cases:2.60%
controls:0.92%
cases:6.28%
controls:3.06%
36
177
723
7385
19
69
740
7493
—
—
—
19
68
711
7320
42
203
627
6423
aciclovir; oral, parenteral
J05AB01 [21603131]
6.0e-01
1.4e+00
—
—
—
1.0e+00
1.2e+00
cases:3.82%
controls:2.13%
cases:2.90%
controls:0.77%
—
—
—
—
—
—
cases:2.47%
controls:0.92%
cases:7.77%
controls:2.46%
29
161
730
7401
22
58
737
7504
—
—
—
18
68
712
7320
52
163
617
6463
duloxetine; oral
N06AX21 [21604749]
1.2e+00
1.2e+00
1.6e+00
—
—
1.4e+00
9.5e-01
cases:2.90%
controls:0.91%
cases:1.58%
controls:0.50%
cases:0.66%
controls:0.13%
—
—
—
—
cases:2.05%
controls:0.53%
cases:3.59%
controls:1.42%
22
69
737
7493
12
38
747
7524
5
10
753
7552
—
—
15
39
715
7349
24
94
645
6532
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
5.2e-01
6.1e-01
6.2e-01
—
1.1e+00
5.7e-01
7.0e-01
cases:12.52%
controls:7.83%
cases:9.09%
controls:5.13%
cases:2.37%
controls:1.30%
—
—
cases:3.04%
controls:1.09%
cases:8.77%
controls:5.17%
cases:20.03%
controls:11.09%
95
592
664
6970
69
388
690
7174
18
98
740
7464
—
23
82
733
7473
64
382
666
7006
134
735
535
5891
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
5.3e-01
1.2e+00
—
—
2.2e+00
8.4e-01
2.7e-01
cases:2.11%
controls:1.26%
cases:2.50%
controls:0.77%
—
—
—
—
cases:1.19%
controls:0.13%
cases:1.64%
controls:0.72%
cases:2.39%
controls:1.84%
16
95
743
7467
19
58
740
7504
—
—
9
10
747
7545
12
53
718
7335
16
122
653
6504
Thorax X-ray examination
GD1AA [2001303617]
6.8e-01
7.2e-01
1.7e+00
—
1.4e+00
1.1e+00
9.3e-01
cases:9.09%
controls:4.83%
cases:3.95%
controls:1.96%
cases:0.79%
controls:0.15%
—
—
cases:0.66%
controls:0.17%
cases:5.21%
controls:1.84%
cases:11.66%
controls:4.95%
69
365
690
7197
30
148
729
7414
6
11
752
7551
—
5
13
751
7542
38
136
692
7252
78
328
591
6298
ciclesonide; inhalant
R03BA08 [21603291]
1.1e+00
1.0e+00
—
—
—
1.3e+00
1.1e+00
cases:2.24%
controls:0.79%
cases:1.45%
controls:0.52%
—
—
—
—
—
—
cases:1.92%
controls:0.54%
cases:2.84%
controls:1.00%
17
60
742
7502
11
39
748
7523
—
—
—
14
40
716
7348
19
66
650
6560
ciclesonide; nasal
R01AD13 [43534836]
1.1e+00
1.0e+00
—
—
—
1.3e+00
1.1e+00
cases:2.24%
controls:0.79%
cases:1.45%
controls:0.52%
—
—
—
—
—
—
cases:1.92%
controls:0.54%
cases:2.84%
controls:1.00%
17
60
742
7502
11
39
748
7523
—
—
—
14
40
716
7348
19
66
650
6560
Hyperplasia of prostate
N40 [45563015]
4.3e-01
7.6e-01
2.3e+00
—
1.9e+00
1.1e+00
6.6e-01
cases:1.98%
controls:1.30%
cases:1.71%
controls:0.81%
cases:1.32%
controls:0.13%
—
—
cases:0.79%
controls:0.12%
cases:1.92%
controls:0.68%
cases:3.14%
controls:1.65%
15
98
744
7464
13
61
746
7501
10
10
748
7552
—
6
9
750
7546
14
50
716
7338
21
109
648
6517
Prostate specific Ag [Mass/volume] in Serum or Plasma
2857-1 [3013603]
1.4e-01
5.7e-01
1.7e+00
—
1.6e+00
6.5e-01
1.0e-01
cases:4.08%
controls:3.57%
cases:4.35%
controls:2.51%
cases:1.58%
controls:0.29%
—
—
cases:1.72%
controls:0.34%
cases:4.25%
controls:2.26%
cases:5.23%
controls:4.75%
31
270
728
7292
33
190
726
7372
12
22
746
7540
—
13
26
743
7529
31
167
699
7221
35
315
634
6311
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
3.8e-01
4.5e-01
5.3e-01
—
1.2e+00
7.1e-01
5.5e-01
cases:16.86%
controls:12.17%
cases:9.35%
controls:6.19%
cases:1.45%
controls:0.86%
—
—
cases:2.25%
controls:0.70%
cases:11.64%
controls:6.08%
cases:23.77%
controls:15.23%
128
920
631
6642
71
468
688
7094
11
65
747
7497
—
17
53
739
7502
85
449
645
6939
159
1009
510
5617
Pain, unspecified
R52.9 [45544151]
7.9e-01
1.7e+00
—
—
—
1.1e+00
1.6e+00
cases:1.45%
controls:0.66%
cases:1.05%
controls:0.20%
—
—
—
—
—
—
cases:0.96%
controls:0.32%
cases:3.89%
controls:0.81%
11
50
748
7512
8
15
751
7547
—
—
—
7
24
723
7364
26
54
643
6572
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
6.8e-01
9.0e-01
—
—
—
1.1e+00
6.2e-01
cases:5.93%
controls:3.08%
cases:2.90%
controls:1.20%
—
—
—
—
—
—
cases:3.42%
controls:1.20%
cases:7.47%
controls:4.18%
45
233
714
7329
22
91
737
7471
—
—
—
25
89
705
7299
50
277
619
6349
Functional capacity evaluation
443351003 [40481051]
3.2e-01
1.0e+00
2.2e+00
—
—
1.1e+00
7.5e-01
cases:1.58%
controls:1.15%
cases:1.32%
controls:0.48%
cases:0.92%
controls:0.11%
—
—
—
—
cases:1.78%
controls:0.61%
cases:3.14%
controls:1.51%
12
87
747
7475
10
36
749
7526
7
8
751
7554
—
—
13
45
717
7343
21
100
648
6526
lamotrigine; oral
N03AX09 [21604431]
1.6e+00
1.4e+00
—
—
-1.0e+50
1.2e+00
1.7e+00
cases:1.84%
controls:0.40%
cases:0.92%
controls:0.24%
—
—
—
—
cases:0.00%
controls:0.11%
cases:0.82%
controls:0.24%
cases:2.39%
controls:0.45%
14
30
745
7532
7
18
752
7544
—
—
0
8
756
7547
6
18
724
7370
16
30
653
6596
Myalgia
M79.1 [45587062]
9.7e-01
6.7e-01
—
—
—
1.4e+00
8.2e-01
cases:2.77%
controls:1.07%
cases:0.92%
controls:0.48%
—
—
—
—
—
—
cases:1.64%
controls:0.39%
cases:3.29%
controls:1.48%
21
81
738
7481
7
36
752
7526
—
—
—
12
29
718
7359
22
98
647
6528
Weakness/tiredness general
A04 [2002000145]
9.9e-01
1.1e+00
—
—
2.3e+00
1.3e+00
8.9e-01
cases:2.77%
controls:1.04%
cases:1.32%
controls:0.46%
—
—
—
—
cases:0.66%
controls:0.07%
cases:1.78%
controls:0.47%
cases:4.04%
controls:1.69%
21
79
738
7483
10
35
749
7527
—
—
5
5
751
7550
13
35
717
7353
27
112
642
6514
Follow-up examination after surgery for other conditions
Z09.0 [45576131]
1.6e+00
1.8e+00
—
—
—
1.5e+00
1.6e+00
cases:1.98%
controls:0.40%
cases:0.66%
controls:0.11%
—
—
—
—
—
—
cases:0.68%
controls:0.15%
cases:2.69%
controls:0.56%
15
30
744
7532
5
8
754
7554
—
—
—
5
11
725
7377
18
37
651
6589
Operation for osteochondritis of knee, arthroscopic
NGF25 [2001308133]
1.8e+00
—
—
—
—
—
1.4e+00
cases:1.45%
controls:0.25%
—
—
—
—
—
—
—
—
—
—
cases:1.49%
controls:0.36%
11
19
748
7543
—
—
—
—
—
10
24
659
6602
Norovirus RNA [Presence] in Stool by NAA with probe detection
7974-9 [3008909]
—
—
—
—
—
-1.0e+50
3.2e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.14%
cases:1.79%
controls:0.08%
—
—
—
—
—
0
10
730
7378
12
5
657
6621
Other specified counselling
Z71.8 [45581061]
6.3e-01
8.7e-01
1.3e+00
—
1.4e+00
9.8e-01
6.8e-01
cases:4.87%
controls:2.66%
cases:3.29%
controls:1.40%
cases:0.92%
controls:0.26%
—
—
cases:1.06%
controls:0.26%
cases:3.42%
controls:1.31%
cases:10.46%
controls:5.61%
37
201
722
7361
25
106
734
7456
7
20
751
7542
—
8
20
748
7535
25
97
705
7291
70
372
599
6254
Diverticular disease of large intestine without perforation or abscess
K57.3 [45567316]
8.9e-01
6.7e-01
—
—
—
1.3e+00
9.6e-01
cases:3.16%
controls:1.32%
cases:1.05%
controls:0.54%
—
—
—
—
—
—
cases:1.64%
controls:0.46%
cases:4.19%
controls:1.65%
24
100
735
7462
8
41
751
7521
—
—
—
12
34
718
7354
28
109
641
6517
Irritable bowel syndrome with diarrhoea
K58.0 [45596336]
1.4e+00
—
—
—
—
—
1.7e+00
cases:1.71%
controls:0.41%
—
—
—
—
—
—
—
—
—
—
cases:3.14%
controls:0.60%
13
31
746
7531
—
—
—
—
—
21
40
648
6586
Neurosurgery
14 [38004459]
7.9e-01
1.0e+00
—
—
—
1.3e+00
1.0e+00
cases:3.56%
controls:1.65%
cases:1.45%
controls:0.52%
—
—
—
—
—
—
cases:2.33%
controls:0.65%
cases:4.78%
controls:1.78%
27
125
732
7437
11
39
748
7523
—
—
—
17
48
713
7340
32
118
637
6508
Telephone prescription or other care instructions
WZB00 [2001310884]
5.8e-01
9.3e-01
—
—
-1.0e+50
9.1e-01
6.8e-01
cases:5.80%
controls:3.35%
cases:2.24%
controls:0.90%
—
—
—
—
cases:0.00%
controls:0.08%
cases:2.60%
controls:1.07%
cases:6.88%
controls:3.59%
44
253
715
7309
17
68
742
7494
—
—
0
6
756
7549
19
79
711
7309
46
238
623
6388
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
1.2e+00
1.1e+00
—
—
—
1.8e+00
6.7e-01
cases:1.71%
controls:0.52%
cases:0.92%
controls:0.30%
—
—
—
—
—
—
cases:1.78%
controls:0.28%
cases:2.54%
controls:1.31%
13
39
746
7523
7
23
752
7539
—
—
—
13
21
717
7367
17
87
652
6539
Spinalanesthesia
WX320 [2001310799]
7.2e-01
1.2e+00
—
—
—
1.2e+00
6.8e-01
cases:3.69%
controls:1.84%
cases:1.98%
controls:0.62%
—
—
—
—
—
—
cases:1.92%
controls:0.61%
cases:4.04%
controls:2.08%
28
139
731
7423
15
47
744
7515
—
—
—
14
45
716
7343
27
138
642
6488
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 [36031861]
1.9e+00
1.7e+00
—
—
—
2.0e+00
1.0e+00
cases:0.79%
controls:0.12%
cases:0.79%
controls:0.15%
—
—
—
—
—
—
cases:1.10%
controls:0.15%
cases:2.09%
controls:0.75%
6
9
753
7553
6
11
753
7551
—
—
—
8
11
722
7377
14
50
655
6576
Cyclic citrullinated peptide Ab [Units/volume] in Serum
53027-9 [3041942]
9.5e-01
4.0e-01
-1.0e+50
—
-1.0e+50
1.3e+00
8.3e-01
cases:4.74%
controls:1.89%
cases:0.92%
controls:0.62%
cases:0.00%
controls:0.07%
—
—
cases:0.00%
controls:0.11%
cases:2.05%
controls:0.60%
cases:5.23%
controls:2.34%
36
143
723
7419
7
47
752
7515
0
5
758
7557
—
0
8
756
7547
15
44
715
7344
35
155
634
6471
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
3.9e-01
5.9e-01
7.8e-01
1.8e+00
1.0e+00
5.6e-01
4.6e-01
cases:16.73%
controls:11.97%
cases:11.73%
controls:6.85%
cases:2.90%
controls:1.35%
cases:0.66%
controls:0.11%
cases:3.31%
controls:1.22%
cases:12.19%
controls:7.36%
cases:23.62%
controls:16.27%
127
905
632
6657
89
518
670
7044
22
102
736
7460
5
8
753
7554
25
92
731
7463
89
544
641
6844
158
1078
511
5548
Gynecological ultrasound examination as part of clinical examination
LX1AE [2001306815]
7.1e-01
1.2e+00
—
1.0e+50
—
1.8e+00
1.2e+00
cases:1.98%
controls:0.98%
cases:1.32%
controls:0.41%
—
—
cases:0.79%
controls:0.00%
—
—
cases:1.37%
controls:0.23%
cases:3.74%
controls:1.13%
15
74
744
7488
10
31
749
7531
—
6
0
752
7562
—
10
17
720
7371
25
75
644
6551
tizanidine; oral
M03BX02 [21604116]
5.7e-01
8.9e-01
7.0e-01
—
1.2e+00
7.9e-01
7.6e-01
cases:18.71%
controls:11.49%
cases:8.30%
controls:3.57%
cases:0.92%
controls:0.46%
—
—
cases:1.46%
controls:0.42%
cases:7.67%
controls:3.64%
cases:22.12%
controls:11.71%
142
869
617
6693
63
270
696
7292
7
35
751
7527
—
11
32
745
7523
56
269
674
7119
148
776
521
5850
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
4.7e-01
9.4e-01
1.6e+00
—
—
1.2e+00
8.1e-01
cases:3.69%
controls:2.33%
cases:2.64%
controls:1.04%
cases:0.66%
controls:0.13%
—
—
—
—
cases:3.29%
controls:0.99%
cases:6.88%
controls:3.18%
28
176
731
7386
20
79
739
7483
5
10
753
7552
—
—
24
73
706
7315
46
211
623
6415
Pulmonary Disease
29 [38004472]
7.7e-01
6.9e-01
6.0e-01
—
8.8e-01
7.4e-01
7.7e-01
cases:11.20%
controls:5.53%
cases:5.67%
controls:2.94%
cases:1.06%
controls:0.58%
—
—
cases:1.46%
controls:0.61%
cases:5.75%
controls:2.83%
cases:12.86%
controls:6.40%
85
418
674
7144
43
222
716
7340
8
44
750
7518
—
11
46
745
7509
42
209
688
7179
86
424
583
6202
miconazole
D01AC02 [21601921]
1.0e+00
1.9e+00
—
—
—
1.4e+00
9.7e-01
cases:2.90%
controls:1.07%
cases:1.19%
controls:0.17%
—
—
—
—
—
—
cases:0.68%
controls:0.18%
cases:1.35%
controls:0.51%
22
81
737
7481
9
13
750
7549
—
—
—
5
13
725
7375
9
34
660
6592
Pelvic and perineal pain
R10.2 [45548947]
—
—
—
—
—
—
2.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.24%
controls:0.12%
—
—
—
—
—
—
15
8
654
6618
cisapride; oral, rectal
A03FA02 [21600485]
1.2e+00
—
—
—
—
1.7e+00
1.7e+00
cases:1.71%
controls:0.53%
—
—
—
—
—
—
—
—
cases:0.68%
controls:0.12%
cases:1.35%
controls:0.24%
13
40
746
7522
—
—
—
—
5
9
725
7379
9
16
660
6610
methylprednisolone; oral, parenteral
H02AB04 [21602732]
8.4e-01
1.2e+00
—
—
1.7e+00
1.1e+00
8.3e-01
cases:3.56%
controls:1.57%
cases:2.24%
controls:0.66%
—
—
—
—
cases:0.66%
controls:0.12%
cases:1.78%
controls:0.62%
cases:3.44%
controls:1.52%
27
119
732
7443
17
50
742
7512
—
—
5
9
751
7546
13
46
717
7342
23
101
646
6525
macrogol; oral
A06AD15 [21600575]
8.7e-01
1.4e+00
—
—
—
1.8e+00
1.1e+00
cases:1.32%
controls:0.56%
cases:0.92%
controls:0.22%
—
—
—
—
—
—
cases:1.78%
controls:0.31%
cases:2.69%
controls:0.92%
10
42
749
7520
7
17
752
7545
—
—
—
13
23
717
7365
18
61
651
6565
Other specified special examinations
Z01.8 [45581003]
7.7e-01
1.2e+00
—
—
—
8.8e-01
8.2e-01
cases:3.82%
controls:1.81%
cases:1.84%
controls:0.54%
—
—
—
—
—
—
cases:1.23%
controls:0.51%
cases:5.08%
controls:2.29%
29
137
730
7425
14
41
745
7521
—
—
—
9
38
721
7350
34
152
635
6474
Cough
R05 [45606792]
7.2e-01
1.3e+00
—
—
—
2.4e-01
7.9e-01
cases:3.69%
controls:1.84%
cases:1.71%
controls:0.46%
—
—
—
—
—
—
cases:0.82%
controls:0.65%
cases:4.48%
controls:2.08%
28
139
731
7423
13
35
746
7527
—
—
—
6
48
724
7340
30
138
639
6488
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
3.1e-01
7.8e-01
1.4e+00
—
—
1.4e+00
6.9e-01
cases:5.14%
controls:3.81%
cases:3.56%
controls:1.67%
cases:0.79%
controls:0.20%
—
—
—
—
cases:4.93%
controls:1.33%
cases:8.52%
controls:4.45%
39
288
720
7274
27
126
732
7436
6
15
752
7547
—
—
36
98
694
7290
57
295
612
6331
Bacteria identified in Isolate by Culture
43409-2 [3042936]
3.8e-01
1.2e+00
—
—
—
1.6e+00
7.1e-01
cases:2.37%
controls:1.64%
cases:1.84%
controls:0.54%
—
—
—
—
—
—
cases:1.92%
controls:0.41%
cases:3.59%
controls:1.80%
18
124
741
7438
14
41
745
7521
—
—
—
14
30
716
7358
24
119
645
6507
Pure hypercholesterolaemia
E78.01 [2000501514]
4.6e-01
7.3e-01
1.8e+00
—
2.0e+00
1.0e+00
9.0e-02
cases:2.64%
controls:1.68%
cases:1.98%
controls:0.97%
cases:0.92%
controls:0.16%
—
—
cases:0.66%
controls:0.09%
cases:2.33%
controls:0.84%
cases:3.59%
controls:3.29%
20
127
739
7435
15
73
744
7489
7
12
751
7550
—
5
7
751
7548
17
62
713
7326
24
218
645
6408
Chronic maxillary sinusitis
J32.0 [45586667]
1.1e+00
—
—
—
—
1.4e+00
1.7e+00
cases:1.84%
controls:0.65%
—
—
—
—
—
—
—
—
cases:0.68%
controls:0.16%
cases:3.59%
controls:0.65%
14
49
745
7513
—
—
—
—
5
12
725
7376
24
43
645
6583
Stomatognathic treatment, simple
SHA01 [2001310405]
7.3e-01
1.3e+00
—
—
—
1.5e+00
1.3e+00
cases:2.11%
controls:1.03%
cases:0.79%
controls:0.22%
—
—
—
—
—
—
cases:1.51%
controls:0.34%
cases:3.59%
controls:1.01%
16
78
743
7484
6
17
753
7545
—
—
—
11
25
719
7363
24
67
645
6559
CT of paranasal sinuses and face area
DM1AD [2001301741]
—
—
—
—
—
—
2.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.20%
controls:0.08%
—
—
—
—
—
—
8
5
661
6621
Urinary symptom/complaint other
U29 [2002001149]
—
—
—
—
—
—
2.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.20%
controls:0.08%
—
—
—
—
—
—
8
5
661
6621
indometacin
C01EB03 [21600365]
1.2e+00
—
—
—
—
1.6e+00
—
cases:2.24%
controls:0.71%
—
—
—
—
—
—
—
—
cases:1.37%
controls:0.28%
—
—
17
54
742
7508
—
—
—
—
10
21
720
7367
—
Chest pain, unspecified
R07.4 [45558450]
9.5e-01
7.0e-01
-1.0e+50
—
—
1.0e+00
7.4e-01
cases:6.06%
controls:2.43%
cases:1.71%
controls:0.86%
cases:0.00%
controls:0.12%
—
—
—
—
cases:2.19%
controls:0.79%
cases:5.98%
controls:2.94%
46
184
713
7378
13
65
746
7497
0
9
758
7553
—
—
16
58
714
7330
40
195
629
6431
colestyramine; oral
C10AC01 [21601876]
2.7e+00
—
—
—
—
—
—
cases:1.19%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
—
—
9
6
750
7556
—
—
—
—
—
—
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
1.0e+00
1.2e+00
—
—
—
1.8e+00
8.5e-01
cases:1.84%
controls:0.69%
cases:1.45%
controls:0.45%
—
—
—
—
—
—
cases:1.92%
controls:0.31%
cases:3.89%
controls:1.71%
14
52
745
7510
11
34
748
7528
—
—
—
14
23
716
7365
26
113
643
6513
indometacin; oral, parenteral, rectal
M01AB01 [21603941]
1.1e+00
—
—
—
—
1.5e+00
5.0e-01
cases:2.24%
controls:0.73%
—
—
—
—
—
—
—
—
cases:1.37%
controls:0.30%
cases:0.75%
controls:0.45%
17
55
742
7507
—
—
—
—
10
22
720
7366
5
30
664
6596
Snapping jaw
K07.60 [2000502791]
1.4e+00
—
—
—
—
—
1.3e+00
cases:1.45%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
cases:1.94%
controls:0.54%
11
28
748
7534
—
—
—
—
—
13
36
656
6590
Orthopedic Surgery
20 [38004465]
6.6e-01
5.9e-01
7.0e-01
—
6.4e-01
6.7e-01
7.3e-01
cases:16.60%
controls:9.32%
cases:6.85%
controls:3.93%
cases:1.32%
controls:0.66%
—
—
cases:0.93%
controls:0.49%
cases:7.67%
controls:4.06%
cases:21.08%
controls:11.42%
126
705
633
6857
52
297
707
7265
10
50
748
7512
—
7
37
749
7518
56
300
674
7088
141
757
528
5869
Physiologic investigation of micturition
XKD06 [2001306098]
2.6e+00
—
—
—
—
—
—
cases:0.92%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
—
—
7
5
752
7557
—
—
—
—
—
—
omeprazole; oral, parenteral
A02BC01 [21600096]
7.2e-01
7.3e-01
1.3e+00
—
1.3e+00
9.6e-01
9.6e-01
cases:7.11%
controls:3.60%
cases:3.16%
controls:1.55%
cases:1.19%
controls:0.33%
—
—
cases:1.06%
controls:0.28%
cases:3.56%
controls:1.39%
cases:8.07%
controls:3.24%
54
272
705
7290
24
117
735
7445
9
25
749
7537
—
8
21
748
7534
26
103
704
7285
54
215
615
6411
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
4.8e-01
1.4e+00
-1.0e+50
—
—
—
1.2e+00
cases:1.45%
controls:0.90%
cases:1.45%
controls:0.36%
cases:0.00%
controls:0.09%
—
—
—
—
—
—
cases:3.14%
controls:0.95%
11
68
748
7494
11
27
748
7535
0
7
758
7555
—
—
—
21
63
648
6563
Migraine with aura [classical migraine]
G43.1 [45562086]
1.3e+00
9.7e-01
—
—
—
8.8e-01
1.3e+00
cases:2.37%
controls:0.66%
cases:0.66%
controls:0.25%
—
—
—
—
—
—
cases:0.68%
controls:0.28%
cases:2.99%
controls:0.81%
18
50
741
7512
5
19
754
7543
—
—
—
5
21
725
7367
20
54
649
6572
Infectious Disease
44 [38004484]
3.9e-01
1.2e+00
—
—
—
1.3e+00
1.3e+00
cases:1.84%
controls:1.26%
cases:1.32%
controls:0.40%
—
—
—
—
—
—
cases:1.78%
controls:0.50%
cases:4.33%
controls:1.19%
14
95
745
7467
10
30
749
7532
—
—
—
13
37
717
7351
29
79
640
6547
Prick test
37968009 [4242723]
1.3e+00
—
—
—
—
—
1.3e+00
cases:1.58%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
cases:1.64%
controls:0.44%
12
34
747
7528
—
—
—
—
—
11
29
658
6597
Bladder symptom/complaint other
U13 [2002001144]
—
2.1e+00
—
—
—
—
2.6e+00
—
—
cases:0.66%
controls:0.08%
—
—
—
—
—
—
—
—
cases:1.20%
controls:0.09%
—
5
6
754
7556
—
—
—
—
8
6
661
6620
baclofen; oral, parenteral
M03BX01 [21604115]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.20%
controls:0.09%
—
—
—
—
—
—
8
6
661
6620
Implementation of physical therapy rehabilitation plan
SPAT1223 [2001700324]
3.6e-01
9.0e-01
—
—
1.1e+00
8.6e-01
8.3e-01
cases:4.61%
controls:3.25%
cases:2.64%
controls:1.08%
—
—
—
—
cases:0.66%
controls:0.21%
cases:2.74%
controls:1.18%
cases:7.03%
controls:3.20%
35
246
724
7316
20
82
739
7480
—
—
5
16
751
7539
20
87
710
7301
47
212
622
6414
Other somatoform disorders
F45.8 [45600750]
1.5e+00
1.8e+00
—
—
—
1.2e+00
1.1e+00
cases:2.77%
controls:0.62%
cases:0.79%
controls:0.13%
—
—
—
—
—
—
cases:1.10%
controls:0.32%
cases:2.09%
controls:0.72%
21
47
738
7515
6
10
753
7552
—
—
—
8
24
722
7364
14
48
655
6578
lansoprazole; oral
A02BC03 [21600098]
1.0e+00
7.3e-01
—
—
1.0e+00
5.9e-01
8.4e-01
cases:8.30%
controls:3.16%
cases:3.56%
controls:1.75%
—
—
—
—
cases:0.79%
controls:0.29%
cases:3.01%
controls:1.69%
cases:8.52%
controls:3.88%
63
239
696
7323
27
132
732
7430
—
—
6
22
750
7533
22
125
708
7263
57
257
612
6369
Rheumatoid factor [Units/volume] in Serum or Plasma
11572-5 [3021614]
6.9e-01
4.6e-01
-1.0e+50
—
-1.0e+50
1.1e+00
7.6e-01
cases:4.35%
controls:2.22%
cases:1.19%
controls:0.75%
cases:0.00%
controls:0.08%
—
—
cases:0.00%
controls:0.13%
cases:2.19%
controls:0.72%
cases:5.53%
controls:2.67%
33
168
726
7394
9
57
750
7505
0
6
758
7556
—
0
10
756
7545
16
53
714
7335
37
177
632
6449
fusidic acid; ointment
D06AX01 [21602062]
7.0e-01
2.4e-01
—
—
—
1.0e+00
8.1e-01
cases:5.53%
controls:2.83%
cases:1.05%
controls:0.83%
—
—
—
—
—
—
cases:2.05%
controls:0.73%
cases:6.58%
controls:3.05%
42
214
717
7348
8
63
751
7499
—
—
—
15
54
715
7334
44
202
625
6424
fusidic acid
D09AA02 [21602265]
7.0e-01
2.4e-01
—
—
—
1.0e+00
8.1e-01
cases:5.53%
controls:2.83%
cases:1.05%
controls:0.83%
—
—
—
—
—
—
cases:2.05%
controls:0.73%
cases:6.58%
controls:3.05%
42
214
717
7348
8
63
751
7499
—
—
—
15
54
715
7334
44
202
625
6424
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
1.1e+00
1.1e+00
—
—
—
1.4e+00
1.9e-01
cases:1.71%
controls:0.56%
cases:1.19%
controls:0.38%
—
—
—
—
—
—
cases:1.51%
controls:0.38%
cases:1.94%
controls:1.61%
13
42
746
7520
9
29
750
7533
—
—
—
11
28
719
7360
13
107
656
6519
Ileoscopy through colon
UJF30 [2001305028]
1.1e+00
9.2e-01
—
—
—
—
1.5e+00
cases:1.98%
controls:0.69%
cases:0.79%
controls:0.32%
—
—
—
—
—
—
—
—
cases:3.29%
controls:0.78%
15
52
744
7510
6
24
753
7538
—
—
—
—
22
52
647
6574
propranolol; oral, parenteral
C07AA05 [21601670]
8.2e-01
5.7e-01
1.2e+00
—
1.1e+00
1.1e+00
6.4e-01
cases:7.11%
controls:3.27%
cases:2.50%
controls:1.43%
cases:0.66%
controls:0.20%
—
—
cases:0.93%
controls:0.30%
cases:4.38%
controls:1.56%
cases:7.17%
controls:3.91%
54
247
705
7315
19
108
740
7454
5
15
753
7547
—
7
23
749
7532
32
115
698
7273
48
259
621
6367
salbutamol; inhalant
R03AC02 [21603256]
4.3e-01
7.1e-01
7.4e-01
—
6.5e-01
6.2e-01
7.6e-01
cases:16.21%
controls:11.19%
cases:10.41%
controls:5.42%
cases:1.98%
controls:0.95%
—
—
cases:1.59%
controls:0.83%
cases:9.86%
controls:5.55%
cases:24.07%
controls:12.93%
123
846
636
6716
79
410
680
7152
15
72
743
7490
—
12
63
744
7492
72
410
658
6978
161
857
508
5769

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
432
1852
3.51
75.75
6.0
2.0
—
—
—
0
0
721
4649
3.52
57.36
10.9
3.3
2286.00
1579.22
e6/l
—
8
67
97
165
6.45
55.68
2.2
2.7
—
—
—
0
0
468
2478
2.80
51.38
7.4
3.1
135.23
48.75
e6/l
0.84
360
1650
520
3016
2.66
45.98
5.6
2.8
6.28
6.25
ph
0.21
324
1674
407
2104
2.67
45.41
6.4
2.6
90.30
89.12
e6/l
0.01
332
1561
389
1987
2.66
44.21
4.6
2.5
0.00
0.06
—
8
50
607
3853
2.68
43.71
7.0
3.1
0.01
3.76
estimate
0.80
124
807
597
3798
2.62
42.13
7.0
3.0
0.01
0.00
estimate
0.39
122
806
360
1807
2.63
41.94
6.2
2.6
0.23
0.43
e6/l
2.05
285
1281
605
3879
2.62
41.91
7.3
3.1
0.00
0.40
estimate
0.51
125
761
306
1418
2.73
41.87
4.2
2.3
5.16
6.95
e6/l
1.27
283
1282
275
1232
2.76
39.93
4.9
2.4
531.30
529.01
mosm/kgh2o
0.06
249
1070
230
998
2.74
35.01
5.7
2.4
3.44
3.28
e6/l
0.07
124
467
238
1091
2.59
32.15
5.3
2.3
1.22
1.06
e6/l
0.18
138
560
213
980
2.53
28.17
1.4
1.2
—
—
—
0
0
412
2507
2.16
28.13
7.2
6.2
—
—
—
0
0
560
3899
2.11
26.09
7.7
6.1
0.04
0.04
e9/l
0.17
494
3376
525
3573
2.09
25.96
8.1
6.4
8.51
8.75
%
1.26
493
3344
536
3678
2.09
25.89
8.1
6.2
28.60
28.16
%
0.41
511
3486
568
3990
2.10
25.66
7.7
6.1
1.97
1.94
e9/l
0.13
512
3544
528
3611
2.08
25.64
7.9
6.1
57.18
57.12
%
0.05
505
3442
557
3889
2.09
25.52
7.7
6.1
0.57
0.57
e9/l
0.30
490
3371
522
3567
2.07
25.26
8.2
6.3
0.67
0.68
%
0.20
487
3318
379
2315
2.08
24.81
3.5
2.6
55.22
63.90
u/l
1.91
356
2138
521
3572
2.05
24.81
8.1
6.2
2.86
2.77
%
0.42
487
3339
138
543
2.81
24.75
4.2
2.0
6.06
6.08
ph
0.06
86
366
447
2903
2.05
24.71
6.9
3.0
4.77
0.04
estimate
0.50
106
679
350
2098
2.08
23.91
5.7
2.6
0.02
0.05
estimate
0.32
98
661
566
4035
2.04
23.75
8.1
6.3
0.19
0.19
e9/l
0.24
506
3552
550
3883
2.03
23.69
6.5
6.4
10.33
11.24
umol/l
1.67
528
3703
731
5773
2.28
22.89
9.8
7.7
75.96
78.41
u/l
0.69
698
5443
526
3696
1.98
22.48
8.2
6.8
1.22
1.21
mmol/l
0.71
453
3184
597
4393
2.02
22.23
11.2
9.3
4.02
4.06
e9/l
0.15
538
3851
480
3299
1.95
21.56
2.4
2.0
99.10
96.35
pmol/l
0.63
272
1697
290
1674
2.07
21.51
2.1
1.7
0.80
1.19
mg/l
3.77
230
1267
222
1170
2.18
20.80
1.8
1.7
1142.14
1142.71
nmol/l
0.00
170
874
501
3527
1.92
20.59
2.8
2.4
77.38
76.99
nmol/l
0.11
454
3189
197
1013
2.20
19.51
2.7
2.5
94.28
116.87
ug/g
0.46
164
803
141
630
2.46
19.35
2.9
1.8
0.18
0.02
estimate
0.42
17
122
466
3300
1.83
17.86
7.7
6.2
1.21
1.21
mmol/l
0.15
427
3038
147
693
2.33
17.82
2.3
2.1
364.23
389.42
nmol/l
0.86
139
637
170
857
2.21
17.54
1.7
1.5
—
—
—
0
0
509
3753
1.79
16.60
3.9
2.9
114.28
112.87
ug/l
0.05
479
3501
575
4397
1.82
16.57
6.3
4.8
6.43
6.63
mmol/l
1.53
550
4095
236
1383
1.95
16.08
1.5
1.3
11.03
12.23
u/ml
0.09
91
543
422
2986
1.76
15.49
2.4
2.1
—
—
—
0
0
182
994
2.04
15.07
2.2
1.9
—
—
—
0
0
244
1474
1.89
15.05
1.5
1.3
18.07
32.31
iu/ml
3.72
81
472
856
7607
2.73
14.85
25.2
13.2
20.98
22.99
mg/l
1.13
732
6132
133
655
2.20
14.39
4.3
2.4
30.85
44.68
u/l
1.16
118
550
314
2096
1.75
13.73
3.2
3.1
1044.75
1179.51
ng/l
0.35
261
1750
320
2151
1.75
13.63
7.4
3.1
0.00
0.01
estimate
1.08
112
751
297
1955
1.77
13.61
2.7
2.2
2.65
2.88
mg/l
1.14
258
1682
331
2253
1.73
13.45
2.8
2.1
147.70
182.75
u/l
1.05
318
2149
187
1073
1.93
13.31
1.6
1.4
585.45
504.00
titre
0.24
44
245
442
3292
1.66
12.56
13.9
13.1
1.19
1.23
inr
0.73
375
2710
254
1632
1.77
12.49
1.6
1.5
2.12
2.35
g/l
1.68
168
1020
278
1833
1.74
12.48
4.9
3.7
93.69
91.29
%
0.92
268
1795
719
6108
1.80
12.22
5.9
4.4
14.67
14.71
pmol/l
0.16
669
5604
346
2433
1.68
12.19
2.7
2.2
—
—
—
0
0
151
829
1.98
12.15
1.4
1.4
—
—
—
0
0
125
647
2.08
11.82
1.2
1.2
—
—
—
0
0
305
2088
1.69
11.82
1.9
1.6
19.77
19.83
nmol/l
0.02
255
1746
161
916
1.92
11.64
1.7
1.4
—
—
—
0
0
360
2584
1.64
11.56
3.7
3.1
29.22
32.41
u/l
1.38
341
2449
854
7736
2.39
11.42
25.8
15.7
3.97
3.96
mmol/l
0.41
840
7549
277
1864
1.69
11.37
5.6
3.8
—
—
—
0
0
259
1712
1.71
11.35
6.8
3.1
1.02
1.93
kg/l
0.50
196
1103
429
3230
1.61
11.26
5.5
4.7
36.19
36.04
g/l
0.20
406
3011
213
1336
1.77
11.23
5.3
3.7
424.28
512.63
ng/l
0.13
157
1014
147
825
1.93
11.04
2.4
2.5
5.50
7.62
umol/l
1.12
124
732
851
7720
2.31
10.95
25.6
15.5
139.68
139.70
mmol/l
0.11
836
7551
808
7196
1.99
10.83
7.3
5.3
1.80
1.90
mu/l
1.67
759
6682
243
1611
1.69
10.41
2.6
2.0
—
—
—
0
0
86
404
2.24
10.38
7.6
8.5
25.49
24.98
mmol/l
0.56
86
404
274
1879
1.65
10.29
1.4
1.3
2.49
1.43
u/ml
0.40
67
517
64
266
2.51
10.16
2.7
1.6
—
—
—
0
0
460
3579
1.57
10.13
2.9
2.6
—
—
estimate
—
0
0
631
5285
1.61
10.06
4.0
3.1
45.22
46.66
u/l
0.15
598
4983
315
2247
1.61
10.05
7.5
5.9
—
—
—
0
0
352
2587
1.58
9.86
3.6
3.4
2.36
2.36
mmol/l
0.08
312
2352
309
2205
1.60
9.79
4.9
3.9
7.40
7.40
ph
0.51
238
1577
57
232
2.55
9.46
1.4
1.5
359.96
280.66
ug/g
2.20
34
138
98
505
2.05
9.34
3.3
2.4
31.55
19.77
au/ml
0.47
15
50
87
429
2.13
9.31
5.4
3.3
7.42
7.42
ph
0.03
70
365
92
464
2.09
9.29
1.7
1.3
64.66
40.77
au/ml
—
8
36
157
949
1.79
9.25
1.9
1.5
—
—
—
0
0
79
381
2.17
8.94
1.4
1.2
—
—
—
0
0
189
1215
1.70
8.94
4.5
3.2
0.82
0.82
mmol/l
0.22
180
1145
227
1532
1.64
8.90
1.7
1.7
46354580.08
16809103.23
pmol/l
0.27
192
1291
270
1904
1.59
8.83
2.9
2.5
334.66
337.54
umol/l
0.17
235
1684
165
1025
1.74
8.82
2.7
2.4
21.27
22.82
%
0.92
152
954
90
462
2.05
8.67
1.5
1.8
1.09
1.32
g/l
1.45
84
425
187
1209
1.69
8.63
2.8
2.3
13.30
13.29
umol/l
0.01
179
1131
71
333
2.23
8.61
4.5
2.7
1.01
1.02
ratio
2.49
64
305
95
502
1.99
8.45
1.2
1.2
—
—
—
0
0
106
584
1.92
8.35
3.3
3.0
9.27
10.80
g/l
4.85
101
528
102
557
1.93
8.25
7.4
9.6
—
—
—
0
0
20
46
4.42
8.18
2.2
1.4
4.98
5.77
u/l
0.83
15
38
120
693
1.84
8.18
4.3
3.8
7.39
7.35
ph
2.90
87
505
71
342
2.17
8.07
2.8
2.0
0.10
0.00
estimate
—
10
91
173
1116
1.68
8.01
2.7
2.3
2.38
2.35
g/l
0.27
161
1030
789
7128
1.74
8.00
7.2
5.9
38.73
38.87
mmol/mol
0.18
746
6680
364
2796
1.50
7.88
5.1
3.4
37.25
68.62
ng/l
0.57
235
1886
869
8126
2.19
7.45
28.8
17.4
75.22
74.44
umol/l
0.46
859
8029
36
132
2.80
7.36
5.1
3.4
—
—
—
0
0
852
7930
1.97
7.10
18.9
12.2
—
—
—
0
0
98
557
1.85
7.02
1.5
1.3
150.25
165.66
u/ml
0.13
93
515
97
552
1.85
6.92
3.1
2.9
66.33
67.28
g/l
0.70
89
510
95
545
1.83
6.61
3.9
3.3
76.07
81.08
ng/l
0.25
85
475
142
915
1.65
6.54
1.7
1.4
—
—
—
0
0
116
708
1.73
6.54
2.5
2.3
0.22
0.21
g/l
0.71
109
666
99
580
1.79
6.43
2.6
2.3
12.64
12.99
nmol/l
0.16
88
531
22
66
3.39
6.30
1.4
1.4
7.03
7.07
g/l
0.02
16
52
60
300
2.07
6.24
1.2
1.2
3.48
1.71
u/ml
—
6
17
106
640
1.74
6.21
4.7
2.9
2.61
1.87
mmol/l
1.51
91
546
193
1356
1.54
6.16
1.7
1.7
—
—
—
0
0
99
591
1.76
6.03
1.5
1.3
94.56
135.88
u/ml
0.90
34
237
22
68
3.29
6.03
1.4
1.4
—
—
—
0
0
414
3386
1.40
5.92
14.1
10.3
0.00
0.00
e9/l
0.49
339
2790
714
6440
1.48
5.75
27.2
16.8
13.53
13.55
%
0.11
704
6345
20
60
3.39
5.74
1.1
1.2
—
—
—
0
0
858
8081
1.88
5.74
15.3
11.1
25.09
26.09
u/l
1.24
841
7844
123
793
1.64
5.64
6.9
9.2
1.40
0.84
mmol/l
0.81
113
657
21
66
3.23
5.62
1.4
1.4
0.33
0.37
g/l
0.30
15
51
21
66
3.23
5.62
1.4
1.4
2.44
2.91
g/l
0.87
15
52
797
7373
1.59
5.55
5.8
4.8
5.88
5.87
mmol/l
0.06
742
6779
30
117
2.62
5.51
4.8
3.3
9.35
8.76
kpa
0.47
30
117
323
2557
1.40
5.47
4.5
3.4
—
0.57
—
0
7
19
57
3.38
5.46
1.4
3.8
71.58
125.88
nmol/l
0.98
19
57
78
447
1.81
5.46
1.8
2.7
—
—
—
0
0
123
803
1.61
5.36
7.0
9.2
7.42
7.42
ph
0.05
64
451
51
255
2.06
5.33
4.3
2.9
583.56
361.17
mg/l
0.31
16
105
19
58
3.32
5.32
1.1
1.2
—
—
—
0
0
101
629
1.68
5.30
1.7
1.4
—
—
—
0
0
53
270
2.02
5.27
1.5
1.6
4.84
7.88
u/ml
—
9
61
45
217
2.13
5.17
2.9
1.8
—
—
—
0
0
105
666
1.65
5.14
4.8
2.9
5.86
5.75
kpa
0.59
100
644
53
273
2.00
5.12
2.1
2.1
0.52
1.37
ug/l
1.45
45
248
105
668
1.65
5.08
5.1
3.0
7.38
7.38
ph
0.69
56
371
54
281
1.98
5.07
1.6
2.0
1.59
1.47
g/l
0.27
44
245
144
988
1.54
5.07
3.0
3.1
3.98
5.48
e9/l
1.49
121
854
29
117
2.53
5.00
4.8
3.3
3.32
2.62
mmol/l
0.66
23
78
29
117
2.53
5.00
4.8
3.3
5.17
5.06
kpa
0.32
29
117
320
2571
1.37
4.84
3.6
3.3
7.66
7.71
mmol/l
0.06
262
2197
54
286
1.94
4.84
1.6
1.9
22.13
20.98
s
0.40
46
259
37
170
2.23
4.81
1.2
1.2
—
—
—
0
0
50
259
1.98
4.77
1.4
1.2
—
—
—
0
0
104
675
1.61
4.65
7.7
10.0
120.26
120.99
g/l
0.15
104
660
93
587
1.65
4.65
2.5
2.6
71.72
71.47
e9/l
0.02
70
439
114
760
1.57
4.55
2.5
2.7
1.77
1.81
%
0.18
97
674
30
129
2.37
4.54
1.4
1.7
0.46
0.79
g/l
2.03
21
107
55
300
1.89
4.53
6.4
3.3
—
—
—
0
0
36
168
2.19
4.52
1.8
1.3
—
—
—
0
0
138
962
1.51
4.51
1.3
1.3
—
—
—
0
0
13
27
4.87
4.51
1.5
1.2
144.00
178.33
mmol/24h
0.71
13
27
133
920
1.52
4.50
2.3
1.8
—
—
—
0
0
61
345
1.82
4.49
1.7
1.6
3.24
7.15
iu/ml
1.25
16
76
49
258
1.95
4.48
1.1
1.2
—
—
—
0
0
45
230
2.01
4.47
1.3
1.3
1.67
3.42
u/ml
—
6
23
115
773
1.56
4.43
1.5
1.5
—
—
—
0
0
39
190
2.10
4.40
1.2
1.2
—
—
—
0
0
877
8398
1.89
4.37
35.1
20.8
253.04
253.79
e9/l
0.13
868
8239
877
8400
1.88
4.34
34.9
20.8
91.15
90.88
fl
1.02
871
8307
24
95
2.57
4.32
2.0
1.7
1.76
1.56
mmol/l
0.66
24
95
300
2422
1.35
4.30
4.3
4.0
4.60
6.90
mg/mmol
0.89
188
1473
877
8402
1.88
4.30
35.4
21.3
40.13
40.35
%
0.59
871
8303
877
8402
1.88
4.30
34.9
20.7
30.31
30.26
pg
0.39
871
8309
877
8402
1.88
4.30
35.0
20.8
4.46
4.50
e12/l
1.57
865
8220
71
426
1.72
4.29
3.6
2.8
124.98
129.81
g/l
1.09
66
412
877
8404
1.87
4.27
35.0
20.9
6.80
6.69
e9/l
0.81
864
8219
234
1818
1.38
4.27
5.2
4.6
—
—
—
0
0
53
292
1.86
4.25
1.1
1.1
—
—
—
0
0
40
200
2.05
4.23
1.2
1.1
—
—
—
0
0
294
2372
1.35
4.22
3.7
3.4
25.89
40.07
mg/l
1.25
186
1477
877
8407
1.87
4.22
35.3
21.0
134.41
135.33
g/l
1.15
872
8319
30
135
2.26
4.12
2.3
1.8
—
—
—
0
0
57
325
1.80
4.11
1.4
1.6
0.25
0.36
mg/l
0.91
25
142
25
105
2.42
4.01
1.6
1.3
—
—
—
0
0
59
343
1.77
3.99
2.5
2.4
—
—
—
0
0
82
522
1.63
3.98
4.1
3.4
4.52
4.61
pmol/l
0.21
73
457
67
405
1.71
3.96
8.6
12.5
15.51
15.78
%
0.31
67
389
29
131
2.25
3.96
1.9
1.4
152.55
155.59
au/ml
0.05
11
33
34
165
2.10
3.91
2.6
2.4
138.88
129.65
g/l
1.52
26
141
23
95
2.46
3.83
1.4
1.3
—
—
nmol/l
—
0
0
91
601
1.57
3.80
7.7
2.9
—
—
—
0
0
130
930
1.46
3.74
8.3
4.9
1.01
1.04
mmol/l
0.64
120
861
85
555
1.59
3.73
3.2
2.2
5.42
7.62
ug/l
0.48
71
494
55
321
1.76
3.69
1.2
1.2
—
—
—
0
0
31
149
2.12
3.66
1.5
1.2
242.45
204.24
u/ml
0.33
22
82
9
16
5.67
3.66
1.2
1.1
—
—
—
0
0
17
63
2.73
3.50
2.1
1.7
9.18
10.41
%
0.48
17
63
377
3216
1.29
3.50
2.0
1.9
1.40
1.36
mmol/l
0.41
325
2751
28
132
2.16
3.48
1.1
1.0
0.27
0.91
u/ml
1.55
15
46
39
209
1.90
3.44
4.9
2.8
7.42
7.41
ph
1.30
39
209
227
1810
1.34
3.43
5.6
4.7
1.97
2.11
ug/l
0.16
202
1637
55
330
1.71
3.37
1.3
1.7
—
—
—
0
0
8
14
5.75
3.34
1.4
1.1
—
—
—
0
0
55
332
1.70
3.30
2.7
2.2
3715.99
4721.96
u/l
0.16
20
137
55
332
1.70
3.30
1.3
1.7
—
—
—
0
0
55
333
1.69
3.27
1.3
1.7
—
—
—
0
0
43
243
1.81
3.24
1.4
1.4
10.74
9.35
u/l
0.34
36
198
78
517
1.56
3.24
3.4
3.2
105.68
191.27
ng/l
3.38
66
463
145
1090
1.39
3.18
3.3
2.9
0.66
0.72
ug/l
0.44
84
639
30
151
2.02
3.18
2.0
1.4
—
—
—
0
0
22
98
2.28
3.14
1.2
1.4
—
—
—
0
0
22
98
2.28
3.14
1.2
1.4
—
—
—
0
0
22
98
2.28
3.14
1.2
1.4
—
—
—
0
0
22
98
2.28
3.14
1.2
1.4
—
—
—
0
0
17
67
2.57
3.14
1.7
1.6
—
—
—
0
0
54
330
1.68
3.12
1.3
1.6
—
—
—
0
0
11
30
3.70
3.09
2.9
2.7
—
—
—
0
0
32
168
1.94
3.03
4.4
3.3
60.19
58.56
%
0.28
32
168
50
302
1.69
3.02
1.3
1.7
—
—
—
0
0
36
197
1.86
3.02
2.1
3.9
1.65
2.26
ratio
0.54
18
113
28
141
2.02
2.98
1.1
1.0
3.42
8.16
u/ml
1.30
18
75
15
57
2.66
2.97
1.9
1.8
40.81
39.43
%
0.12
15
57
806
7669
1.40
2.95
6.3
5.5
2.72
2.76
mmol/l
0.77
760
7150
90
629
1.48
2.94
1.4
1.4
—
—
—
0
0
13
46
2.85
2.92
1.1
1.2
—
—
—
0
0
63
408
1.58
2.91
1.8
1.7
—
—
—
0
0
25
122
2.08
2.89
1.4
2.1
—
—
—
0
0
29
150
1.96
2.87
1.1
1.1
—
—
—
0
0
28
143
1.99
2.87
3.1
4.5
—
—
—
0
0
38
216
1.79
2.84
2.9
4.1
39.06
73.42
mg/l
0.64
25
183
29
151
1.95
2.82
1.1
1.1
—
—
—
0
0
13
47
2.79
2.82
1.8
1.3
78.77
79.98
umol/l
0.05
13
47
797
7582
1.37
2.80
5.6
4.9
4.64
4.70
mmol/l
1.02
764
7095
23
110
2.12
2.80
1.6
1.3
0.52
16.97
nmol/l
0.50
23
104
57
364
1.60
2.80
1.2
1.1
—
—
—
0
0
10
28
3.60
2.79
1.0
1.1
105.38
134.62
nmol/l
—
5
21
38
218
1.78
2.76
2.9
4.1
35.84
63.27
mg/l
0.76
25
184
19
85
2.26
2.72
1.8
1.3
66.94
25.23
ng/l
0.40
19
85
761
7199
1.33
2.70
4.7
4.1
1.30
1.28
mmol/l
0.41
709
6637
63
416
1.55
2.69
1.5
1.3
33.63
27.60
iu/l
0.45
53
359
32
176
1.85
2.67
1.5
1.6
18209.86
14398.68
e6/l
0.11
21
127
19
86
2.23
2.65
1.9
1.3
—
—
—
0
0
13
49
2.68
2.63
1.2
1.2
—
—
—
0
0
23
114
2.04
2.58
1.5
1.3
—
0.64
nmol/l
—
0
8
23
114
2.04
2.58
1.3
1.2
—
—
—
0
0
26
135
1.95
2.57
1.3
1.1
1.33
2.17
u/ml
0.29
15
66
25
129
1.96
2.52
4.6
3.5
4.91
4.39
e9/l
0.39
25
129
60
399
1.54
2.50
6.6
6.3
—
—
—
0
0
9
26
3.49
2.48
8.4
2.2
—
—
—
0
0
182
1470
1.30
2.47
3.0
2.8
2.45
2.45
mmol/l
0.12
157
1333
36
211
1.73
2.46
1.3
1.2
—
1066.00
—
0
5
41
250
1.67
2.44
2.2
1.8
43.39
39.07
nmol/l
0.70
41
242
29
160
1.84
2.42
1.2
1.1
4.74
2.20
u/ml
0.43
17
80
6
12
5.02
2.40
1.8
1.4
—
—
—
0
0
16
71
2.28
2.35
1.8
1.7
91.38
89.71
%
0.54
16
71
18
85
2.14
2.30
1.6
1.6
54.00
54.28
%
0.01
13
58
789
7542
1.32
2.29
5.6
4.8
1.47
1.48
mmol/l
0.53
746
7006
6
13
4.64
2.27
1.2
1.2
0.01
0.09
u/ml
—
6
13
21
107
1.99
2.21
1.1
1.0
0.12
0.41
u/ml
—
9
28
47
306
1.56
2.18
1.3
1.3
208.47
229.12
miu/ml
0.19
27
156
22
115
1.94
2.17
1.0
1.1
2.54
1.98
eliau/ml
—
10
58
7
19
3.70
2.15
3.3
1.5
—
—
—
0
0
6
14
4.31
2.15
7.3
7.1
7.17
7.50
%
—
6
14
6
14
4.31
2.15
3.7
3.6
50.50
43.71
%
—
6
14
9
30
3.02
2.15
8.4
2.1
—
—
—
0
0
9
30
3.02
2.15
1.0
1.2
137.44
158.35
nmol/l
—
9
30
8
25
3.22
2.10
1.0
1.8
—
—
—
0
0
8
25
3.22
2.10
1.3
1.5
538.75
73.64
nmol/24h
—
8
25
19
96
2.00
2.06
1.6
1.3
0.20
0.39
nmol/l
0.43
14
68
6
15
4.02
2.04
1.3
1.4
7.65
8.86
mmol/l
—
6
15
23
125
1.86
2.04
1.1
1.0
—
—
—
0
0
10
39
2.58
1.94
1.4
3.4
720.80
970.67
u/ml
—
10
39
11
45
2.46
1.93
1.5
2.7
702.73
720.13
mg
0.02
11
45
15
71
2.13
1.93
1.0
1.1
—
—
—
0
0
21
113
1.88
1.93
1.2
1.1
1.06
4.18
u/ml
—
10
46
33
209
1.60
1.76
1.3
1.4
—
—
—
0
0
7
24
2.93
1.72
1.1
1.6
—
—
—
0
0
25
148
1.71
1.71
1.4
1.5
—
—
—
0
0
5
13
3.86
1.71
1.8
2.0
—
—
—
0
0
113
903
1.29
1.69
1.5
1.7
—
—
—
0
0
10
43
2.34
1.59
1.5
1.2
197.67
174.31
pmol/l
—
10
43
22
129
1.72
1.57
1.6
1.6
—
—
—
0
0
14
71
1.99
1.54
1.4
1.6
—
—
—
0
0
26
161
1.63
1.54
1.3
1.2
3.55
3.67
mmol/l
0.43
26
153
21
123
1.72
1.52
1.3
1.0
1.27
2.99
u/ml
—
10
61
20
118
1.71
1.42
1.3
1.2
—
—
—
0
0
26
165
1.59
1.41
6.7
3.3
—
—
—
0
0
84
665
1.29
1.38
5.1
4.1
0.66
0.59
%
0.18
35
194
6
23
2.62
1.37
3.8
3.7
—
—
—
0
0
21
130
1.63
1.27
1.3
1.2
2.45
3.52
u/ml
0.64
11
44
83
665
1.27
1.26
1.6
1.7
3.31
3.49
mmol/l
0.81
55
484
6
25
2.41
1.24
1.5
1.8
—
—
—
0
0
10
49
2.05
1.22
2.0
1.2
6.50
6.39
ug/l
—
10
41
10
49
2.05
1.22
1.2
1.4
0.99
1.13
promille
—
10
39
5
19
2.64
1.21
4.2
2.5
—
—
—
0
0
86
697
1.26
1.19
5.6
4.3
0.79
0.84
%
0.07
34
213
19
117
1.64
1.18
1.1
1.1
—
—
—
0
0
19
117
1.64
1.18
1.6
1.3
—
—
—
0
0
12
64
1.89
1.18
1.2
1.1
—
—
—
0
0
20
125
1.61
1.18
1.4
1.3
37.15
24.82
u/l
0.80
15
105
5
20
2.51
1.15
1.0
1.0
—
—
—
0
0
5
20
2.51
1.15
1.0
1.1
—
—
—
0
0
13
73
1.79
1.11
1.2
1.3
477296.50
296131.89
e6/l
—
8
47
7
31
2.27
1.10
2.3
2.3
38.74
41.29
g/l
—
7
31
11
59
1.87
1.07
1.3
1.1
—
—
—
0
0
5
22
2.28
1.03
4.6
3.6
0.65
0.60
mmol/l
—
5
22
81
665
1.24
1.03
5.8
4.3
0.03
0.09
%
0.70
29
180
7
34
2.07
1.03
1.4
1.4
0.54
0.51
e9/l
—
7
34
29
205
1.43
1.02
3.5
3.2
1.38
2.35
index
0.60
13
104
23
155
1.50
1.02
1.3
1.5
23.12
22.64
e6/l
0.01
17
108
23
157
1.48
0.96
1.3
1.5
58.67
682.83
e6/l
0.64
18
114
17
109
1.57
0.94
1.0
1.2
—
—
—
0
0
13
78
1.68
0.92
3.4
2.3
1.22
1.19
mmol/l
0.89
13
78
18
119
1.52
0.88
1.1
1.1
—
—
—
0
0
13
79
1.65
0.88
3.4
2.3
106.08
105.85
mmol/l
0.05
13
79
13
79
1.65
0.88
3.4
2.3
4.04
4.03
mmol/l
0.03
13
79
21
144
1.47
0.88
14.1
10.8
105.67
105.38
mmol/l
0.11
21
131
21
144
1.47
0.88
14.1
10.8
10.43
11.31
mmol/l
1.02
21
131
11
64
1.73
0.86
1.4
1.1
367.18
390.11
nmol/l
0.15
11
54
17
113
1.51
0.82
1.4
2.4
—
—
—
0
0
6
32
1.88
0.82
1.2
4.5
16.07
16.88
%
—
6
32
12
73
1.65
0.82
1.1
1.2
111.25
114.71
pmol/l
0.10
12
73
13
81
1.61
0.81
1.1
1.1
—
—
—
0
0
53
429
1.25
0.80
9.4
8.0
25.92
24.36
mmol/l
2.75
53
407
10
58
1.73
0.80
1.2
1.0
—
—
—
0
0
38
295
1.30
0.79
9.7
7.1
0.92
0.90
%
0.10
38
277
18
253
0.71
0.72
20.2
8.8
—
—
—
0
0
7
39
1.80
0.72
1.1
1.0
1690.00
1577.44
miu/ml
—
7
39
7
40
1.76
0.71
1.6
1.3
—
—
—
0
0
9
58
1.56
0.70
1.7
1.9
28.41
21.87
nmol/l
—
9
53
5
27
1.86
0.68
1.0
1.8
33.60
34.22
%
—
5
27
68
577
1.19
0.68
4.8
3.6
1.23
1.23
mmol/l
0.11
61
497
86
745
1.17
0.68
3.4
4.4
3.13
24.92
ug/l
1.34
72
610
14
94
1.50
0.67
2.6
2.3
—
—
—
0
0
78
672
1.18
0.66
6.1
4.6
0.00
0.08
%
0.99
27
162
5
29
1.73
0.64
1.2
1.0
149.80
187.81
iu/ml
—
5
29
20
147
1.37
0.62
7.9
3.4
23.26
26.97
mg/l
0.17
13
102
11
73
1.51
0.56
1.5
1.8
—
—
—
0
0
10
65
1.54
0.55
1.8
2.6
—
—
—
0
0
8
125
0.64
0.54
1.6
1.7
—
—
—
0
0
15
108
1.40
0.53
2.1
2.3
—
—
—
0
0
10
68
1.48
0.47
1.3
1.1
18.98
14.76
u/ml
—
5
30
5
83
0.60
0.46
1.2
1.3
6.46
6.51
mmol/l
—
5
77
18
138
1.31
0.45
2.8
2.4
145.67
58.44
ug/min
0.29
12
79
5
84
0.59
0.45
2.0
1.3
—
—
—
0
0
7
51
1.38
0.44
1.9
1.4
37.55
36.35
nmol/l
—
7
42
8
56
1.43
0.42
1.8
1.5
—
—
—
0
0
8
59
1.36
0.41
1.1
1.3
—
—
—
0
0
8
60
1.34
0.40
1.1
1.1
74.53
44.98
mg/l
—
8
47
8
61
1.31
0.39
1.3
1.1
268.00
297.00
mg/l
—
8
56
301
3139
0.94
0.38
3.1
3.0
—
—
—
0
0
30
252
1.20
0.38
2.5
2.1
3.69
25.51
iu/l
0.51
14
108
5
36
1.39
0.38
1.0
1.3
—
—
—
0
0
5
76
0.66
0.36
1.4
1.2
—
—
—
0
0
19
154
1.24
0.34
1.6
1.4
0.35
0.37
nmol/l
0.08
14
126
6
47
1.28
0.32
1.0
1.3
0.72
0.53
ratio
—
6
22
19
156
1.22
0.31
8.0
2.2
1.26
0.84
nmol/l
1.49
14
134
18
148
1.22
0.29
1.7
1.8
—
—
—
0
0
7
57
1.23
0.29
1.0
1.2
—
—
—
0
0
11
85
1.30
0.28
1.7
1.9
32.45
32.13
pg
0.08
11
85
242
2330
1.05
0.27
1.6
1.5
—
—
—
0
0
5
38
1.32
0.23
3.8
1.8
86.80
105.22
ng/l
—
5
38
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
5
43
1.16
0.21
2.2
3.7
0.80
0.86
index
—
5
43
30
268
1.12
0.21
1.2
1.6
56.68
61.82
ug/l
0.30
25
236
11
89
1.24
0.21
1.7
2.1
0.82
0.95
%
—
5
59
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
6
48
1.25
0.20
1.3
1.8
—
—
—
0
0
7
63
1.11
0.17
1.7
1.7
—
—
—
0
0
25
226
1.11
0.15
3.0
4.2
1.25
1.36
mmol/l
0.35
25
220
9
82
1.10
0.15
1.1
1.2
—
—
—
0
0
33
304
1.09
0.14
1.3
1.1
0.86
0.90
g/l
0.56
33
304
32
295
1.09
0.14
1.2
1.1
1.50
1.53
g/l
0.38
32
295
8
99
0.81
0.13
1.0
1.2
—
—
—
0
0
19
208
0.91
0.10
1.3
1.6
—
—
—
0
0
11
97
1.14
0.09
1.7
2.2
—
—
—
0
0
8
76
1.05
0.07
2.5
2.7
—
—
—
0
0
10
89
1.12
0.07
1.0
1.1
—
—
—
0
0
19
202
0.94
0.05
1.3
1.5
—
—
—
0
0
46
468
0.98
0.01
1.4
1.6
1123.25
958.29
mu/l
0.92
37
401
14
146
0.96
0.00
1.5
1.1
14.46
22.22
au/ml
—
5
45
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.7
—
188.00
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
69
1.01
-0.00
1.4
1.3
—
—
—
0
0
8
88
0.91
-0.00
1.5
1.4
36.71
33.55
g/l
—
8
80
0
5
0.00
-0.00
0.0
2.2
—
0.54
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
16.41
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
402.00
—
0
5
0
6
0.00
-0.00
0.0
1.5
—
0.15
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
66.58
—
0
6
0
7
0.00
-0.00
0.0
1.0
—
20.04
—
0
7
0
6
0.00
-0.00
0.0
1.7
—
527.35
—
0
6
0
8
0.00
-0.00
0.0
1.8
—
40.50
—
0
8
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint N14_URETHRITISANDURSYNDR and mortality.

Females

Parameter HR [95% CI] p-value
N14_URETHRITISANDURSYNDR 1.345 [1.17, 1.54] < 0.001
Birth year 0.997 [0.99, 1.01] 0.536

During the follow-up period (1.1.1998 — 31.12.2019), 608 out of 3107 females with N14_URETHRITISANDURSYNDR died.

Males

Parameter HR [95% CI] p-value
N14_URETHRITISANDURSYNDR 1.552 [1.27, 1.89] < 0.001
Birth year 0.986 [0.98, 1.0] 0.004

During the follow-up period (1.1.1998 — 31.12.2019), 327 out of 1942 males with N14_URETHRITISANDURSYNDR died.

Mortality risk

Mortality risk for people of age

years, who have N14_URETHRITISANDURSYNDR.

N-year risk Females Males
1 0.172% 0.323%
5 0.933% 1.761%
10 2.163% 4.378%
15 4.029% 8.145%
20 7.197% 14.021%

Relationships between endpoints

↥

Index endpoint: N14_URETHRITISANDURSYNDR – Urethritis and urethral syndrome

GWS hits: 2

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data